Sentence,class,file
"Available from: http://www.fhi360.org/sites/default/files/media/ documents/  Contraception for PMTCT enrh.pdf , accessed on  February 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/48/13/IJMR-143-464.PMC4928553.pdf
"Available from:  http://pdf.usaid.gov/pdf_docs/Pnadi792.pdf , accessed on  April 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/48/13/IJMR-143-464.PMC4928553.pdf
"Available from: http://naco.gov.in/   upload/Policies%20&%20Guidelines/20,%20Operational%20 Guidelines%20for%20Integr ated%20Counseling%20and%20 Testing%20Centres.pdf, accessed on February 21, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/9b/IJMR-143-495.PMC4928557.pdf
"Available  from: http://www.naco.gov.in , accessed on March 20, 2015.",OADS,/arxiv_data1/oa_pdf/4f/a3/IJMR-143-518.PMC4928561.pdf
"Available from:  http://www.naco.gov.in , accessed on March 24, 2016.",OADS,/arxiv_data1/oa_pdf/4f/a3/IJMR-143-518.PMC4928561.pdf
"Available from: http://www.naco.gov.in , accessed on March  24, 2016.",OADS,/arxiv_data1/oa_pdf/4f/a3/IJMR-143-518.PMC4928561.pdf
Available from: http://stacks.cdc.,Non-OADS,/arxiv_data1/oa_pdf/4f/a3/IJMR-143-518.PMC4928561.pdf
"Available from: http://www.naco.gov.in , accessed on March  24, 2016.",OADS,/arxiv_data1/oa_pdf/4f/a3/IJMR-143-518.PMC4928561.pdf
Available from: https://www.webmedcentral.,Non-OADS,/arxiv_data1/oa_pdf/4c/38/IJMR-143-521.PMC4928562.pdf
"Available from:  http://www.strobe-statement.org/index.php?id=available- checklists , accessed on November 12, 2015.Indian J Med Res 143, April 2016, pp 525-526 DOI:10.4103/0971-5916.184291 Correspondence Adherence to research reporting guidelines is needed",Non-OADS,/arxiv_data1/oa_pdf/04/3f/IJMR-143-525.PMC4928563.pdf
"Key Words:  Dissection, Superior mesenteric artery, Natural course Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/87/vsi-32-037.PMC4928602.pdf
Vasc Spec Int 2016;32(2):37-43  • http://dx.doi.org/10.5758/vsi.2016.32.2.37Review,Non-OADS,/arxiv_data1/oa_pdf/4c/87/vsi-32-037.PMC4928602.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.37 Current Understandings of SISMAD 39of the SMA, the presence of mesentery hematoma,  any signs of bowel ischemia, and the presence of other  concurrent arterial dissections.",Non-OADS,/arxiv_data1/oa_pdf/4c/87/vsi-32-037.PMC4928602.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.37 Current Understandings of SISMAD 41on an outpatient basis.,Non-OADS,/arxiv_data1/oa_pdf/4c/87/vsi-32-037.PMC4928602.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.37 Current Understandings of SISMAD 43Self-limited spontaneous dissection  of the main trunk of the superior  mesenteric artery.,Non-OADS,/arxiv_data1/oa_pdf/4c/87/vsi-32-037.PMC4928602.pdf
"Key Words:  Abdominal aortic aneurysm, Therapeutic embolization, Intermittent  claudication, Risk factors Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/0b/vsi-32-044.PMC4928603.pdf
Vasc Spec Int 2016;32(2):44-50  • http://dx.doi.org/10.5758/vsi.2016.32.2.44,Non-OADS,/arxiv_data1/oa_pdf/49/0b/vsi-32-044.PMC4928603.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.44 Claudication after IIA Embolization 45deployed for aneurysm exclusion.,Non-OADS,/arxiv_data1/oa_pdf/49/0b/vsi-32-044.PMC4928603.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.44 Claudication after IIA Embolization 47identify the risk factors for BC after IIA embolization, we  performed univariate and multivariate analysis ( Table 4 ).",OADS,/arxiv_data1/oa_pdf/49/0b/vsi-32-044.PMC4928603.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.44 Claudication after IIA Embolization 49Bakal CW, Creager MA, Halperin  JL, et al.",OADS,/arxiv_data1/oa_pdf/49/0b/vsi-32-044.PMC4928603.pdf
"Key Words:  Arteriovenous fistula, Basilic vein, Renal dialysis Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/87/vsi-32-051.PMC4928604.pdf
Vasc Spec Int 2016;32(2):51-56  • http://dx.doi.org/10.5758/vsi.2016.32.2.51,Non-OADS,/arxiv_data1/oa_pdf/f1/87/vsi-32-051.PMC4928604.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.51 300 Cases of Upper Arm Basilic Vein Transposition 53allowed to course from the axilla over the biceps brachii  muscle.,Non-OADS,/arxiv_data1/oa_pdf/f1/87/vsi-32-051.PMC4928604.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.51 300 Cases of Upper Arm Basilic Vein Transposition 55reported re-performance of AVBG in 89% of patients who  failed BaVT.,Non-OADS,/arxiv_data1/oa_pdf/f1/87/vsi-32-051.PMC4928604.pdf
"Key Words:  Obturator bypass, Graft, Infection Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/37/vsi-32-057.PMC4928605.pdf
Vasc Spec Int 2016;32(2):57-61  • http://dx.doi.org/10.5758/vsi.2016.32.2.57,Non-OADS,/arxiv_data1/oa_pdf/f9/37/vsi-32-057.PMC4928605.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.57 Aortobifemoral Reconstruction with Right Extra-Anatomic Obturator Bypass 59angiography with three-dimensional reconstruction  demonstrated the patent aorto-bifemoral graft ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/f9/37/vsi-32-057.PMC4928605.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.57 Aortobifemoral Reconstruction with Right Extra-Anatomic Obturator Bypass 611) Leriche R, Morel A.",Non-OADS,/arxiv_data1/oa_pdf/f9/37/vsi-32-057.PMC4928605.pdf
"Key Words:  Subclavian artery occlusion, Artery bypass, Upper limb salvage Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/9f/vsi-32-062.PMC4928606.pdf
Vasc Spec Int 2016;32(2):62-64  • http://dx.doi.org/10.5758/vsi.2016.32.2.62,Non-OADS,/arxiv_data1/oa_pdf/67/9f/vsi-32-062.PMC4928606.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.62 Femoro-Axillary Artery Retrograde Bypass 63DISCUSSION SCA occlusion causes insufficient blood flow with  various symptoms such as vertigo, arm weakness or numb - ness.",Non-OADS,/arxiv_data1/oa_pdf/67/9f/vsi-32-062.PMC4928606.pdf
"Key Words:  Acute limb ischemia, Cold leg, Arterial thrombosis, Acute promyelocytic  leukemia, Acute myeloid leukemia-M3 Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/ca/vsi-32-065.PMC4928607.pdf
Vasc Spec Int 2016;32(2):65-71  • http://dx.doi.org/10.5758/vsi.2016.32.2.65,Non-OADS,/arxiv_data1/oa_pdf/20/ca/vsi-32-065.PMC4928607.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.65 Recurrent Arterial Thrombosis in Leukemia 67popliteal/pedal pulses.,Non-OADS,/arxiv_data1/oa_pdf/20/ca/vsi-32-065.PMC4928607.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.65 Recurrent Arterial Thrombosis in Leukemia 69case (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/20/ca/vsi-32-065.PMC4928607.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.65 Recurrent Arterial Thrombosis in Leukemia 7122) Belizna C, Pistorius MA, Planchon B.",Non-OADS,/arxiv_data1/oa_pdf/20/ca/vsi-32-065.PMC4928607.pdf
"Key Words:  Venous thrombosis, Laser therapy, Catheter ablation Copyright © 2016, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/4f/vsi-32-072.PMC4928608.pdf
Vasc Spec Int 2016;32(2):72-76  • http://dx.doi.org/10.5758/vsi.2016.32.2.72,Non-OADS,/arxiv_data1/oa_pdf/68/4f/vsi-32-072.PMC4928608.pdf
"http://dx.doi.org/10.5758/vsi.2016.32.2.72 Endovenous Heat-Induced Thrombosis 73hours of thrombolytic therapy, but there was no significant  improvement.",Non-OADS,/arxiv_data1/oa_pdf/68/4f/vsi-32-072.PMC4928608.pdf
http://dx.doi.org/10.5758/vsi.2016.32.2.72 Endovenous Heat-Induced Thrombosis 75days.,Non-OADS,/arxiv_data1/oa_pdf/68/4f/vsi-32-072.PMC4928608.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/c5/tcrm-12-1017.PMC4928622.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1017–1022Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1017ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10780 8 Effects of no-reflow phenomenon on ventricular  systolic synchrony in patients with acute anterior  myocardial infarction after percutaneous coronary  intervention le Wang1 gang liu1 Jun liu1 Mingqi Zheng1 liang li2 1Department of Cardiology, The First  hospital of hebei Medical University,   2Department of Cardiology, The  second hospital of hebei Medical  University, shijiazhuang, hebei,   People’s Republic of ChinaObjectives:  The aim of this study was to investigate the effect of no-reflow phenomenon  on ventricular systolic synchrony via myocardial blush grades (MBGs) in patients with acute  anterior myocardial infarction after percutaneous coronary intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/20/c5/tcrm-12-1017.PMC4928622.pdf
"Correspondence: liang li Department of Cardiology, The second  hospital of hebei Medical University,  no 215, West heping Road, shijiazhuang  050000, hebei, People’s Republic  of China Tel +86 186 3010 3882 email leinll@aliyun.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: No-reflow and ventricular systolic synchrony DOI: http://dx.doi.org/10.2147/TCRM.S107808",Non-OADS,/arxiv_data1/oa_pdf/20/c5/tcrm-12-1017.PMC4928622.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/20/c5/tcrm-12-1017.PMC4928622.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c5/tcrm-12-1017.PMC4928622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/42/16/ceor-8-305.PMC4928623.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/42/16/ceor-8-305.PMC4928623.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/42/16/ceor-8-305.PMC4928623.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 305ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/42/16/ceor-8-305.PMC4928623.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 305 CORRIGENDUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S107803Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]  Cher DJ, Frasco MA, Arnold RJ, Polly DW .",Non-OADS,/arxiv_data1/oa_pdf/42/16/ceor-8-305.PMC4928623.pdf
The authors report no other conflicts of interest in this work.Journal name: ClinicoEconomics and Outcomes Research Article Designation: CORRIGENDUMY ear: 2016V olume: 8Running head verso: Cher et alRunning head recto: DOI: http://dx.doi.org/10.2147/CEOR.S107803,Non-OADS,/arxiv_data1/oa_pdf/42/16/ceor-8-305.PMC4928623.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 843–856Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  843RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7243 6 Orthogeriatric care: improving patient outcomes Francisco José Tarazona- Santabalbina1,2 Ángel Belenguer-v area1,2 eduardo Rovira1,2 David Cuesta-Peredó1,2 1Geriatric Medicine Unit, Internal  Medicine Department, Hospital  Universitario de la Ribera, 2Medical  School, Universidad Católica de  valencia San vicente Mártir, valencia,   SpainAbstract:  Hip fractures are a very serious socio-economic problem in western countries.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
"A total of 1.3 million hip fractures were diagnosed in 1990,1 and this figure is expected  to increase to over 6 million by 2050.2 A total of 80% of the fractures in women and  50% of those in men occur at over 70 years of age.3 Ninety percent of the fractures  are a result of falls from standing height.4 The mortality rate can reach 10% during  admission in hospital and 30% after 12 months.5,6 Only 50% of those who survive  recover the functional level they had before the accident7,8 and 25% of the patients  who were independent before the fall require admission to a home for the elderly.9  The estimated socio-economic costs represent 0.1% of the global health care costs  worldwide, reaching 1.4% in the more developed countries.1 The mean age of  patients with hip fracture10 and the presence of comorbidity11 are the main reasons  warranting orthogeriatric comanagement of these individuals, which reduces the risk  of perioperative complications, functional deterioration, and mortality.12  In this regard, geriatric joint trauma management units were introduced in the UK  in the mid-twentieth century.13 However, it is over the last 20 years that the design and  implementation of coordinated perioperative models have increased.14 Such coordinated  patient care has been shown to reduce in-hospital complications,15,16 hospital stay  and readmissions,17 disability, and in-hospital mortality.16 A recent editorial18 considers that geriatric medicine improves our knowledge of  the extra-traumatology factors that complicate the patient’s course and influence the Correspondence: Francisco José  Tarazona-Santabalbina  Hospital Universitario de la Ribera,  Carretera de Corbera, e46600 Alzira,  valencia, Spain Tel +34 962 458 387 Fax +34 962 458 151 email fjtarazona@hospital-ribera.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Tarazona-Santabalbina et al Running head recto: Orthogeriatric care: improving outcomes DOI: http://dx.doi.org/10.2147/CIA.S72436 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
Or use: http://youtu.be/fTNFyeBAkk Ivideo abstract,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
"Available from: http://www.bgs.org.u k. Accessed  January 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
"Available from: http://www.nice.org.u k. Accessed  January 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/cia-11-843.PMC4928624.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/73/tcrm-12-1009.PMC4928625.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1009–1015Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1009Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8073 2 New developments in the treatment of  chemotherapy-induced neutropenia: focus  on balugrastim Michele Ghidini1 Jens Claus Hahne2 Francesco Trevisani3 Stefano Panni1 Margherita Ratti1 Laura T oppo1 Gianluca T omasello1 1Medical Department, Division of  Oncology, ASST di Cremona, Ospedale  di Cremona, Cremona, italy; 2Division  of Molecular Pathology, The institute of  Cancer Research, London and Sutton,   UK; 3Department of Urology, Unit of  Urology/Division of Oncology, iRCCS  Ospedale San Raffaele, URi, Milan, italyAbstract:  Neutropenia and febrile neutropenia are two major complications of chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/4c/73/tcrm-12-1009.PMC4928625.pdf
"It has been shown to primarily affect neutrophil Correspondence: Michele Ghidini Medical Department, Division of Oncology,  ASST di Cremona, Ospedale di Cremona,  Largo Priori n 1, 26100 Cremona, italy Tel +39 372 405 248 Fax +39 372 405 702 email micheleghidini@outlook.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Ghidini et al Running head recto: Balugrastim for chemotherapy-induced neutropenia DOI: http://dx.doi.org/10.2147/TCRM.S80732 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/4c/73/tcrm-12-1009.PMC4928625.pdf
Or use: http://youtu.be/1MhijIe3IF svideo abstract,Non-OADS,/arxiv_data1/oa_pdf/4c/73/tcrm-12-1009.PMC4928625.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4c/73/tcrm-12-1009.PMC4928625.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/73/tcrm-12-1009.PMC4928625.pdf
"However, in  postmenopausal patients, the addition of ZA resulted in a significant, near doubling of the pCRb  rate (10.8% for CT only versus 17.7% with CT+ZA; odds ratio [OR] 2.14, 95% confidence  interval [CI] 1.01–4.55) and a non-significant benefit of the pCR rate (7.8% for CT only versus  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a2/3f/nihms-797121.PMC4928630.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.ejca.2015.10.011 HHS Public Access Author manuscript Eur J Cancer .,OADS,/arxiv_data1/oa_pdf/a2/3f/nihms-797121.PMC4928630.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/dddt-10-2047.PMC4928654.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2047–2048Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2047LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11337 3 Anti-dengue drug: viral polyprotein, a potential  target Syed Uzair Mahmood Maryam Mushtaq Maryam Jamil Syed Sindh Medical College, Jinnah Sindh  Medical University, Karachi, PakistanDear editor We would like to add our views regarding the article “Identification of covalent active  site inhibitors of dengue virus protease” by Koh-Stenta et al.1 The article suggests  the development of a possible drug to combat dengue virus.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/dddt-10-2047.PMC4928654.pdf
"It could be possible to manufacture drugs that stop the virus from  entering the cell (entry inhibitors) or drugs that inhibit the strand of RNA (5 ′ capping)  inhibiting viral replication.6 Disclosure The authors report no conflicts of interest in this communication.Correspondence: Syed Uzair Mahmood 43-8-D, Block 6, PeCHS, Karachi 75400,  Pakistan Tel +92 33 1846 1557 email uzair.hbb@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Letter Y ear: 2016 Volume: 10 Running head verso: Mahmood et al Running head recto: Anti-dengue drug: viral polyprotein, a potential target DOI: http://dx.doi.org/10.2147/DDDT.S113373",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/dddt-10-2047.PMC4928654.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/dddt-10-2047.PMC4928654.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/3c/dddt-10-2047.PMC4928654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2016:9 117–128Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 117 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S85615Smoking cessation strategies for patients with  asthma: improving patient outcomes Jennifer L Perret1–3  Billie Bonevski4  Christine F McDonald2,3,5  Michael J Abramson6,7 1Allergy and Lung Health Unit, The  University of Melbourne, Melbourne,   VIC, 2Institute for Breathing & Sleep,   Melbourne, VIC, 3Department of  Respiratory and Sleep Medicine,  Austin Hospital, Melbourne, VIC,   4School of Medicine & Public Health,   University of Newcastle, NSW,   5Department of Medicine, The  University of Melbourne, Melbourne,  VIC,  6School of Public Health  & Preventive Medicine, Monash University, Melbourne, VIC,  7Allergy,   Immunology & Respiratory Medicine,  The Alfred Hospital, Melbourne, VIC,  AustraliaAbstract: Smoking is common in adults with asthma, yet a paucity of literature exists on smoking  cessation strategies specifically targeting this subgroup.",Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
"They were excluded if primarily related to COPD and/or practice change, rather than to asthma patient outcomes (n=16).Correspondence: Jennifer L Perret   Allergy and Lung Health Unit, Center for  Epidemiology and Statistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 3, 207 Bouverie St, Melbourne, VIC 3010, Australia Tel +61 3 8344 0900 Fax +61 3 9349 5815   Email jperret@unimelb.edu.auJournal name: Journal of Asthma and Allergy Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Perret et alRunning head recto: Smoking cessation strategies for patients with asthmaDOI: http://dx.doi.org/10.2147/JAA.S85615",Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
103 The National Asthma  Council offers a website for adolescents with a link to this program: http://www.asthmahandbook.org.au/populations/ adolescents/self-management.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
"The following website: http://www.asthmahandbook.org.au/management/adults, may be appropriate for relatively well educated adults.",Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
Available from: http://profiles.nlm.nih.gov/NN/B/B/Z/D.,OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
Available from: http://www.aihw.gov.au/publications/index.cfm/title/10518.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
"Journal of Asthma and Allergy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/fd/60/jaa-9-117.PMC4928655.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/45/ppa-10-1151.PMC4928656.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1151–1158Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1151OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10643 7 coping strategies and self-stigma in patients  with schizophrenia-spectrum disorders Michaela holubova1,2 Jan Prasko1 radovan hruby3 Klara latalova1 Dana Kamaradova1 Marketa Marackova1 Milos slepecky4 T erezia gubova2 1Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacký  University Olomouc, University  hospital Olomouc, Olomouc,   czech republic; 2Department of  Psychiatry, hospital liberec, liberec,   czech republic; 3Private Psychiatric  Practice, Martin, slovak republic;   4Department of Psychology sciences,   Faculty of social science and health  care, constantine the Philosopher  University, nitra, slovak republicBackground:  Maladaptive coping strategies may adversely disturb the overall functioning  of people with mental disorders.",Non-OADS,/arxiv_data1/oa_pdf/1a/45/ppa-10-1151.PMC4928656.pdf
"The authors of the Stress Coping  Style Questionnaire (Stressverarbeitungsfragebogen [SVF]-78 questionnaire) divided  coping strategies into positive and negative because of their maladaptive or adaptive  potential in solving a stressful situation.4 The strategies which are flexible and efficient correspondence: Jan Prasko Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacký  University Olomouc, 8 Křížkovského  street, Olomouc 77147, czech republic email praskojan@seznam.c z Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Holubova et al Running head recto: Coping strategies and self-stigma in schizophrenia DOI: http://dx.doi.org/10.2147/PPA.S106437",Non-OADS,/arxiv_data1/oa_pdf/1a/45/ppa-10-1151.PMC4928656.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/1a/45/ppa-10-1151.PMC4928656.pdf
"Ferney- Voltaire, France: WMA; 2013. http://www.wma.net/en/30publications/   10policies/b 3.",Non-OADS,/arxiv_data1/oa_pdf/1a/45/ppa-10-1151.PMC4928656.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2069–2080Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2069Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10526 3 Secukinumab for rheumatology: development and  its potential place in therapy Marije i Koenders wim B van den Berg experimental Rheumatology, Radboud  University Medical Center, Nijmegen,   the NetherlandsAbstract:  Rheumatic disease is not a single disorder, but a group of more than 100 diseases  that affect joints, connective tissues, and/or internal organs.",Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
"This chronic auto - immune disease has been associated with genetic predisposition (eg, HLA-DR4, cyto - toxic T-lymphocyte-associated antigen [CTLA]-4, and PTPN22) and environmental Correspondence: Marije i Koenders experimental Rheumatology, Radboud  University Medical Center, PO Box 9101,  6500 HB Nijmegen, the Netherlands Tel +31 24 361 6619 Fax +31 24 354 0403 email m arije.koenders@radboudumc.n l Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Koenders and van den Berg Running head recto: Secukinumab in rheumatic diseases DOI: http://dx.doi.org/10.2147/DDDT.S105263",Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
Available from: http://www.fda.gov/NewsEvents/News room/ PressAnnouncements/ucm43 0969.ht m  24.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
Available from: https://www.novartis.co m/news/media-releases/ novartis -receives-two-new-fda-approvals -cosentyx-treat-patients- ankylosin g  25.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
Available from:  https://clinicaltrials.gov/ct2/show/ NCT0137701 2  90.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
Available from: https://www.novartis.co m/news/ media- releases /novartis -receives-two-landmark-europ ean-approvals- cosentyx-treat-pati ents  93.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/dddt-10-2069.PMC4928657.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/be/f2/clep-8-241.PMC4928658.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/be/f2/clep-8-241.PMC4928658.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Positive predictive value of diagnosis coding for  hemolytic anemias in the Danish National Patient  Register Dennis Lund Hansen1 Ulrik Malthe Overgaard2 Lars Pedersen3 Henrik Frederiksen1,3 1Department of Haematology,   Odense University Hospital, Odense,   2Department of Haematology, Herlev  Hospital, Herlev, 3Department  of Clinical Epidemiology, Aarhus  University Hospital, Aarhus, Denmark Correspondence: Dennis Lund Hansen   Department of Haematology, Odense  University Hospital, Sdr Boulevard 29,  DK-5000, Odense C, Denmark   T el +45 6541 2923   Email dlh@dadlnet.d kPurpose:  The nationwide public health registers in Denmark provide a unique opportunity for  evaluation of disease-associated morbidity if the positive predictive values (PPVs) of the primary  diagnosis are known.",Non-OADS,/arxiv_data1/oa_pdf/be/f2/clep-8-241.PMC4928658.pdf
"Available from:  http://www.epidata.d k. Accessed on March 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/be/f2/clep-8-241.PMC4928658.pdf
Available from: http://www.uptodate.com/contents/approach-to-the- diagnosis-of-hemolytic-anemia-in-the-adult?source =search_result &search =hemolysis&selectedTitle =1%7E15 0.,Non-OADS,/arxiv_data1/oa_pdf/be/f2/clep-8-241.PMC4928658.pdf
"Abbreviation:  ICD, International Classification of Diseases.Supplementary materials Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/be/f2/clep-8-241.PMC4928658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 275–278Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 275 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S111812Integration of quality improvement and   cost-efficiency through industrial   improvement techniques Jasper P Vink1  Maxime T Rigaudy1,2  Karl O Elmqvist1 1Imperial College Business School,   Imperial College London, London,   2Hull Y ork Medical School, Y ork, UKDear editor In this journal, Crema and Verbano1 discussed the importance of defining quality of  health care and how quality can be improved through various industrial instruments  and techniques.",Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
"5 Changing health provision to 1) reduce  medical error, 2) improve clinical outcomes, and 3) increase patient satisfaction will therefore inherently lead to cost reduction by the system.Correspondence: Jasper P Vink Imperial College London, Exhibition Road, South Kensington, SW7 2AZ London, UKEmail jasper.vink12@imperial.ac.ukJournal name: Journal of Multidisciplinary Healthcare Article Designation: LETTERY ear: 2016V olume: 9Running head verso: Vink et alRunning head recto: Quality improvement and cost-efficiencyDOI: http://dx.doi.org/10.2147/JMDH.S111812",Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
Available from: http://www.procesverbeteren.nl/Lean_Six_Sigma/Lean_Six_Sigma.php.,Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 278 Vink et al adverse events and at decreasing costs of drug supplying  that are pursued simultaneously.,Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
Available from: http://www.who.int/management/quality/assurance/QualityCare_B.Def.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
Available from: http://www.ahrq.gov/research/findings/nhqrdr/nhqr11/nhqr11.pdf.,OADS,/arxiv_data1/oa_pdf/84/54/jmdh-9-275.PMC4928659.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/0f/copd-11-1413.PMC4928660.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1413–1424International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1413OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10161 2Prevention of clinically important deteriorations  in COPD with umeclidinium/vilanterol Dave singh1 M reza Maleki-Yazdi2 lee T ombs3 ahmar Iqbal4 William a Fahy5 Ian naya5 1Medicines evaluation Unit, University  of Manchester, University hospital of  south Manchester nhs  Foundation  Trust, Manchester, UK; 2Division  of respiratory Medicine, Women’s  College hospital, University of  T oronto, On , Canada; 3Precise  approach lTD, london UK;   4respiratory Medical Franchise, gsK,   research Triangle Park, nC, Usa;   5respiratory Medicines Development  Centre, gsK, stockley Park,   Middlesex, UKBackground:  Minimizing the risk of disease progression and exacerbations is the key goal  of COPD management, as these are well-established indicators of poor COPD prognosis.",Non-OADS,/arxiv_data1/oa_pdf/d8/0f/copd-11-1413.PMC4928660.pdf
"Keywords:  COPD, deterioration, airway stability, UMEC/VI Introduction The management goals of COPD emphasize the need to reduce symptoms, improve  health status, increase exercise tolerance, prevent exacerbations, slow disease  progression, and reduce mortality.1 In patients with moderate-to-severe COPD without  a history of frequent exacerbations, bronchodilator monotherapy with long-acting  muscarinic antagonist (LAMA) is recommended.1 However, most patients receiving  long-acting bronchodilator monotherapy still report moderate-to-severe breathlessness  and regular rescue medication use.2 Consequently, maintenance therapy with fixed- dose combinations of LAMA and long-acting- β2-agonist (LABA) is an alternative  treatment option for patients with high symptom burden.3Correspondence: Dave singh Medicines evaluation Unit, University  of Manchester, University hospital  of south Manchester nhs Foundation  Trust, southmoor road, Manchester  M23 9QZ, UK Tel +44 161 946 4052 Fax +44 161 946 1459 email dsingh@meu.org.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Singh et al Running head recto: Preventing deterioration in COPD with UMEC/VI DOI: http://dx.doi.org/10.2147/COPD.S101612",Non-OADS,/arxiv_data1/oa_pdf/d8/0f/copd-11-1413.PMC4928660.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d8/0f/copd-11-1413.PMC4928660.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/0f/copd-11-1413.PMC4928660.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/fc/ott-9-3815.PMC4928661.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3815–3827OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3815Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10063 3long noncoding rna aK126698 inhibits  proliferation and migration of non-small cell  lung cancer cells by targeting Frizzled-8 and  suppressing Wnt/ β-catenin signaling pathway Xiao Fu1 hui li1 chunxiao liu2 Bin hu1 T ong li1 Yang Wang1 1Department of Thoracic surgery,   Beijing chao-Yang hospital,   capital Medical University, Beijing,   2Department of cardiovascular  surgery, Qilu hospital of shandong  University, Jinan, shandong, People’s  republic of chinaBackground:  Recent studies indicate that long noncoding RNAs (lncRNAs) play a key role  in the control of cellular processes such as proliferation, metastasis, and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/46/fc/ott-9-3815.PMC4928661.pdf
"Non-small  cell lung cancer (NSCLC) accounts for 80%–85% of all lung cancers and is generally  diagnosed at an advanced stage.1 Despite considerable progress in treating the disease,  the outcome of NSCLC remains unfavorable, with a 5-year overall survival rate of  11%–15%.2 The main reason for the high mortality rate is the sustained proliferation correspondence: hui li Department of Thoracic surgery, Beijing  chao-Yang hospital, capital Medical  University, 8 gongren Tiyuchang nanlu,  chaoyang District, Beijing 100020,  People’s republic of china email huilee1960@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Fu et al Running head recto: Long noncoding RNA AK126698 DOI: http://dx.doi.org/10.2147/OTT.S100633",Non-OADS,/arxiv_data1/oa_pdf/46/fc/ott-9-3815.PMC4928661.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/46/fc/ott-9-3815.PMC4928661.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/fc/ott-9-3815.PMC4928661.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/27/fnw135.PMC4928666.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/6f/dddt-10-2061.PMC4928669.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2061–2068Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2061Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9809 6 The cytotoxicity study of praziquantel enantiomers Qian sun ruifeng Mao Dongling Wang changyan hu Yang Zheng Dequn sun Department of Pharmacy, Marine  college, shandong University, Weihai,   People’s republic of chinaAbstract:  Praziquantel (PZQ) is prescribed as a racemic mixture (racemic-PZQ, rac-PZQ),  which is composed of ( R)-PZQ and ( S)-PZQ.",Non-OADS,/arxiv_data1/oa_pdf/34/6f/dddt-10-2061.PMC4928669.pdf
"So far, research and  development of chiral PZQ have been carried out in order to decrease the pill dose, reduce  the side effects,14 and remove the bitter taste of pill mainly caused by ( S)-PZQ.15 Recently,  the metabolic profiling of chiral PZQ was studied by our group to reveal the in silico, in  vitro, and in vivo enantioselective metabolic differences of PZQ enantiomers,16 and the correspondence: Dequn sun Marine college, shandong University,  Weihai, no 180, Wenhua West road,  Weihai 264209, People’s  republic of china Tel +86 631 568 8303 email dequn.sun@sdu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Sun et al Running head recto: The cytotoxicity study of praziquantel enantiomers DOI: http://dx.doi.org/10.2147/DDDT.S98096",Non-OADS,/arxiv_data1/oa_pdf/34/6f/dddt-10-2061.PMC4928669.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/34/6f/dddt-10-2061.PMC4928669.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/6f/dddt-10-2061.PMC4928669.pdf
"Available from: http://www.who.int/tdr/publications/documents/ bl6-business-plan.pd f. Accessed Sept 1, 2008.",Non-OADS,/arxiv_data1/oa_pdf/34/6f/dddt-10-2061.PMC4928669.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/48/ott-9-3807.PMC4928670.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3807–3813OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3807Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10686 9 superiority of helical tomotherapy on liver sparing  and dose escalation in hepatocellular carcinoma: a  comparison study of three-dimensional conformal  radiotherapy and intensity-modulated radiotherapy Qianqian Zhao1,2 renben Wang2 Jian Zhu2 linzhi Jin1,2 Kunli Zhu2 Xiaoqing Xu2 rui Feng2 shumei Jiang2 Zhonghua Qi1,2 Y ong Yin2 1school of Medicine and life sciences,   University of Jinan- shandong academy  of Medical sciences, 2Department of  radiation Oncology, shandong cancer  hospital affiliated to shandong  University, Jinan, People’s republic of  chinaBackground and purpose:  To compare the difference of liver sparing and dose escalation  between three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy  (IMRT), and helical tomotherapy (HT) for hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/ed/48/ott-9-3807.PMC4928670.pdf
"According to the National Comprehensive Cancer Network (NCCN)  practice guidelines of 2015 (revised), all tumors of HCC irrespective of the location may correspondence: renben Wang Department of radiation Oncology,  Shandong Cancer Hospital affiliated  to shandong University, 440 Jiyan  road, huaiyin, Jinan, shandong 250117,  People’s republic of china Tel/fax +86 531 6762 6441 email wangrenben@sina.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhao et al Running head recto: Superiority of helical tomotherapy in HCC DOI: http://dx.doi.org/10.2147/OTT.S106869",Non-OADS,/arxiv_data1/oa_pdf/ed/48/ott-9-3807.PMC4928670.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ed/48/ott-9-3807.PMC4928670.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/48/ott-9-3807.PMC4928670.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4e/f2/ndt-12-1561.PMC4928671.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1561–1570Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1561Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147NDT .S10572 8 Unmet needs of bipolar disorder patients Miroslav Hajda1 Jan Prasko1 Klara Latalova1 Radovan Hruby2 Marie Ociskova1 Michaela Holubova1,3 Dana Kamaradova1 Barbora Mainerova1 1Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacky  University Olomouc, University  Hospital Olomouc, Olomouc, Czech  Republic; 2Outpatient Psychiatric  Department, Martin, Slovak Republic;   3Department of Psychiatry, Regional  Hospital Liberec, Liberec, Czech  RepublicBackground:  Bipolar disorder (BD) is a serious mental illness with adverse impact on the  lives of the patients and their caregivers.",Non-OADS,/arxiv_data1/oa_pdf/4e/f2/ndt-12-1561.PMC4928671.pdf
"The aim of this article Correspondence: Jan Prasko Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacky  University Olomouc, University Hospital  Olomouc, iP Pavlova 6, 77520 Olomouc,  Czech Republic Tel +420 603 414 930 email praskojan@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Hajda et al Running head recto: Unmet needs of bipolar disorder patients DOI: http://dx.doi.org/10.2147NDT.S105728",Non-OADS,/arxiv_data1/oa_pdf/4e/f2/ndt-12-1561.PMC4928671.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4e/f2/ndt-12-1561.PMC4928671.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/f2/ndt-12-1561.PMC4928671.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/54/ndt-12-1539.PMC4928674.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1539–1551Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1539OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10430 1 Psychological factors and treatment effectiveness  in resistant anxiety disorders in highly comorbid  inpatients Marie Ociskova Jan Prasko Klara latalova Dana Kamaradova ales grambal Department of Psychiatry, Olomouc  University hospital, Faculty of  Medicine and Dentistry, Palacký  University Olomouc, czech republicBackground:  Anxiety disorders are a group of various mental syndromes that have been related  with generally poor treatment response.",Non-OADS,/arxiv_data1/oa_pdf/71/54/ndt-12-1539.PMC4928674.pdf
"Keywords:  anxiety disorders, self-stigma, hope, personality, dissociation, treatment  effectiveness Introduction Anxiety disorders are highly prevalent mental disorders with the potential to be  persistently disabling if not treated.1 Both psychotherapy and pharmacotherapy (PT)  have demonstrated their treatment efficacy.2,3 Nevertheless, almost 30%–60% of patients  continue to be symptomatic after outpatient management.4–10 There is also a deficiency correspondence: Jan Prasko Department of Psychiatry, Olomouc  University hospital, Faculty of Medicine  and Dentistry, Palacký University  Olomouc, 6 iP Pavlova street, Olomouc  77520, czech republic Tel +420 588 443 519 email praskojan@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Ociskova et al Running head recto: Psychological factors and treatment efficacy in anxiety disorders DOI: http://dx.doi.org/10.2147/NDT.S104301",Non-OADS,/arxiv_data1/oa_pdf/71/54/ndt-12-1539.PMC4928674.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/71/54/ndt-12-1539.PMC4928674.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/54/ndt-12-1539.PMC4928674.pdf
"Available from: http://www.edctp.org/fileadmin/documents/EMEA_ ICH-GCP_Guidelines_July_2002.pd f. Accessed May 19, 2016.",OADS,/arxiv_data1/oa_pdf/71/54/ndt-12-1539.PMC4928674.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/01/ott-9-3829.PMC4928675.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3829–3840OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3829Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10692 5 lXY6090 – a novel manassantin a derivative – limits  breast cancer growth through hypoxia-inducible  factor-1 inhibition Fangfang lai1 Qian liu2 Xiaoyu liu3 Ming Ji1 Ping Xie3 Xiaoguang chen1 1Department of Pharmacology,   state Key laboratory of Bioactive  substances and Functions of natural  Medicines, institute of Materia Medica,   chinese academy of Medical sciences  and Peking Union Medical college,   2Department of Pharmacology,   national institutes for Food and  Drug control, 3Department of  Pharmacochemistry, institute of  Materia Medica, chinese academy  of Medical sciences and Peking  Union Medical college, Beijing,   People’s republic of chinaAbstract:  Hypoxia-inducible factor-1 (HIF-1) represents a novel antitumor target owing to  its involvement in vital processes considered hallmarks of cancer phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/05/01/ott-9-3829.PMC4928675.pdf
"HIF-1 is a heterodimeric protein composed of an oxygen-regulated HIF-1 α subunit  and a constitutively expressed HIF-1 β subunit.6,7 Under normoxic conditions, the  prolyl-4-hydroxylases employing oxygen, ferrous iron, and oxoglutarate as substrates  hydrolyze HIF-1 α at proline residues (Pro402 and Pro564).8 The hydroxylated HIF-1 α  is recognized by a von Hippel–Lindau (VHL) tumor suppressor protein, which recruits  an E3 ubiquitin-protein ligase complex; thus, the HIF-1 α subunit is kept low by abun - dant ubiquitination and subsequent proteasome degradation.9 However, during hypoxic  conditions, the two proline residues cannot be hydroxylated, resulting in HIF-1 α  accumulation.10,11 The stabilized HIF-1 α protein translocates to the nucleus and couples correspondence: Xiaoguang chen Department of Pharmacology, state  Key laboratory of Bioactive substances  and Functions of natural Medicines,  institute of Materia Medica, chinese  academy of Medical sciences and Peking  Union Medical college, 1 Xiannongtan  street, Xicheng District, Beijing 100050,  People’s republic of china Tel/fax +86 10 6316 5207 email chenxg@imm.ac.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lai et al Running head recto: LXY6090 limits breast cancer by HIF-1 inhibition DOI: http://dx.doi.org/10.2147/OTT.S106925",Non-OADS,/arxiv_data1/oa_pdf/05/01/ott-9-3829.PMC4928675.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/05/01/ott-9-3829.PMC4928675.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/01/ott-9-3829.PMC4928675.pdf
"Band densitiesfrom independent blots were quantiﬁed using ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD,USA).",OADS,/arxiv_data1/oa_pdf/b9/13/i1552-5783-57-7-3145.PMC4928694.pdf
"Image Analysis, Segmentation, and 3D Rendering Acquired TPM images from a total of eight different eyes were postprocessed using both the microscope control software(Zen 2012 black edition; Carl Zeiss AG) and ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/3c/5f/i1552-5783-57-7-3159.PMC4928697.pdf
"TheSeg3D software package (University of Utah Center forIntegrative Biomedical Computing, Salt Lake City, UT, USA;http://www.sci.utah.edu/cibc-software/seg3d.html) was usedfor the segmentation processing.",OADS,/arxiv_data1/oa_pdf/3c/5f/i1552-5783-57-7-3159.PMC4928697.pdf
Available at: http://www.ncbi.nlm.nih.gov/books/NBK20231/.,Non-OADS,/arxiv_data1/oa_pdf/3c/5f/i1552-5783-57-7-3159.PMC4928697.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600581/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/10/9e/1600581.PMC4928880.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501326/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/4d/c0/1501326.PMC4928881.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501764/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/16/23/1501764.PMC4928885.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501672/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/1501672.PMC4928887.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/4/e1600038/DC1S1.,Non-OADS,/arxiv_data1/oa_pdf/d5/5d/1600038.PMC4928888.pdf
"Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper, in the Supplementary Materials, and/or through the following data archives: (i) theVLT data are accessible through the ESO Science Archive Facility at http://archive.eso.org/cms.html; and (ii) the CFHT data are accessible through the Canadian Astronomy Data Centre atwww.cadc-ccda.hia-iha.nrc-cnrc.gc.ca/en/.",OADS,/arxiv_data1/oa_pdf/d5/5d/1600038.PMC4928888.pdf
We aligned sequences by eye using Se-Al ver- sion 2.0a11 (http://tree.bio.ed.ac.uk /software/seal/).,OADS,/arxiv_data1/oa_pdf/ed/e3/1501682.PMC4928889.pdf
Sequences were aligned by eye using Se-Al version 2.0a11 (http://tree.bio.ed.ac.uk/software/seal/).,OADS,/arxiv_data1/oa_pdf/ed/e3/1501682.PMC4928889.pdf
Results of the individual and com- bined runs were visualized using Tracer 1.4 (http://tree.bio.ed.ac.uk/ software/tracer) to check for convergence and to ensure that all EffectiveSample Size scores were >200 (sugge sting sufficient sampling and run length).,OADS,/arxiv_data1/oa_pdf/ed/e3/1501682.PMC4928889.pdf
The trees were annotated and visualized using FigTree 1.1.2 (http://tree.bio.ed.ac.uk/software/figtree).,OADS,/arxiv_data1/oa_pdf/ed/e3/1501682.PMC4928889.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/1501682/DC1Supplementary MethodsSupplementary Resultsfig.,Non-OADS,/arxiv_data1/oa_pdf/ed/e3/1501682.PMC4928889.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501632/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/54/5f/1501632.PMC4928890.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600502/DC1 table S1.,Non-OADS,/arxiv_data1/oa_pdf/3a/de/1600502.PMC4928894.pdf
Pvalues were calculated using t h el o g - r a n kt e s t .T h ea n a l y s i sw a sp e rformed using the survival package in R. Associations between tumor PR status and other clinical and path- ologic variables were studied using c 2contingency test in R. SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501924/DC1 table S1.,Non-OADS,/arxiv_data1/oa_pdf/a9/4c/1501924.PMC4928895.pdf
"For an independent check and a quantification of the quality of the hydrogen ADPs, we used the checkCIF service normally used for quality control when submitting crystal structures for publication (http://checkcif.iucr.org), which emits “alerts ”(labeled A, B, and C) of succes- sively decreasing severity.",OADS,/arxiv_data1/oa_pdf/58/7a/1600192.PMC4928899.pdf
"Full details of the compounds with relevant information (source for the list of measured reflection data, st ructure, literature references, HAR details, and previous high-resoluti on refinement details) are presented in table S1 and in the extended supplementary document “Raw refine- ment and statistical data ”(including representations of the HAR- refined geometries with anisotropic atomic displacement ellipsoids), which has been deposited at www.figshare.com and can be obtained un- der https://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/58/7a/1600192.PMC4928899.pdf
CSD-430202) and can be ob-tained at http://icsd.fiz-karlsruhe.de.,Non-OADS,/arxiv_data1/oa_pdf/58/7a/1600192.PMC4928899.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600192/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/58/7a/1600192.PMC4928899.pdf
"Further raw data are deposited as additional supplementary materials with Science Advances or with the service www.figshare.com: 1) Raw refinement and statistical data as a separate PDF document, deposited at www.figshare.com under https://dx.doi.org/10.6084/m9.figshare.3205588.v1.2) Crystallographic information files (CIFs) of all refinements in native text format REFERENCES AND NOTES 1.",OADS,/arxiv_data1/oa_pdf/58/7a/1600192.PMC4928899.pdf
CIFs for all refine-ments have also been uploaded with Science Advances .“Raw refinement and statistical data ”as a separate PDF document has been deposited at www.figshare.com under https://dx.doi.org/ 10.6084/m9.figshare.3205588.v1.,OADS,/arxiv_data1/oa_pdf/58/7a/1600192.PMC4928899.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501631/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/17/41/1501631.PMC4928900.pdf
"K. M. Beck, M. Hosseini, Y. Duan, V. Vuleti ć,“Large conditional single-photon cross-phase modulation, ”http://arxiv.org/abs/1512.02166.",Non-OADS,/arxiv_data1/oa_pdf/c7/bb/1600036.PMC4928902.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600265/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/90/25/1600265.PMC4928903.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501372/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5c/3c/1501372.PMC4928904.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501591/DC1 Supplementary Materials and Methods A BWt %  2 h  Time (h) Mw C PDI  Time (h) 4 h 6 h 8 h 24 h 48 h 96 h 0% 20% 40% 60% 80% 100%  10.1  7.4  6.7  6.4  1.5 1.4 1.3  0 2 4 6 8 10  0 20 40 60 80 100 4390  3920  3270  2020  1060 840 780  500 1500 2500 3500 4500  0 20 40 60 80 100 Fig.,Non-OADS,/arxiv_data1/oa_pdf/b3/43/1501591.PMC4928905.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501258/DC1Meta-elementEngineered dispersion of DRWsQuality of the designed intensity distribution in the reconstruction plane Optical image of the fabricated device Illumination with visible lightPixel far field in the visible rangePolarization-dependent response of the meta-elementChiral hologram featuresfig.,Non-OADS,/arxiv_data1/oa_pdf/ff/da/1501258.PMC4928906.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600345/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/4e/30/1600345.PMC4928907.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600288/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/9f/5f/1600288.PMC4928910.pdf
"Acknowledgments: We would like to thank the Japan Aerospace Exploration Agency for access t ot h eA L O Sd a t au n d e rp r o j e c tR A 4 - 1 0 9 3 ,t h eE S Af o ra c c e s st ot h eE n v i s a td a t au n d e rp r o j e c tC1P-14029, and GeoNet (http://geonet.org.nz) for the CGPS data.",Non-OADS,/arxiv_data1/oa_pdf/9f/5f/1600288.PMC4928910.pdf
S2 was sourced from the Land Information New Zealand(LINZ) Data Service (https://data.linz.go vt.nz/layer/1757-bay-ofplenty-04m -rural-aerial-photos-2010-2012/) and licensed by BOPLASS Limited for reuse under the Creative Commons Attribution 3.0 NewZealand license.,Non-OADS,/arxiv_data1/oa_pdf/9f/5f/1600288.PMC4928910.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600102/DC1 Experimental procedurefig.,Non-OADS,/arxiv_data1/oa_pdf/8a/08/1600102.PMC4928911.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501742/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/91/c6/1501742.PMC4928915.pdf
"BBC News, Russian students targeted as recruits by Islamic State; http://linkis.com/dmFgu [accessed March 23, 2016].",Non-OADS,/arxiv_data1/oa_pdf/91/c6/1501742.PMC4928915.pdf
"https://lta.cr.usgs.gov/GTOPO30, corresponding to the geographic limits of the locations of our 43 study areas.",Non-OADS,/arxiv_data1/oa_pdf/0d/e2/1501639.PMC4928921.pdf
"Wetlands were masked using a modified version of the Global Lakes and Wetlands Database created by Lehner and Döll (46), available at http://www.worldwildlife.org/pages/global-lakes-and- wetlands-database, which we refined through removal of areas having ag-riculture or OGF.",OADS,/arxiv_data1/oa_pdf/0d/e2/1501639.PMC4928921.pdf
CEC was obtained from the Harmonized World SoilDatabase from http://webarchive.iiasa.ac.at/Research/LUC/External- World-soil-database/HTML/.,OADS,/arxiv_data1/oa_pdf/0d/e2/1501639.PMC4928921.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501639/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/0d/e2/1501639.PMC4928921.pdf
"JRC98184, PBL1803; http://edgar.jrc.ec.europa.eu/news_docs/jrc-2015-trends-in-global-co2-emissions-2015-report-98184.pdf [accessed November 2015].",Non-OADS,/arxiv_data1/oa_pdf/0d/e2/1501639.PMC4928921.pdf
"Federal Republic of Brazil, http://www4.unfccc.int/submissions/INDC/Published% 20Documents/Brazil/1/BRAZIL%20iNDC%20english%20FINAL.pdf [accessed October 28, 2015].",Non-OADS,/arxiv_data1/oa_pdf/0d/e2/1501639.PMC4928921.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600112/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/f2/7a/1600112.PMC4928922.pdf
We obtained historical closing daily price data from https://quantquote.com/.,Non-OADS,/arxiv_data1/oa_pdf/f6/2e/1501495.PMC4928924.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501495/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/f6/2e/1501495.PMC4928924.pdf
http://arxiv.org/abs/1105.3803.,Non-OADS,/arxiv_data1/oa_pdf/f6/2e/1501495.PMC4928924.pdf
Data and materials availability: All data needed to evaluate the conclusions in the paper are available at http://quantquote.com or are present in the paper and/or the Supplementary Materials.Additional data related to this paper may be requested from the authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/2e/1501495.PMC4928924.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600353/DC1Powder x-ray diffraction Fig.,Non-OADS,/arxiv_data1/oa_pdf/fd/3d/1600353.PMC4928925.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501790/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/b8/b6/1501790.PMC4928927.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600519/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/38/ff/1600519.PMC4928928.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501588/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/05/2a/1501588.PMC4928933.pdf
"C. J. Willmott, K. Matsuura, “Terrestrial air temperature and precipitation: Monthly and an- nual time series (1950 –1999), ”2001; http://climate.geog.udel.edu/~climate/html_pages/ README.ghcn_ts2.html.",Non-OADS,/arxiv_data1/oa_pdf/05/2a/1501588.PMC4928933.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/4/e1501648/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/26/67/1501648.PMC4928934.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600084/DC1 S1.,Non-OADS,/arxiv_data1/oa_pdf/aa/bd/1600084.PMC4928936.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501690/DC1I.,Non-OADS,/arxiv_data1/oa_pdf/fc/16/1501690.PMC4928939.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501459/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/1501459.PMC4928943.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600282/DC1Comparison between the results obtained by Chelton et al.,OADS,/arxiv_data1/oa_pdf/97/a6/1600282.PMC4928944.pdf
"F .F a l c h i ,P .C i n z a n o ,D .D u r i s c o e ,C .C .M .K y b a ,C .D .E l v i d g e ,K .B a u g h ,B .P o r t n o v ,N .A .R y b n i k o v a , R. Furgoni, Supplement to the New World Atlas of Artificial Night Sky Brightness, GFZ DataServices (2016); http://doi.org/10.5880/GFZ.1.4.2016.001.",Non-OADS,/arxiv_data1/oa_pdf/b4/9c/1600377.PMC4928945.pdf
"U.S. National Park Service, Night Sky Monitoring Database , http://nature.nps.gov/night/skymap.cfm [accessed May 28, 2016].",Non-OADS,/arxiv_data1/oa_pdf/b4/9c/1600377.PMC4928945.pdf
"ArcGIS, World Countries , http://www.arcgis.com/home/item.html?id=3864c63872d84ae- c91933618e3815dd2 [accessed May 28, 2016].",Non-OADS,/arxiv_data1/oa_pdf/b4/9c/1600377.PMC4928945.pdf
"Oak Ridge National Laboratory, LandScan ™, http://web.ornl.gov/sci/landscan/ [accessed May 28, 2016].",Non-OADS,/arxiv_data1/oa_pdf/b4/9c/1600377.PMC4928945.pdf
Additional data of nightsky brightness measurements related to this paper may be requested from the cor-responding author or from http://doi.org/10.5880/GFZ.1.4.2016.001 ( 35) or from the following: F. Giubbilini data: Buiometria Partecipativa project (buiometria@attivarti.org); RASC data: http://old.rasc.ca/~admin/sqm/SQM_data_view.php; Catalonia data: darksky@parcastronomic.cat; Espey/Owens data: Brian.Espey@tcd.ie and steve@owens-online.co.uk; Haenel/Frank data: ahaenel@uos.de; Madrid data: http://dx.doi.org/10.5281/zenodo.51713; Globe at Night data:http://www.globeatnight.org/; Unihedron data: http:/ /www.unihedron.com/projects/darksky/database/; and IDSP data: J. Barentine (john@darksky.org).,OADS,/arxiv_data1/oa_pdf/b4/9c/1600377.PMC4928945.pdf
"With this method, the corrected mobil- ity is dependent on the gate voltage and can be 1.3 to 1.9 times higher than the uncorrected ones at VGSfrom 0 to −30 V. SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600076/DC1 fig.",Non-OADS,/arxiv_data1/oa_pdf/9a/08/1600076.PMC4928946.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600375/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/80/1600375.PMC4928949.pdf
"Press, Oxford, 2013); https://c14.arch.ox.ac.",Non-OADS,/arxiv_data1/oa_pdf/e7/80/1600375.PMC4928949.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600246/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/4b/e9/1600246.PMC4928950.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501026/DC1Description of the model Acclimatefig.,Non-OADS,/arxiv_data1/oa_pdf/6e/de/1501026.PMC4928955.pdf
Map figures havebeen made using https://github.com/swillner/colour-map.,Non-OADS,/arxiv_data1/oa_pdf/6e/de/1501026.PMC4928955.pdf
Genomic analysis PopART version 1.7.2 (http://popart.otago.ac.nz) was used to createhaplotype networks using the media n-joining reconstruction method.,OADS,/arxiv_data1/oa_pdf/6a/04/1600378.PMC4928956.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/4/e1600378/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/6a/04/1600378.PMC4928956.pdf
"Cotten, A. Rambaut, P. Kellam, “Recent evolution patterns of Ebola virus obtained by direct sequencing in Sierra Leone, ”2015; http://virological.org/t/recent-evolution-patterns-of- ebola-virus-obtained-by-direct-sequencing-in-sierra-leone/150.",Non-OADS,/arxiv_data1/oa_pdf/6a/04/1600378.PMC4928956.pdf
"World Health Organization, Ebola data and statistics, 30 March 2016; http://apps.who.int/gho/ data/node.ebola-sitrep.ebola-country-LBR-latest?lang=en.",OADS,/arxiv_data1/oa_pdf/6a/04/1600378.PMC4928956.pdf
Note that we have made the entire source code available as well (at https://github.com/xyjprc/hon).,Non-OADS,/arxiv_data1/oa_pdf/28/19/1600028.PMC4928957.pdf
"From the network perspective, although there have been efforts to incorporateHON structures for clustering ( 34,35), ranking ( 36), and so on, these m e t h o d sa r em o d i f i c a t i o n so fe x i s t i n ga l g o r i t h m sa n da r ea p p l i c a t i o n - specific; instead, we embed higher-order dependencies into the network structure, so that the wide range of existing network analysis tools canbe applied without modification.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600028/DC1note S1.",Non-OADS,/arxiv_data1/oa_pdf/28/19/1600028.PMC4928957.pdf
Data and materials availability: All data needed to evaluate the conclusions in the paper are available in https://github.com/xyjprc/hon or present in the paper and/or the SupplementaryMaterials.,Non-OADS,/arxiv_data1/oa_pdf/28/19/1600028.PMC4928957.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501768/DC1 Supplementary Materials and Methods fig.,Non-OADS,/arxiv_data1/oa_pdf/e9/f2/1501768.PMC4928958.pdf
"G. Parker, 1D Sediment Transport Morphodynamics with Applications to Rivers and Turbidity Currents; http://hydrolab.illinois.edu/people/parkerg/morphodynamics_e-book.htm.",Non-OADS,/arxiv_data1/oa_pdf/e9/f2/1501768.PMC4928958.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600285/DC1 Fragmentation patternSearch for the amino acid alaninePhosphorusfig.,Non-OADS,/arxiv_data1/oa_pdf/d5/52/1600285.PMC4928965.pdf
Data and materials availability: All ROSINA data have been/will be released to the Planetary Science Archive of ESA (http://www.sciops.esa.int/index.php?project=PSA&page=home) and to the Planetary DataSystem archive of NASA (https://pds.nasa.gov/).,OADS,/arxiv_data1/oa_pdf/d5/52/1600285.PMC4928965.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600149/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/54/56/1600149.PMC4928966.pdf
Anagoria: Museum für Naturkunde Berlin (used under CC-BY); https://commons.wikimedia.,Non-OADS,/arxiv_data1/oa_pdf/54/56/1600149.PMC4928966.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600002/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/99/67/1600002.PMC4928967.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600477/DC1Experimental setupEstimation of energy shift DE Quantum mechanical description of the OSEEstimation of the Rabi energy Comparison of the Rabi energy Estimation of the equivalent Bfield for Zeeman splitting of energy levels Estimation of the TDM of PEPIEstimation of ħW Rand oscillator strength in various organic-inorganic halide perovskite systems Estimation of the exciton reduced massEstimation of the radiative lifetime Fig.,Non-OADS,/arxiv_data1/oa_pdf/de/80/1600477.PMC4928968.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501769/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/0c/1501769.PMC4928970.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600154/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/fd/29/1600154.PMC4928971.pdf
"W. P. Maddison, D. R. Maddison, Mesquite: A modular system for evolutionary analysis, version 3.04 [Program and documentation available at: http://mesquiteproject.org (2015)] [accessed17 May 2016].",OADS,/arxiv_data1/oa_pdf/fd/29/1600154.PMC4928971.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600241/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/40/08/1600241.PMC4928972.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501439/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/41/fd/1501439.PMC4928974.pdf
Data and materials availability: All data needed to evaluate the conclusions in the paper are available at https://figshare.com/s/7a1d308d49470d430864 or are present in the paper and/or the Supplementary Materials.,Non-OADS,/arxiv_data1/oa_pdf/41/fd/1501439.PMC4928974.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600134/DC1 Geological background Potential of sulfur MIF signals originated from weathering of preexisting S-MIFSensitivity analysis of C-O-S biogeochemical cycling modelfig.,Non-OADS,/arxiv_data1/oa_pdf/f7/b3/1600134.PMC4928975.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600148/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/05/b0/1600148.PMC4928977.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501772/DC1Supplementary MethodsSupplementary Discussiontable S1.,Non-OADS,/arxiv_data1/oa_pdf/a3/f1/1501772.PMC4928978.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501705/DC1Statisticstable S1.,Non-OADS,/arxiv_data1/oa_pdf/80/6e/1501705.PMC4928979.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501624/DC1note S1.,Non-OADS,/arxiv_data1/oa_pdf/60/a7/1501624.PMC4928980.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501033/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/57/1e/1501033.PMC4928981.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1600349/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/29/fd/1600349.PMC4928982.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501869/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/dd/53/1501869.PMC4928983.pdf
"LBL Report-37206, thesis, Univer- sity of California, Berkeley (1995); https://publications.lbl.gov/islandora/object/ir:101737.",Non-OADS,/arxiv_data1/oa_pdf/dd/53/1501869.PMC4928983.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501729/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/80/e2/1501729.PMC4928984.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501912/DC1 movie S1.,Non-OADS,/arxiv_data1/oa_pdf/92/25/1501912.PMC4928985.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600245/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/79/d8/1600245.PMC4928986.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501118/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/41/14/1501118.PMC4928987.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1600124/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/05/16/1600124.PMC4928988.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/4/e1500961/DC1Supplementary Materials and Methodstable S1.,Non-OADS,/arxiv_data1/oa_pdf/46/67/1500961.PMC4928989.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1501732/DC1 Characterization of the tunable couplingCharacterization at higher photon numbersGeometric phases acquired by the eigenstates Y ± n/C12/C12/C11 Geometric phase estimation based on open loops Dynamic phase cancellation Insensitivity to small deviations from the resonant frequency Phase calibration of spin-echo coupling pulsesfig.,Non-OADS,/arxiv_data1/oa_pdf/88/7e/1501732.PMC4928991.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/e1501918/DC1 Brief description of fossils fig.,Non-OADS,/arxiv_data1/oa_pdf/a9/2f/1501918.PMC4928993.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/6/1600077/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/9c/1600077.PMC4928994.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/5/e1500842/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/3f/8e/1500842.PMC4928996.pdf
"tRNA sequences The original tRNA sequences were from the Genomic tRNA Database(25) (http://gtrnadb.ucsc.edu).tRNA Gly GCC(Homo_sapiens_Gly-GCC-2-1): GCATTGGTGGTTCAGTGGTAGAATTCTCGC CTGCCAC - GCGGGAGGCCCGGGTTCGATTCCCGGCCAATGCA tRNAGly ACC (GCC) (G34A mutation): GCATTGGTGGTTCAGTGGTAGAATTCTCGC CTACCAC - GCGGGAGGCCCGGGTTCGATTCCCGGCCAATGCA tRNAGly CCC(Homo_sapiens_Gly-CCC-2-1): GCGCCGCTGGTGTAGTGGTATCATGCAAGA TTCCCAT - TCTTGCGACCCGGGTTCGATTCCCGGGCGGCGCA tRNAGly ACC (CCC) (C34A mutation): GCGCCGCTGGTGTAGTGGTATCATGCAAGA TTACCAT - TCTTGCGACCCGGGTTCGATTCCCGGGCGGCGCA tRNAGly UCC(Homo_sapiens_Gly-TCC-2-1): GCGTTGGTGGTATAGTGGTGAGCATAGCTGC CTTCC- AAGCAGTTGACCCGGGTTCGATTCCCGGCCAACGCA tRNAGly ACC (UCC) (U34A mutation): GCGTTGGTGGTATAGTGGTGAGCATAGCTGC CTACC- AAGCAGTTGACCCGGGTTCGATTCCCGGCCAACGCA tRNAAla AGC(Homo_sapiens_Ala-AGC-2-1): GGGGGTGTGGCTCAGTGGTAGAGCGCGTGC TTAGCAT - GCACGAGGcCCCGGGTTCAATCCCCGGCACCTCCA tRNAAla ACC(G35C mutation): GGGGGTGTGGCTCAGTGGTAGAGCGCGTGC TTACCAT - GCACGAGGcCCCGGGTTCAATCCCCGGCACCTCCA tRNAAla AGC(U32C; U38C mutation): GGGGGTGTGGCTCAGTGGTAGAGCGCGTGC CTAGCAC - GCACGAGGcCCCGGGTTCAATCCCCGGCACCTCCA tRNAAlaanticodon stem-loop Gly ACC: GGGGGTGTGGCTCAGTGGTAGAGCGCTCGC CTACCAC - GCGGGAGGcCCCGGGTTCAATCCCCGGCACCTCCA tRNAAlaanticodon loop Gly ACC: GGGGGTGTGGCTCAGTGGTAGAGCGCGTGC CTACCAC - GCACGAGGcCCCGGGTTCAATCCCCGGCACCTCCA tRNAAlaanticodon stem Gly: GGGGGTGTGGCTCAGTGGTAGAGCGCTCGC TTAGCAT - GCGGGAGGcCCCGGGTTCAATCCCCGGCACCTCCA tRNAVal AAC(Homo_sapiens_Val-AAC-1-1): GTTTCCGTAGTGTAGTGGTtATCACGTTCGC CTAACAC - GCGAAAGGtCCCCGGTTCGAAACCGGGCGGAAACA tRNAVal ACC(A35C mutation): GTTTCCGTAGTGTAGTGGTtATCACGTTCGC CTACCAC - GCGAAAGGtCCCCGGTTCGAAACCGGGCGGAAACA In vitro tRNA preparation W i l d - t y p eo rm u t a t e dt R N A sw e r ea ssembled using six DNA oligonu- cleotides that were first annealed, and then ligated, between Hind III and Bam HI restriction sites of plasmid pUC19.",Non-OADS,/arxiv_data1/oa_pdf/ee/1f/1501860.PMC4928997.pdf
"To evaluate thenumber of tRNA genes of all the species of bacteria, we made a dis- tribution of their relative numbers using the Genomic tRNA Database (http://gtrnadb.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/ee/1f/1501860.PMC4928997.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/4/e1501860/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/1501860.PMC4928997.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/4/e1501704/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/24/95/1501704.PMC4928998.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cardiometabolic disease (cardiovascular dis- ease, diabetes, and kidney disease) Participation in two-stage screeningPrimary careUnderserved, high-risk populations 1.",Non-OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.009 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
"The I-change model, from http://www.maastricht-university.eu/hein.devries/interests/i-change-model.35 I. Groenenberg et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
Available from: (http://www.ncbi.nlm.nih.gov/pubmed/22399541 ).,OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
(Avail- able from:) http://www.who.int/mediacentre/factsheets/fs310_2008.pdf .43 I. Groenenberg et al.,Non-OADS,/arxiv_data1/oa_pdf/a2/f7/main.PMC4929048.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Food preparation DietNutrition 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.004 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
"Let's Move: Chefs Move to Schools, d. http://www.chefsmovetoschools.org (Accessed March 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
"National Farm to School Network, 2007. http://www.farmtoschool.org (Accessed March 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
"Share Our Strength: Cooking Matters, 2013. http://cookingmatters.org (Accessed March 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
"Slow Food USA, 2000. https://www.slowfoodusa.org (Accessed March 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d9/b1/main.PMC4929050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Colorectal neoplasms Mass screening Physician-patient relationsHealth behaviorTailoring 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/main.PMC4929051.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.008 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/main.PMC4929051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/main.PMC4929051.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/main.PMC4929051.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Leisure-time activityPsychological distressCommunity dwellers 1.,Non-OADS,/arxiv_data1/oa_pdf/be/74/main.PMC4929052.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.007 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/74/main.PMC4929052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/74/main.PMC4929052.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/be/74/main.PMC4929052.pdf
"Annual Report on the Labour Force Survey 2009 (in Japanese) http://www.stat.go.jp/data/roudou/ report/2009/ (Accessed March 13, 2016).",OADS,/arxiv_data1/oa_pdf/be/74/main.PMC4929052.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Electronic cigaretteAsian AmericanPaciﬁcI s l a n d e r FlavorsRisk perceptionYoung adults 1.,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.011 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
"http://dx.doi.org/10.1016/j.addbeh.2015.06.023 .Ambrose, B.K., Day, H.R., Rostron, B., et al., 2015.",OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
"http://dx.doi.org/10.1001/ jama.2015.13802 (Published online October 26, 2015).",Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://dx.doi.org/ 10.1097/ADM.0000000000000049 .,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://dx.doi.org/10.1111/j.1475- 682X.2009.00317.x .,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://dx.doi.org/10.1093/ntr/ntt013 .,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://dx.doi.org/10.1136/tobaccocontrol-2014-051743 .,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://dx.doi.org/10.1093/ntr/ntu060 .,Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
"22 (1), 19–23.http://dx.doi.org/10.1136/tobaccocontrol-2011-050044 .",Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
http://www.census.gov/prod/ cen2010/doc/sf2.pdf .,OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
"Pediatrics 135 (1), e43 –e5 1.http://dx.doi.org/10.1542/peds.2014-0760 .32 D.D.",Non-OADS,/arxiv_data1/oa_pdf/52/38/main.PMC4929057.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Occupational status Job stress Cardiovascular stress reactivityHeart rate variabilityPeripheral blood ﬂow 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.010 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1371/journal.pone.0037158 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
"Atherosclerosis 232, 94 –98.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
"BMC Public Health 5, 53. http://dx.doi.org/10.1186/1471-2458-5-53 (27).",Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1097/01.psy.0000170335.92770.7a .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1016/j.socscimed.2008.12.040 .,OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
"http://dx.doi.org/10.1097/PSY.0000000000000121 .Kawachi, I., Knodo, N., 2007.",OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1196/annals.1391.006 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
"Mental health countermeasure for teachers.http://www.mext.go.jp/component/b_menu/shingi/toushin/__icsFiles/a ﬁeldﬁle/ 2013/03/29/1332655_03.pdf (accessed September, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1016/j.neuroscience.2011.07.014 (13).,OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/ 10.1097/01.psy.0000160464.63264.5d .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/ 10.1016/j.ijpsycho.2011.08.002 .,OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
"78, 80 –88.http://dx.doi.org/10.1016/j.ijpsycho.2010.04.006 .",OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1161/STROKEAHA.107.495523 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1136/ bmj.e1191 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
http://dx.doi.org/10.1136/jech.2007.062315 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/main.PMC4929058.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Epidemiology Socio-economic positionHealth survey 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/cc/main.PMC4929059.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.009 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/cc/main.PMC4929059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/cc/main.PMC4929059.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/cf/cc/main.PMC4929059.pdf
http://www.ons.gov.uk/ons/guide-method/classi ﬁcations/current-standard- classi ﬁcations/soc2010/soc2010-volume-3-ns-sec –rebased-on-soc2010 –user- manual/index.html#2 (Accessed 07/07) .59 D. Roberts et al.,OADS,/arxiv_data1/oa_pdf/cf/cc/main.PMC4929059.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: WorkplaceSedentary behaviorDeterminants 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/74/main.PMC4929063.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.0112211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/74/main.PMC4929063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/74/main.PMC4929063.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/8d/74/main.PMC4929063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human papillomavirus (HPV) vaccinationPatient-provider communication 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/3e/main.PMC4929064.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.002 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/3e/main.PMC4929064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/3e/main.PMC4929064.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/a9/3e/main.PMC4929064.pdf
Healthy People 2020 Objectives: immu- nization and infectious diseases .Vol 2013: http://www.healthypeople.gov/2020/ topicsobjectives2020/overview.aspx?topicid=23 .,Non-OADS,/arxiv_data1/oa_pdf/a9/3e/main.PMC4929064.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: adolescent overweight health disparitiesAsian American healthsocial determinants of health 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/cf/main.PMC4929066.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.010 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/cf/main.PMC4929066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/cf/main.PMC4929066.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/5e/cf/main.PMC4929066.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Applied informaticsMedical informaticsPrimary careElectronic health recordsPrediabetesBehavior changeGoal setting Clinical decision support 1.,Non-OADS,/arxiv_data1/oa_pdf/03/23/main.PMC4929067.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.012 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/23/main.PMC4929067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/23/main.PMC4929067.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/03/23/main.PMC4929067.pdf
http://www.ncbi.nlm.nih.gov/books/NBK50888 .,Non-OADS,/arxiv_data1/oa_pdf/03/23/main.PMC4929067.pdf
"NCQA, d. Patient-centered medical home recognition http://www.ncqa.org/Programs/ Recognition/Practices/PatientCenteredMedicalHomePCMH.aspx (Accessed August 7, 2015).",Non-OADS,/arxiv_data1/oa_pdf/03/23/main.PMC4929067.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cosmetic programInterventionGeriatric Depression Scale (GDS)Frail older women 1.,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.009 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
"http://www.mhlw.go.jp/ seisakunitsuite/bunya/hukushi_kaigo/kaigo_koureisha/yobou/tyousa/dl/h23_01.pdf (Accessed: January 16, 2016,in Japanese).",OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
http://dx.doi.org/10.1056/nejm199406233302501 .,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
"6, 66 –71.http://dx.doi.org/10.5432/ijshs.6.66 .",Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
http://dx.doi.org/10.1080/ 09687590801954042 .,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
http://dx.doi.org/10.1093/ageing/afg123 .,Non-OADS,/arxiv_data1/oa_pdf/41/11/main.PMC4929069.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Tobacco industry MarketingTobaccoSmokingMenthol 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.0202211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
http://investor.altria.com/phoenix.zhtml?c= 80855&p=irol-reportsannual (accessed 27 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
"http://dx.doi.org/10.1186/1617-9625-9-S1-S1 .Choi, K., Hennrikus, D.J., Forster, J.L., et al., 2013.",Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
"http://dx.doi.org/10.1136/tobaccocontrol-2015-052314 (Published Online First, August 4).",Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
http://www.lorillard.com/wp-content/uploads/2013/04/ Lorillard_AnnualReport_2012.pdf (accessed 27 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
http://www.reynoldsamerican.com/ secﬁling.cfm?,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
"http://dx.doi.org/10.1136/tobaccocontrol-2014-051657 (Published On- line First, September 1).",Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
http://www.swedishmatch.com/Reports/2013/ 20130325-swedish-match-publishes-annual-report-for-2012-en-1-757112.pdf(accessed 27 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/88/main.PMC4929071.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Walking speed Quality of lifeHealthy aging 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.0052211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
Details of NHANES methodolo-gy are available at: http://wwwn.cdc.gov/nchs/nhanes/search/ nhanes01_02.aspx .,OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
Further details of balance testing proce- dures are available at: http://www.cdc.gov/nchs/data/nhanes/ba.pdf .,OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1093/gerona/glv157 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"Life Outcomes 13, 118. http://dx.doi.org/10.1186/s12955-015- 0314-5 .",Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1016/j.archger.2008.12.006 .,OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1111/j.1532-5415.1994.tb06206.x .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"Age Ageing 43 (1), 31 –37.http://dx.doi.org/10.1093/ageing/aft111 .",Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1016/j.amjcard.2015.04.024 .,OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"Health 7, 43. http://dx.doi.org/10.1186/1744-8603-7-43 .",Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1371/ journal.pmed.1000316 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1080/ 13607860701366335 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1080/03610730802545028 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"BMC Public Health 14,1013. http://dx.doi.org/10.1186/1471-2458-14-1013 .",Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.2519/jospt.1999.29.2.116 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"71 (1), 63 –71.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1093/ageing/afr156 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"305 (1), 50 –58.http://dx.doi.org/10.1001/jama.2010.1923 .",Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.2522/ptj.20100391 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1111/j.1532-5415.2011.03336.x .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://dx.doi.org/10.1111/jocn.12280 .,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
"http://www.who.int/classi ﬁcations/icf/training/icfbeginnersguide.pdf (2002, Accessed December 13, 2015).147 M. Warren et al.",OADS,/arxiv_data1/oa_pdf/e2/5b/main.PMC4929072.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: WalkingRecreationTransportationNeighborhood environmentAgeGender 1.,Non-OADS,/arxiv_data1/oa_pdf/3d/d9/main.PMC4929074.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.001 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/d9/main.PMC4929074.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/d9/main.PMC4929074.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/3d/d9/main.PMC4929074.pdf
@ERSpublications Priority digital health products will be profiled and developed to support the scale-up of WHO ’s End TB Strategy http://ow.ly/4mRRjR The content of this work is ©the authors or their employers.,Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"By the end of 2015, half of the world ’s population had a mobile telephone subscription, representing more than a doubling in coverage within the space of 5 years (https://gsmaintelligence.com/).About 40% of the world ’s population can access the Internet, although coverage and broadband speed differ substantially between and within regions [33].",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"A one-stop Internet hub that links up to differentservices of relevance to TB care could serve to channel health professionals, patients and the wider publicto an appropriate service ( e.g.http://e-sanatate.md/).",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"One reason for this is that the chain of requirements necessary for its properfunctioning at the scale of a country or a laboratory network often has weaknesses in one or more elements.The difficulty of sharing data between different diagnostic technologies has been one formidable hurdle,resulting from either insufficient knowledge or willingness by the manufacturers of equipment to rendertheir machine software compliant with accepted standards that facilitate the interoperability of data withoutadditional costs to the user ( e.g.Health Level Seven (www.hl7.org) and LOINC (http://loinc.org)).",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"These include broader issues in lunghealth and in prevention of NCD, money transfers viamobiles to reward health-promoting behaviour and alleviate poverty, universal health care ( e.g.unique digital identifiers, such as the e-AADHAAR project in India (https://uidai.gov.in)), and other contributors to health system strengthening.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/ bitstream/10665/191102/1/9789241565059_eng.pdf Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"Global strategy and targets for tuberculosis prevention, care and control after 2015. http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R1-en.pdf Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://dannorth.net/introducing-bdd/ Date last accessed: May 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://en.wikipedia.org/wiki/Behavior-driven_development Date last accessed: December 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/135617/1/WHO_HTM_TB_2014.18_eng.pdf Date last accessed: May 9, 2016.",OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://digitalprinciples.org/ Date last accessed: November 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/130918/1/9789241548809_eng.pdf Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://clinicaltrials.gov/ct2/show/NCT01690754 Date last updated: March 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://clinicaltrials.gov/show/NCT01549457 Date last updated: October 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://clinicaltrials.gov/ct2/show/NCT01582711?term=tuberculosis+sms&rank=1 Date last updated: July 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://gph.ucsd.edu/research/active-projects/Pages/vcp-dot.aspx Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://clinicaltrials.gov/ct2/show/NCT02331732 Date last updated: September 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"https://projectreporter.nih.gov/project_info_description.cfm?aid=8848622&icde=27233251&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC Date last accessed: May 9, 2016.",OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/137334/1/WHO_HTM_TB_ 2014.23_eng.pdf Date last accessed: May 9, 2016.",OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/204465/1/WHO_HTM_TB_2015.28_eng.pdf Date last accessed: May 9, 2016.",OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/medicinedocs /documents/s22248en/s22248en.pdf 77 Labrique AB, Vasudevan L, Kochi E, et al.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/200009/1/9789241565110_eng.pdf?ua=1 Date lastaccessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.528.5038&rep=rep1&type=pdf Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://manas.com.ar/projects/cepheid-xpert-platform/ Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://apps.who.int/iris/bitstream/10665/162712/1/9789241508612_eng.pdf Date last accessed: May 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"www.webarchive.org.uk/wayback/archive/20140614020907/http://www.jisc.ac.uk/ whatwedo/programmes/elearning.aspx Date last accessed: May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://elearning.ncsct.co.uk/free Date last accessed: May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://rxforchange.ucsf.edu/ Date last accessed: May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://ctttp.org/ Date last accessed: May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://learnonline.health.nz/index.php Date last accessed: May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"http://eric.ed.gov/?id=ED416377 Date last accessed: May 9, 2016.",OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
"In Orlando, Florida, US, Association for Advancement of Computing in Education, 1998.http://files.eric.ed.gov/fulltext/ED427680.pdf Date last accessed: May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/ERJ-00424-2016.PMC4929075.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sedentary behaviorContextual factorsCommunity belongingPerceived health 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.014 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
http://dx.doi.org/10.1016/j.ypmed.,OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
Available from: http://www23.statcan.,OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
http://dx.doi.org/10.1093/aje/kwv164 .,Non-OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
World Health Organization Available from: http://who.int/mediacentre/factsheets/fs310/en/index2.html .241 S. Anderson et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/53/main.PMC4929076.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: SmokingAbdominal obesityVisceral adipose tissue 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/main.PMC4929077.pdf
1Member of the SESSA Research Group are listed in Appendix A. http://dx.doi.org/10.1016/j.pmedr.2016.06.013 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/main.PMC4929077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/main.PMC4929077.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/main.PMC4929077.pdf
([in Japanese] http://www.healthnet.or.jp/tobacco/product/pd100000.html ).,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/main.PMC4929077.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Attributable fraction (AF)Lifetime healthcare expenditure (LTHE)Work-related cancer Quality-adjusted life expectancy (QALE) 1.,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.0152211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"American Cancer Society, Atlanta (c2014, bhttp://www.cancer.org/Cancer/ColonandRectum Cancer/DetailedGuide/index N).",Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1002/sim.5943 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.5271/sjweh.3282 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"Bureau of Health Promotion Administration, Ministry of Health and Welfare in Taiwan, l. 2010 Cancer Registry Report http://www.hpa.gov.tw/BHPNet/Web/Stat/Statistics Show.aspx?No=201305060001 .",OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://www.ttl.,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1016/S0929- 6646(08)60078-9 .,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/ 10.1111/j.1524-4733.2008.00350.x .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"30, 364– 374. http://dx.doi.org/ 10.1111/j.1365-2036.2009.04050.x .",Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://win.dgbas.gov.tw/dgbas04/ bc4/timeser/ .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1016/S0140- 6736(02)11403-6 .,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1093/qjmed/hcl141 .,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1002/ (SICI)1097-0258(19990715)18:13 b1627::AID-SIM159 N3.0.CO;2-D .,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1186/1745-6673-6-24 .92 L.J.-H. Lee et al.,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1136/oemed-2011-100462 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1111/j.1524- 4733.2009.00518.x .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"Health Metrics 7, 7. http://dx.doi.org/10.1186/1478-7954-7-7 .",Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1016/ S0140-6736(12)61689-4 .,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://www.nhi.gov.tw/webdata/ webdata.aspx?menu=17&menu_id=1023&WD_ID=1043&webdata_id=4004 .,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.5271/sjweh.605 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"http://dx.doi.org/10.1038/bjc.2011.487 .Parkin, D., Rice, N., Devlin, N., 2010.",Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1177/ 0272989X09357473 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/ 10.1080/02841860902913546 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"53, 64 –71.http://dx.doi.org/10.1002/ajim.20778 .",Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"Of ﬁce of Pollution Prevention and Toxics, Economics Exposure and Technology Division, RegulatoryImpacts Branch, Washington, DC ( bhttp://yosemite.epa.gov/ee/epa/eed.nsf/pages/ InternetLinksSubject.html?OpenDocument&Count=300&ExpandView N).",OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1002/ajim.1056 .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
"Value Health 12, S5–S9.http://dx.doi.org/10.1111/j.1524-4733.2009.00515.x .",Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://www.who.int/occupational_health/globstrategy/en/ .,Non-OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
http://dx.doi.org/10.1086/497131 .93 L.J.-H. Lee et al.,OADS,/arxiv_data1/oa_pdf/be/14/main.PMC4929078.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Intellectual disability Physical activityPhysical activity levelMeasurement of physical activity Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.008 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
Available at http://www.crd.york.ac.uk/PROSPERO .,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
(Available from: http://www.health.gov.au/internet/ main/publishing.nsf/content/health-pubhl th-strateg-phys-act-guidelines#apaadult ).,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
(Available from: https://data.gov.uk/dataset/social- care-and-mental-health-indicators-from-the-national-indicator-set ).,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
": Contract No., http://www.hscic.gov.uk/catalogue/PUB13648/ Obes-phys-acti-diet-eng-2014-rep.pdf).218 Y.M.",Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
(Available from: http://www.who.int/dietphysicalactivity/ publications/recommendations18_64yearsold/en/Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC4929079.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Motor activityPhysical ﬁtness Social class 1.,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC4929080.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.010 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC4929080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC4929080.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC4929080.pdf
http://dx.doi.org/10.1111/joim.12384 .,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC4929080.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Smart gunViolence Gun purchasing 1.,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
In the 1990s Congress and the National Institutes of Justice funded several gun manufactures and the New Jersey Institute of Tech-nology to support research aimed at developing advanced safety fea- tures that would prevent unauthorized use of police-issued handgunsPreventive Medicine Reports 4 (2016) 11 –16 http://dx.doi.org/10.1016/j.pmedr.2016.05.005 2211-3355/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
"79, 5 –14.http://dx.doi.org/10.1016/j.ypmed.2015.06.002 .",OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
Gallup.com URL http://www.gallup.com/poll/ 1645/Guns.aspx (accessed 7.27.15).,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
http://www.popsci.com/how- guns-got-smarter .,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
"13, 15 –19.http://dx.doi.org/10.1136/ip.2006.",OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
Urban Inst URL http://www.urban.org/ research/publication/state-variation-hospital-use-and-cost- ﬁrearm-assault-injury- 2010 (accessed 2.26.16).,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
http://dx.doi.org/10.1542/peds.2013- 1809 .,OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
URL http://www.nj.com/politics/index.ssf/2016/01/christie_pocket_vetoes_ controversial_smart_gun_bil.html .,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
URL https://www.nraila.org/issues/smart-gunspersonalized- ﬁrearms/ (accessed 2.19.16).,OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
URL http://www.gallup.com/poll/165605/personal-safety- top-reason-americans-own-guns-today.aspx .,Non-OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
"Public Health 106, 411– 413. http://dx.doi.org/10.2105/ AJPH.2015.303041 .Table 4 Logistic and ordered logistic regression model predicting smart gun preference for non-owners (n = 263), odds ratios shown.",OADS,/arxiv_data1/oa_pdf/45/70/main.PMC4929081.pdf
Keywords: Clostridium difﬁcile infection; Fecal microbiota; Fecal transplant; Patient perspectives; Patient reported outcomes; QuestionnaireEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 7A84F0601DE3BEE1 .,Non-OADS,/arxiv_data1/oa_pdf/ab/48/40121_2016_Article_106.PMC4929085.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, provide a linkto the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ab/48/40121_2016_Article_106.PMC4929085.pdf
"The implementation of meningococcal conjugate vaccination programs in many areas of the world (including the massive campaign in sub-Saharan Africa using a serogroup A conjugate vaccine) has led to dramaticEnhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/ DB84F0607E9D292D .",Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Can be administered when repeat dosing not anticipated Canada Note: Provinces/territories may vary in schedule Seehttp://healthycanadians.gc.ca/apps/schedule-calendrier/index-eng.php Protein B MenB-4C (Bexsero)2 months–17 years Not routinely administered.,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditInfect Dis Ther (2016) 5:89–112 107",Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
http://www.cdc.gov/meningococcal/ clinical-info.html .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at https://www.gov.uk/ government/groups/joint-committee-on-vaccinati on-and-immunisation .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ﬁle/309218/Green_Book_Chapter_7_v1_3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at https://www.gov.uk/government/uploads/system/ uploads/attachment_data/ﬁle/462629/2904512_Green_Book_Chapter_22_v6_0W.PDF .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ﬁle/147882/Green-Book-Chapter-12.pdf .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
"74. WHO Weekly epidemiological record-Meningococcal A conjugate vaccine: updated guidance, February 2015;90, 57–68.Available at http://www.who.int/wer/2015/ wer9008.pdf?ua=1 .",Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at: http://vaccine-schedule.ecdc.europa.eu/Pages/ Scheduler.aspx .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at http://www.fda.gov/downlo ads/biologicsbloodvacci nes/vaccines/approvedproducts/ucm131170.pdf .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at: http://www.cdc.gov/vaccines/ schedules/downloads/child /0-18yrs-child-combined- schedule.pdf .,Non-OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
Available at:http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?,OADS,/arxiv_data1/oa_pdf/99/4a/40121_2016_Article_107.PMC4929086.pdf
"Funding : Vaxart, Inc. Keywords: Ferret; Inﬂuenza; Mouse; Oral; VaccinationEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5E84F06034FA1B2F .",Non-OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
Statistical Analysis Signiﬁcance between groups was determined by Mann–Whitney analysis using Prism software or by Fisher’s exact test ( http://vassarstats.net/ tab2x2.html ).Pvalues \0.05 were considered signiﬁcant.,OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
http://emergency.cdc.gov/han/han00374.,OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
http://www.cdc.gov/ﬂu/professionals/ vaccination/effectiveness-studies.htm .,Non-OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
http://www.cdc.gov/ﬂu/protect/ vaccine/vaccines.htm .,Non-OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
FLUARIX QUADRIVALENT Prescribing Information.http://www.fda.gov/downloads/BiologicsBloodVac cines/Vaccines/ApprovedProducts/UCM220624.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/f0/40121_2016_Article_108.PMC4929087.pdf
"ICU hospitalization, prolonged hospital stay,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 64C4F0605464E11B .",Non-OADS,/arxiv_data1/oa_pdf/3c/39/40121_2016_Article_109.PMC4929088.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3c/39/40121_2016_Article_109.PMC4929088.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B3D4F06064AD711D .,Non-OADS,/arxiv_data1/oa_pdf/92/6a/40121_2016_Article_110.PMC4929089.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/92/6a/40121_2016_Article_110.PMC4929089.pdf
"Clinicians should be aware that daptomycin can cause immediate-type hypersensitivity reactions, including acute angioedema, even upon ﬁrst administration.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 04D4F0603DE6E6DC .",Non-OADS,/arxiv_data1/oa_pdf/32/df/40121_2016_Article_111.PMC4929090.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.204 Infect Dis Ther (2016) 5:201–205",Non-OADS,/arxiv_data1/oa_pdf/32/df/40121_2016_Article_111.PMC4929090.pdf
REFERENCES 1. http://www.fda.gov/Drugs/ DrugSafety/Postmarket DrugSafetyInformationforPatientsandProviders/ucm 220282.htm .,Non-OADS,/arxiv_data1/oa_pdf/32/df/40121_2016_Article_111.PMC4929090.pdf
2. http://www.swissmedicinfo.ch .,Non-OADS,/arxiv_data1/oa_pdf/32/df/40121_2016_Article_111.PMC4929090.pdf
15. https://vigilyze.who-umc.org .,Non-OADS,/arxiv_data1/oa_pdf/32/df/40121_2016_Article_111.PMC4929090.pdf
EUCAST criteria produced intermediate and resistant MIC values for these oralEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 44D4F0602B558BD5 .,Non-OADS,/arxiv_data1/oa_pdf/85/6c/40121_2016_Article_112.PMC4929091.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate ifchanges were made.",Non-OADS,/arxiv_data1/oa_pdf/85/6c/40121_2016_Article_112.PMC4929091.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ C6D4F0603D2C3510 .,Non-OADS,/arxiv_data1/oa_pdf/b0/24/40121_2016_Article_113.PMC4929092.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b0/24/40121_2016_Article_113.PMC4929092.pdf
Disponible sur: http://apps.who.int/iris/bitstream/10665/191102/1/978924156 5059_eng.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/b0/24/40121_2016_Article_113.PMC4929092.pdf
"International studies, largely centered in Europe, demonstrate high overall concordance between procalcitonin algorithms andEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 07D4F0600FD6303A .",Non-OADS,/arxiv_data1/oa_pdf/61/04/40121_2016_Article_114.PMC4929093.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.190 Infect Dis Ther (2016) 5:185–191",Non-OADS,/arxiv_data1/oa_pdf/61/04/40121_2016_Article_114.PMC4929093.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HPV vaccineAdolescentYoung adultImmunizationNIS-Teen 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.014 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
Centers for Disease Control and Prevention ([05/09/2016]; Availablefrom: http://www.cdc.gov/nchs/nis/data_ ﬁles_teen.htm ).,OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
Centers for Disease Control and Prevention ([01/16/2016]; Available from: http://www.cdc.gov/vaccines/imz-managers/coverage/ nis/teen/tables/12/tab01_iap_2012.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
National Center for Immunization and Respiratory Diseases and Na- tional Center for Health Statistics ([01/21/2016]; Available from: ftp://ftp.cdc.gov/ pub/Health_statistics/NCHS/Dataset_Documentation/NIS/NISPUF12_DUG.PDF ).,OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
U.S. Department of Health and Human Services: Of ﬁce of Disease Prevention and Health Promotion ([01/16/2016]; Available from: http://www.healthypeople.gov/2020/topics-objectives/topic/ immunization-and-infectious-diseases/objectives ).,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
Centers for Disease Control and Prevention ([01/ 16/2016]; Available from: http://www.cdc.gov/vaccines/imz-managers/coverage/ nis/teen/tables/14/tab01_iap_2014.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/0a/13/main.PMC4929120.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Workplace injuryAgriculture Obesity SexPrevention 1.,Non-OADS,/arxiv_data1/oa_pdf/da/0e/main.PMC4929122.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.003 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/da/0e/main.PMC4929122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/0e/main.PMC4929122.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/da/0e/main.PMC4929122.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Adverse childhood experience Childhood traumaHIV risk behaviorsGender-speci ﬁc Sexual health 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/8d/main.PMC4929123.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.019 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/3c/8d/main.PMC4929123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/8d/main.PMC4929123.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/3c/8d/main.PMC4929123.pdf
Detailed information about the study design and methodology is available from the CDC'swebsite: http://www.cdc.gov/brfss/ .,Non-OADS,/arxiv_data1/oa_pdf/3c/8d/main.PMC4929123.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Dysexecutive functionChronic kidney diseaseMetabolic syndromeAbdominal obesity 1.,Non-OADS,/arxiv_data1/oa_pdf/84/57/main.PMC4929124.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.007 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/84/57/main.PMC4929124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/57/main.PMC4929124.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/84/57/main.PMC4929124.pdf
Available from: http://www.idf.org/webdata/docs/IDF_Meta_def_ ﬁnal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/84/57/main.PMC4929124.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Community-basedEpidemiologic studiesExpert assessmentExtremely low frequency magnetic ﬁelds Job-exposure matrixOccupational exposure 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/0e/main.PMC4929127.pdf
"1Present address: Division of Cancer Epidemiology, McGill University, 546 Pine Avenue West, Montréal, Québec, Canada, H2W 1S6 http://dx.doi.org/10.1016/j.pmedr.2016.05.0172211-3355/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/0e/main.PMC4929127.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/0e/main.PMC4929127.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/d6/0e/main.PMC4929127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: FatherhoodExercisePhysical activitySportParenthood Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.018 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1016/j.amepre.2012.02.032 .,OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1093/her/cyl063 .,OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
"Sports 4 (1), 19–25.http://dx.doi.org/10.1111/j.1600-0838.1994.tb00401.x .",Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1542/peds.2010-3218 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1006/pmed.2000.0763 .,OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1080/02614360500467735 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1001/jama.296.19.2365 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1037/ 0893-3200.21.3.331 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1080/17430430903137746 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1503/cmaj.051351 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
http://dx.doi.org/10.1177/1012690211403196 .,Non-OADS,/arxiv_data1/oa_pdf/87/23/main.PMC4929128.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ObesityDay carePreschoolYoung childrenAmerican Indian Introduction During 2011 –2012, 8.4% of 2-to-5-year-old U.S. children (i.e., young children) were reported to be obese ( Ogden et al., 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/b5/ad/main.PMC4929137.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.0032211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/ad/main.PMC4929137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/ad/main.PMC4929137.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b5/ad/main.PMC4929137.pdf
"http://www.okchildcareportfolio.org/default.asp (Accessed June, 2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/ad/main.PMC4929137.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
http://dx.doi.org/10.1016/j.pmedr.2014.11.003 2211-3355/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
Available at: http://www.sfbos.org/ftp/ uploaded ﬁles/bdsupvrs/committees/materials/lu092710_101096.pdf (Accessed: March 8 2014).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
Available at: http://webprod3.hc-sc.,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
Avail- able at: http://www.hc-sc.gc.ca/fn-an/label-etiquet/nutrition-facts-valeur-nutritive-fs- fr-eng.php (Accessed: July 28 2014).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
Available at: http://www.fda.gov/food/guidanceregulation/ guidancedocumentsregulatoryinforma tion/labelingnutrition/ucm385663.htm (Accessed: July 28 2014 2014).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
"Available at:, http://ndb.nal.usda.gov/ (Accessed: March 23 2014).",Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
Available at: http://www.who.int/mediacentre/news/notes/ 2014/consultation-sugar-guideline/en/ (Accessed: March 9 2014).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/main.PMC4929138.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Return on investmentPublic healthSavingsEconomic evaluation Introduction Return on investment (ROI) is a ratio that has come into increasing use over recent years.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.11.015 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
"American Public Health Association, Washington, DC (Available at: https://www.youtube.com/watch?v=B5M9JefYxJ ).Table 1 Examples of public health intervention ROIs, ranked highest to lowest.",Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
"Canadian Institute for Health Information, Ottawa, ON (Available at: https://secure.cihi.ca/free_products/ NHEXTrendsReport2012EN.pdf .",Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
"Canadian Public Health Association, Ottawa, ON (Available at:http://www.cpha.ca/uploads/policy/enhance_ph_e.pdf .",Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
"Canadian Public Health Association., Ottawa, ON (Available at: http://www.cpha.ca/en/internal/homepage/roi-video.aspx .",Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
Available at: http://www.hsph.harvard.edu/news/magazine/public-health-economy- election/ .,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
"Julian King & Associ- ates Ltd., Auckland, NZ (Available at: http://www.julianking.co.nz/wp-content/ uploads/2014/09/140908-VFI-JK-web.pdf .",Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
iHEA 2007 6th World Congress: Ex- plorations in Health Economics (Available at: http://papers.ssrn.com/sol3/papers.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
Available at: http://www.who.int/healthpromotion/conferences/previous/ottawa/en/ .,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
Avail- able at: http://www.who.int/trade/glossary/story076/en/ .,Non-OADS,/arxiv_data1/oa_pdf/b5/61/main.PMC4929139.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MelanomaTanningRisk factorsPreventionAdolescents Contents I n t r o d u c t i o n ................................................................ 1 3 9 M e t h o d s.................................................................. 1 4 0R e s u l t s a n d d i s c u s s i o n ............................................................ 1 4 0 T h e h e a l t h r i s k s o f U V r a d i a t i o n o b t a i n e d f r o m i n d o o r t a n n i n g....................................... 1 4 0I n d o o r t a n n i n g a n d s u n s e n s i t i v i t y .................................................... 1 4 1P o p u l a t i o n s a t i n c r e a s e d r i s k o f i n d o o r t a n n i n g.............................................. 1 4 1I n d o o r t a n n i n g l e g i s l a t i o n a n d p r e v e n t i o n i n t h e U n i t e d S t a t e s : c u r r e n t a p p r o a c h e s .............................. 1 4 2 D o e s t a n n i n g b e d l e g i s l a t i o n w o r k ?,Non-OADS,/arxiv_data1/oa_pdf/f4/7c/main.PMC4929140.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.11.0162211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/7c/main.PMC4929140.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/7c/main.PMC4929140.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f4/7c/main.PMC4929140.pdf
http://www.cdc.gov/cancer/skin/burningtruth/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/f4/7c/main.PMC4929140.pdf
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm350790.,Non-OADS,/arxiv_data1/oa_pdf/f4/7c/main.PMC4929140.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Physical activity program Classroom behavior Elementary school Introduction Physical activity (PA) is associated with extensive health bene ﬁts (Janssen and LeBlanc, 2010 ), but a large proportion of American youth do not meet the national PA guidelines ( National Physical Activity Plan Alliance, 2014; Troiano et al., 2008 ).",Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.0102211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
"Re- trieved from: http://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/ tool_for_schools.html Chang, Y.K., Liu, S., Yu, H.H., Lee, Y.H., 2012.",Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1093/arclin/acr094 .,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1016/j.tate.2010.,OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
"7, 40. http://dx.doi.org/10.1186/1479-5868-7-40 .Jarrett, O.S., Maxwell, D.M., Dickerson, C., Hoge, P., Davies, G., Yetley, A., 1998.",Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1249/01.mss.0000235359.16685.,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
"1 5), 24. http://dx.doi.org/10.1249/01.",Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1016/j.beth.,OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1016/ j.beth.2010.08.006 .,OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1080/17470210500162854 .,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
http://dx.doi.org/10.1249/mss.0b013e31815a51b3 .202 M. Stylianou et al.,Non-OADS,/arxiv_data1/oa_pdf/61/e0/main.PMC4929141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Healthy People 2020 US Peace Corps Health indicatorsHealth metrics 1.,Non-OADS,/arxiv_data1/oa_pdf/11/d2/main.PMC4929143.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.05.016 2211-3355/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/11/d2/main.PMC4929143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/d2/main.PMC4929143.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/11/d2/main.PMC4929143.pdf
"http://www.peacecorps.gov/about/fastfacts/ (Accessed November 15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/11/d2/main.PMC4929143.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cost-effectiveness PreventionReturn on investmentWorksite health promotion Introduction The cost of insurance premiums and employee medical claims costs have increased in recent years and are at an all-time high ( The Henry J. Kaiser Family Foundation, 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.002 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
"US Department of Health and Human Services, CDC, Atlanta, GA (Retrieved from http://www.cdc.gov/brfss/questionnaire/pdf-ques/2006brfss.pdf ).",OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
"US Department of Health and Human Services, Atlanta, GA (Retrieved from http://www.cdc.gov/ sustainability/worksitewellness/ ).",Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
Retrieved from http://www.nytimes.com/2014/09/12/ upshot/do-workplace-wellness-programs-work-usually-not.html?abt=0002&abg= 0&_r=1 .,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
Retrieved from https://www.dol.gov/ebsa/pdf/workplacewellnessmarketreview2012.,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
Retrieved from https://www.metlife.com/assets/cao/foundation/MetLife- Teacher-Survey-2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
Retrieved from http://www.cdc.gov/ nchs/hus.htm .,OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
Available at http://www.halfhill.com/in ﬂation_js.html .,Non-OADS,/arxiv_data1/oa_pdf/64/70/main.PMC4929144.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Religion SpiritualityPreventionEmergency medicineBurnout Introduction According to a recent survey conducted by the Physicians' Foundation, more than half of physicians in the United States are pessimistic about the future of the medical profession, about one third report feeling “overextended and overworked ”, and almost half plan to retire or take various steps to reduce patient load —such as cutting back on hours or re- ducing the number of patients they see (Anon., 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/bd/e1/main.PMC4929145.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.009 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/e1/main.PMC4929145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/e1/main.PMC4929145.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/bd/e1/main.PMC4929145.pdf
The Physicians Foundation (Accessed 5/23/2015 at http://www.physiciansfoundation.,Non-OADS,/arxiv_data1/oa_pdf/bd/e1/main.PMC4929145.pdf
"February 2015, Available at http://www.fetzer.org (Accessed 5/27/2015).",OADS,/arxiv_data1/oa_pdf/bd/e1/main.PMC4929145.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HispanicsObesityPsychosocialDietary behavior 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/80/main.PMC4929149.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.002 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/80/main.PMC4929149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/80/main.PMC4929149.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/1f/80/main.PMC4929149.pdf
"Available at: http://quickfacts.census.gov/qfd/states/06/0620802.html (Accessed: July 12, 2014).",OADS,/arxiv_data1/oa_pdf/1f/80/main.PMC4929149.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.006 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
This study is registered at Clinicaltrials.gov # NCT01373320 and additional protocol information may be accessed at https://www.clinicaltrials.gov/ct2/ show/NCT01373320?term=smoking+cessation&state1=NA%3AUS% 3AKY&rank=19 .,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
"http://apps.nccd.cdc.gov/DDTSTRS/default.aspx (Accessed June 20, 2012).",OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
http://www.arc.gov/research/researchreportdetails.,OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
http://www.wpro.who.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/main.PMC4929151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: China Physical activity EnvironmentTransportationRecreation Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.007 2211-3355/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"69 (2014), S79 –S85 ( http://dx.doi.org/10.1016/j.ypmed.",OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"http://dx.doi.org/10.1249/MSS.0000000000000367 .Table 3 Results in the expected or unexpected/null direction, organized by environmental factors and by type of physical activity.",OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
China Bus Rev (At: http://www.chinabusinessreview.com/chinas-emerging-tier-2- cities-opportunities-for-us-companies/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"A guide to prosperous, low- carbon urbanization (At: http://energyinnovation.org/wp-content/uploads/2014/11/ Planning-Cities-for-People.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.1111/tesg.12068 .,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
At: https://sites.google.com/site/theipaq/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
At: http://news.nationalgeographic.com/news/2006/08/060808-china-fat.,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.2105/AJPH.,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.1016/j.socscimed.2009.01.035 .,OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"Monash University, Business and Economics (At: http://www.buseco.monash.edu.au/units/ dru/papers/working-papers-05/0805-crime.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"At: http://www.time.com/time/world/article/0 ,8599,1904334,00.html#-ix zz1xdLqTXVlS).",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"http://dx.doi.org/ 10.1249/MSS.0b013e31817c67a4.Sallis, J.F., 2011.",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
(At: http://www.epa.gov/ogc/china/air%20pollution.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"51, 26 –34.http://dx.doi.org/10.1016/j.apgeog.2014.03.006 .",OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"World Health Organization., Geneva (At: http://www.who.int/chp/ chronicdiseasereport/fullreport.pdf?ua=1 ).",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"At:http://www.who.int/gho/ncd/riskfactors/overweight/en/ Xu, F., Li, J., Liang, Y., Wang, Z., Hong, X., Ware, R.S., Leslie, E., Sugiyama, T., Owen, N., 2009.",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.1007/s11524-009-9409-9 .,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.1136/jech.2009.094169 .,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.3390/su6063599 .,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
http://dx.doi.org/10.3390/su6021076 .,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"Public Health http://dx.doi.org/10.1155/2013/239595 (2013, Article ID 239595).316 K. Day / Preventive Medicine Reports 3 (2016) 303 –316",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/main.PMC4929152.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c3/d0/40273_2016_Article_412.PMC4929169.pdf
Available from: https://www.nice.org.uk/article/PMG9/chapter/1-Introduction .,Non-OADS,/arxiv_data1/oa_pdf/c3/d0/40273_2016_Article_412.PMC4929169.pdf
https://www.gov.uk/government/publications/nhs- reference-costs-2013-to-2014 .,Non-OADS,/arxiv_data1/oa_pdf/c3/d0/40273_2016_Article_412.PMC4929169.pdf
Consumer price inﬂation May 2014. http://www.ons.gov.uk/economy/inﬂationandpriceindices/ timeseries/icvj .,Non-OADS,/arxiv_data1/oa_pdf/c3/d0/40273_2016_Article_412.PMC4929169.pdf
"Zaaijer et al., 2016, Cell Reports 16, 148–160 June 28, 2016 http://dx.doi.org/10.1016/j.celrep.2016.05.077",OADS,/arxiv_data1/oa_pdf/03/07/main.PMC4929174.pdf
"Cell Reports Article Rif1 Regulates the Fate of DNA Entanglements during Mitosis Sophie Zaaijer,1,2Nadeem Shaikh,1Rishi Kumar Nageshan,1and Julia Promisel Cooper1,* 1Laboratory of Biochemistry and Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA 2Present address: New York Genome Center, 101 Avenue of the Americas, New York, NY 10013, USA *Correspondence: julie.cooper@nih.gov http://dx.doi.org/10.1016/j.celrep.2016.05.077 SUMMARY Clearance of entangled DNA from the anaphase mid- region must accurately proceed in order for chromo-somes to segregate with high ﬁdelity.",Non-OADS,/arxiv_data1/oa_pdf/03/07/main.PMC4929174.pdf
"The telomere binding protein Taz1 mitigates the tendency of telomere repeats to impede replication in S. pombe (Miller et al., 2006 ); this ability to promote telomere replication has been shown to be a conserved role 148 Cell Reports 16, 148–160, June 28, 2016 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/03/07/main.PMC4929174.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, one table, and four movies and can be found with this article onlineathttp://dx.doi.org/10.1016/j.celrep.2016.05.077 .",Non-OADS,/arxiv_data1/oa_pdf/03/07/main.PMC4929174.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Indoor tanning Skin cancerRisk perceptionSexSkin cancer screening 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.0112211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1097/ DBP.0000000000000050 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.3200/JACH.56.5.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.3109/00952990.2013.850503 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.5888/pcd11.140191 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"66 (1), 63 –70.http://dx.doi.org/10.1016/j.jaad.2010.11.044 .",OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1001/archdermatol.2010.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1111/j.1755-148X.2009.00656.x .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1111/j.1468-3083.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"Multiple skin cancer risk behaviors in the U.S. p o p u l a t i o n .A m .J .P r e v .M e d .3 4( 2 ) ,8 7 –93.http://dx.doi.org/10.1016/j.amepre.",Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.amjmed.,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/S0277-9536(99)00390-1 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1001/archderm.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.canep.2012.12.006 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"Food and Drug Administration, HHS (http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm350790.htm ).",Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"38(3), 74 –82.http://dx.doi.org/10.1080/08964289.",Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1001/jamadermatol.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1001/archderm.143.3.397 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1001/ archdermatol.2010.85 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.jadohealth.2012.09.021 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.amepre.2013.02.014 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"73(1), 83 –92.http://dx.doi.org/10.1016/j.jaad.2015.02.1112 (e1.).",OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1348/ 135 910710X514120 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1093/her/cyv013 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"61, 75 –80.http://dx.doi.org/10.1016/j.ypmed.2014.01.003 .",OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1001/archdermatol.2009.303 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.jadohealth.2011.08.007 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.socscimed.2014.02.014 .286 A.K.,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/ 10.1001/archdermatol.2009.385 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
Retrieved from http://pubs.niaaa.nih.gov/publications/ Newsletter/winter2004/Newsletter_Number3.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
Retrieved from ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/ 2010/srvydesc.pdf .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1007/s10552-005- 0453-9 .,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"5 (1), 71 –83.http://dx.doi.org/10.1080/1369857031000066014 .Physical Activity Guidelines Advisory Committee, 2008.",Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
http://dx.doi.org/10.1016/j.drugalcdep.2012.05.037 .,OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
1 –15 (Retrieved from http://democrats.energycommerce.house.gov/sites/de- fault/ ﬁles/documents/False-Health-Info-by-Indoor-Tanning-Industry-2012-2-1.pdf).,Non-OADS,/arxiv_data1/oa_pdf/7e/26/main.PMC4929176.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cancer risk factorsRisk perceptionsSocio-economic status Introduction Cancer heavily contributes to social health inequalities ( HCSP [French High Council for Public Health], 2009 ;Huisman et al., 2005 ).",Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.008 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
"Boulogne-Billancourt, Inca (http://www.e-cancer.fr/publications/99-recherche/774-la-vie-deux-ans-apres-un-diagnostic-de-cancer-de-lannonce-a- lapres-cancer ).",Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
"INPES, Saint-Denis ( http://www.inpes.sante.fr/CFESBases/catalogue/pdf/991.",Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
"INPES, Saint-Denis ( http://www.inpes.sante.fr/CFESBases/catalogue/pdf/1405.",Non-OADS,/arxiv_data1/oa_pdf/dc/06/main.PMC4929177.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Parental perceptionsBEAP studyBuilt environmentActive play 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.001 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"([Internet] [cited 2015 November 9], Available from:) http://censusreporter.org/ proﬁles/31000US47900-washington-arlington-alexandria-dc-va-md-wv-metro- area/ .",OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"([cited 2015 September 16], Available from:) http://health.gov/paguidelines/ .",Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"([cited 2014 February 11], Avail- able from:) http://www.nikproject.org/About_Us.htm .",Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"([cited 2014 February 11], Available from:) http://www.seattlechildrens.org/ research/child-health-behavior-and-development/saelens-lab/measures-and- protocols/ .",Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"([cited 2015 September 16], Available from:) http://www.childhealthdata.org .",Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"([cited 2014 May 21], Available from:) http://www.walkscore.com/methodology.shtml .",Non-OADS,/arxiv_data1/oa_pdf/f8/e0/main.PMC4929179.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Greenspace ChildrenSelf-reportKid-KINDLGIS spatial analysisHealth-related quality of life Introduction The health and wellbeing of urban residents have become a major research focus ( Nutsford et al., 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.013 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"70, 46 –49.http://dx.doi.org/10.1016/j.ypmed.2014.11.018 .",OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1007/s10393- 014-0952-9 .,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/j.healthplace.2007.11.002 .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1007/BF02310555 .,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"Online 6 (2), 6 –26.http://dx.doi.org/10.4256/mio.2010.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"http://dx.doi.org/10.1146/annurev.psych.57.102904.190057 .Flouri, E., Midouhas, E., Joshi, H., 2014.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/j.jenvp.2014.06.007 .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"Medicine 42 (2), 77 –79.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/j.healthplace.2008.09.006 .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"71, 29 –35.http://dx.doi.org/10.1016/j.envint.2014.06.002 .",OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/S0140-6736(08)61689-X .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/j.puhe.2013.08.016 .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/S0277-9536(02)00163-6 .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"Retrieved: 26th February 2014, from http://www.scotland.gov.uk/Resource/Doc/225179/0060935.pdf .",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://www.sns.gov.uk/Simd/Simd.aspx .,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"Plymouth City Council, Retrieved 18th February, 2014, from http://www.plymouth.gov.uk/parks_services_questionnaire.pdf Spencer, C., Blades, M.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"Community Health 62 (5), e9.http://dx.doi.org/10.1136/jech.2007.064287 .Ulrich, R.S., 1984.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1126/science.6143402 .,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/S0272-4944(05)80184-7 .,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"Retrieved March 20, 2015, from http://www.csd.org.uk/ uploaded ﬁles/ﬁles/value_of_green_space_report.pdf .",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
"105 (3), 221– 229. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1177/0013916503035003001 .,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
http://dx.doi.org/10.1016/j.landurbplan.2014.01.017 .221 D.S.,OADS,/arxiv_data1/oa_pdf/0e/e4/main.PMC4929180.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ovarian cancer AwarenessSymptomsCare seekingEarly detection of cancer Introduction Ovarian cancer causes more deaths in the United States than any other cancer of the female reproductive system.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC4929181.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.0112211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC4929181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC4929181.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC4929181.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC4929181.pdf
http://dx.doi.org/10.1258/jhsrp.2011.010113 .237 C.P.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC4929181.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cigarette smoking Gene –environmental interaction Gene polymorphism Glycated hemoglobinInﬂammatory cytokine 1.,Non-OADS,/arxiv_data1/oa_pdf/12/b4/main.PMC4929182.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.010 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/b4/main.PMC4929182.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/b4/main.PMC4929182.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/12/b4/main.PMC4929182.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Food categories Best price foods Food composition databaseFood costEnergy 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/main.PMC4929183.pdf
"E-mail addresses: Saman.KhalatbariSoltani@unil.ch (S. Khalatbari-Soltani), Pedro-Manuel.Marques-Vidal@chuv.ch (P. Marques-Vidal).1BPF, best price food 2BNF, brand name food http://dx.doi.org/10.1016/j.pmedr.2016.02.0012211-3355/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b6/ed/main.PMC4929183.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/main.PMC4929183.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/main.PMC4929183.pdf
http://www.bfs.admin.ch/bfs/portal/fr/index/themen/20/ 02/blank/dos/03/02.html (accessed June 26 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/main.PMC4929183.pdf
http://www.swissinfo.,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/main.PMC4929183.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Epidemiology MobilityMedicationHypertension 1.,Non-OADS,/arxiv_data1/oa_pdf/55/0c/main.PMC4929186.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.0092211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/55/0c/main.PMC4929186.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/0c/main.PMC4929186.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/55/0c/main.PMC4929186.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sedentary behaviour Sitting ChildrenHealthInterventions Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.016 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
http://dx.doi.org/10.1016/j.amepre.2012.05.027 .,OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
1 –16http://dx.doi.org/10.1080/ 09613218.2015.1058093 (July 2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
"Health 50 (08), 54 –60 (Available at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=35796&#abstract ).",Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
"Public Health 11 (9), 9361 –9375 (Available at: http://www.mdpi.com/1660-4601/11/9/9361/ ).Bhui, K.S., Aslam, R.W., Palinski, A., et al., 2015.",Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
http://dx.doi.org/ 10.1192/bjp.bp.114.158899 .,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
Public Health 1 –8http://dx.doi.org/10.1093/pubmed/fdv084 .,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
1 –10http://dx.doi.org/10.1080/14635240.2015.1029641 (June).,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
"8 (3), 173 –199 (Available at: http://ajl.sagepub.",Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
"Health 9 (7), 1009 –1011 (Available at: http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
"8 (1), 98 (Available at: http://www.ijbnpa.org/content/8/1/98 ).",Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
http://dx.doi.org/10.1038/ijo.2011.68 .,OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4929187.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diet EpidemiologyHealthMortalityPhysical activitySmokingSurvivalWeight 1.,Non-OADS,/arxiv_data1/oa_pdf/68/16/main.PMC4929208.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.013 2211-3355/© 2016 Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/68/16/main.PMC4929208.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/16/main.PMC4929208.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/68/16/main.PMC4929208.pdf
"Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Departmentof Agriculture, Beltsville, MD Available at: http://www.ars.usda.gov/ba/bhnrc/fsrg .",Non-OADS,/arxiv_data1/oa_pdf/68/16/main.PMC4929208.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AdultsBioelectric impedance analysis Domains of physical activity Switzerland Introduction Physical activity and sports contribute to between 25% and 50% of total daily energy expenditure ( Bouchard et al., 2007 ) and can thus be important factors for weight control.",Non-OADS,/arxiv_data1/oa_pdf/f2/00/main.PMC4929209.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.007 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/00/main.PMC4929209.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/00/main.PMC4929209.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f2/00/main.PMC4929209.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: IndigenousAustralianPhysical activity Adults NeighborhoodSocial Networks Introduction Physical inactivity is the third leading cause of the burden of disease for Australian Aboriginal and Torres Strait Islander* adults ( Vos et al., 2007 ).",Non-OADS,/arxiv_data1/oa_pdf/71/7b/main.PMC4929210.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.0062211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/7b/main.PMC4929210.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/7b/main.PMC4929210.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/71/7b/main.PMC4929210.pdf
54 –58 (Available from: http://www.abs.gov.au/websitedbs/ censushome.nsf/home/seifa ).,OADS,/arxiv_data1/oa_pdf/71/7b/main.PMC4929210.pdf
([cited 2014 21 August].Available from: http://www.health.gov.au/internet/main/publishing.nsf/content/ health-pubhlth-strateg-phys-act-guidelines#apaadult ).,Non-OADS,/arxiv_data1/oa_pdf/71/7b/main.PMC4929210.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Knowledge translationCommunityGardensWellbeingHealth promotion Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/44/f4/main.PMC4929211.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.0052211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/main.PMC4929211.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/f4/main.PMC4929211.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/44/f4/main.PMC4929211.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Health behaviorsExerciseMeasurementWomen 1.,Non-OADS,/arxiv_data1/oa_pdf/52/e6/main.PMC4929212.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.0042211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/52/e6/main.PMC4929212.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/e6/main.PMC4929212.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/52/e6/main.PMC4929212.pdf
Available at: http://www.cdc.gov/media/releases/2013/p0502- physical-activity.html .2 0 1 5 .,OADS,/arxiv_data1/oa_pdf/52/e6/main.PMC4929212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/e9/main.PMC4929213.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.014 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/e9/main.PMC4929213.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/e9/main.PMC4929213.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/60/e9/main.PMC4929213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: NutritionPhysical activityChildhood obesity Cognitive development Executive functionEarly learning Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.0032211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
Methods This systematic review followed the PRISMA guidelines and the de- tails of the protocol were registered on PROSPERO which can be accessed at http://www.crd.york.ac.uk/PROSPERO/ (Registration No.,Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
"American Academy of Pediatrics, American Public Health Association, and National Resource Center for Health and Safety in Child Care and Early Educationhttp://nrckids.org/CFOC3/PDFVersion/preventing_obesity.pdf.",Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
"2015; http://data.worldbank.org/income-level/LIC ,2 0 1 5 .",Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
2011; ( https://www.gov.uk/government/publications/ uk-physical-activity-guidelines .,Non-OADS,/arxiv_data1/oa_pdf/40/f6/main.PMC4929214.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ACE Inhibitor ARBNAMCSdiabetes Introduction Diabetes is a chronic disease that increasingly affects a growing percentage of the American population.,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.01.0052211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
Further details on the types of contact excluded can be found at ( http://www.cdc.gov/nchs/ahcd/ahcd_scope.,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
Details of the sampling procedure can be found at ( http://www.cdc.gov/nchs/ahcd/ahcd_ scope.htm#namcs_scope ).,OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
"This data was previously collected, de-identi ﬁed and cleaned by the CDC and is available to the public at ftp://ftp.cdc.gov/pub/Health_ Statistics/NCHS/Datasets/NAMCS/ .",OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
ACEI/ARB prescription was de ﬁned by ac o d eo f ‘042 ’or‘056 ’for any of the level 2 Multum database drug category variables ( http://www.multum.com 2013).,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.2337/dc07-S004 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.2337/dc08-S012 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.2337/dc09-S013 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.2337/dc10-S011 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.2147/DMSO.S51301 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1016/S0002- 9343(02)01125-7[doi] .,OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
"Diabetes Care 27 (6), 1330.http://dx.doi.org/10.2337/diacare.27.6.1330 .",Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1016/S0140-6736(02)08090-X .,OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1056/NEJMoa011489 .,OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1111/j.1525 –1497.,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1001/jama.2014.6451 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1592/phco.23.5.659.32203 .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1161/01.CIR.0000024416.33113.0 A .,Non-OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
http://dx.doi.org/10.1056/NEJM200001203420301 .170 S.L.,OADS,/arxiv_data1/oa_pdf/91/f9/main.PMC4929215.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
Copyright © 2016 Korean Diabetes Association http://e-dmj.orgAre We in the Same Risk of Diabetes Mellitus?,Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Keywords:  Diabetes mellitus; Korea; Obesity; Prevalence; Sarcopenia Corresponding author: Min Kyong Moon    http://orcid.org/0000-0002-5460-2846 Department of Internal Medicine, Seoul Metropolitan Government Seoul  National University Boramae Medical Center, Seoul National University  College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea E-mail: mkmoon@snu.ac.kr Received: Apr.",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
THE PREV ALENCE OF DIABETES The prevalence of diabetes in Korean adults aged ≥30 years Review Epidemiology http://dx.doi.org/10.4093/dmj.2016.40.3.175 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:175-181,Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Koo BK, et al.176 Diabetes Metab J 2016;40:175-181 http://e-dmj.orgremained stable at approximately 9% to 10% between 2000  and 2010 [4,5].",OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Type 2 diabetes in Korea, 2001 to 2014177 Diabetes Metab J 2016;40:175-181 http://e-dmj.orgthe increasing prevalence of diabetes may also increase the  economic burden, a public strategy targeting elderly people  for diabetes prevention is urgent.",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Koo BK, et al.178 Diabetes Metab J 2016;40:175-181 http://e-dmj.orgthe general population has increased from 2005 to 2007; it has  remained steady since then [17].",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Type 2 diabetes in Korea, 2001 to 2014179 Diabetes Metab J 2016;40:175-181 http://e-dmj.orgin Korea [27].",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Koo BK, et al.180 Diabetes Metab J 2016;40:175-181 http://e-dmj.orgCONCLUSIONS In the 2000s, despite a steady state of the overall prevalence of  diabetes, there have been changes in the gender-, age-, and  SES-specific prevalence in Korean adults.",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
Avail - able from: http://www.diabetes.or.kr/temp/Diabetes_Fact_ sheet2012.pdf  (updated 2012 Nov 13).,Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"Type 2 diabetes in Korea, 2001 to 2014181 Diabetes Metab J 2016;40:175-181 http://e-dmj.orgCG, Willett WC.",Non-OADS,/arxiv_data1/oa_pdf/13/81/dmj-40-175.PMC4929220.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgSarcopenia, Frailty, and Diabetes in Older Adults Hak Chul Jang Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Populations are aging and the prevalence of diabetes mellitus is increasing tremendously.",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"Keywords:  Diabetes; Disability; Frailty; Sarcopenia Corresponding author: Hak Chul Jang     http://orcid.org/0000-0002-4188-6536 Department of Internal Medicine, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 82 Gumi-ro  173beon-gil, Bundang-gu, Seongnam 13620, Korea E-mail: janghak@snu.ac.kr Received: Feb. 10, 2016; Accepted: Mar.",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"In this review, the relationship between  sarcopenia, frailty, and physical disability in older adults with  diabetes will be discussed.Sulwon Lecture 2015 Clinical Care/Education  http://dx.doi.org/10.4093/dmj.2016.40.3.182 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:182-189",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"Sarcopenia, frailty, and diabetes183 Diabetes Metab J 2016;40:182-189 http://e-dmj.orgSARCOPENIA AND DIABETES A progressive decrease in muscle mass, especially of the lower  extremities and an increase in fat mass, especially of visceral  and intermuscular fat are common body compositional  changes associated with aging [14,15].",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
Jang HC184 Diabetes Metab J 2016;40:182-189 http://e-dmj.orgheight2) was lower only in older men with diabetes.,Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"Sarcopenia, frailty, and diabetes185 Diabetes Metab J 2016;40:182-189 http://e-dmj.orgFRAILTY AND DIABETES Frailty is a common geriatric syndrome in older adults that  carries an increased risk for poor health outcomes including  falls, incident disability, hospitalization, and mortality because  of decreased physical reserves [49].",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
Jang HC186 Diabetes Metab J 2016;40:182-189 http://e-dmj.orginconsistent results [68].,Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
Available from: http://www.prb.org/pdf14/2014- world-population-data-sheet_eng.pdf  (cited 2016 Feb 27).2.,OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"Sarcopenia, frailty, and diabetes187 Diabetes Metab J 2016;40:182-189 http://e-dmj.org13.",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
Jang HC188 Diabetes Metab J 2016;40:182-189 http://e-dmj.org32.,Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"Sarcopenia, frailty, and diabetes189 Diabetes Metab J 2016;40:182-189 http://e-dmj.orgson of the prognostic importance of diagnosed diabetes, co- morbidity and frailty in older people.",Non-OADS,/arxiv_data1/oa_pdf/e6/06/dmj-40-182.PMC4929221.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/10/dmj-40-190.PMC4929222.pdf
Copyright © 2016 Korean Diabetes Association http://e-dmj.orgHypoglycemia: Culprit or Bystander?,Non-OADS,/arxiv_data1/oa_pdf/63/10/dmj-40-190.PMC4929222.pdf
"Y ou-Cheol Hwang Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine,  Seoul, Korea Corresponding author: Y ou-Cheol Hwang    http://orcid.org/0000-0003-4033-7874 Division of Endocrinology and Metabolism, Department of Medicine, Kyung  Hee University Hospital at Gangdong, Kyung Hee University School of  Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea E-mail: khmcilyong@naver.com In 2012, the American Diabetes Association (ADA) and the  European Association for the Study of Diabetes published a  position statement on the management of hyperglycemia in  patients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/63/10/dmj-40-190.PMC4929222.pdf
"First, patients that are possibly more vulnerable to hypoglyce - mia and/or any cause of death were excluded from this study Editorial Complications http://dx.doi.org/10.4093/dmj.2016.40.3.190 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:190-191",Non-OADS,/arxiv_data1/oa_pdf/63/10/dmj-40-190.PMC4929222.pdf
"Hypoglycemia: culprit or bystander?191 Diabetes Metab J 2016;40:190-191 http://e-dmj.orgincluding elderly, mentally ill, unable to undertake self-care  behaviors, previous episode of severe hypoglycemia, cognitive  dysfunction, alcoholism, or any medical illness.",Non-OADS,/arxiv_data1/oa_pdf/63/10/dmj-40-190.PMC4929222.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgFeasibility of a Patient-Centered, Smartphone-Based,  Diabetes Care System: A Pilot Study Eun Ky Kim1, Soo Heon Kwak2, Seungsu Baek3, Seung Lyeol Lee3, Hak Chul Jang4, Kyong Soo Park2, Y oung Min Cho2 1International Healthcare Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul,  2Department of Internal Medicine, Seoul National University College of Medicine, Seoul,  3Health Connect Co. Ltd., Seoul,  4Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Background:  We developed a patient-centered, smartphone-based, diabetes care system (PSDCS).",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Keywords:  Delivery of health care; Diabetes mellitus; Smartphone Corresponding author: Y oung Min Cho    https://orcid.org/0000-0002-2331-6126 Department of Internal Medicine, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: ymchomd@snu.ac.kr Received: Jun.",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Among the interventions, three mobile phone- based interventions decreased HbA1c by –0.5% (95% CI, –0.7 Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2016.40.3.192 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:192-201",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
Patient-centered mobile diabetes care193 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgto –0.3) compared with the control interventions [5].,Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Kim EK, et al.194 Diabetes Metab J 2016;40:192-201 http://e-dmj.org(MyGlucoHealth; Entra Health Systems, Seoul, Korea), and  the participants were recommended to measure their glucose  level at least once a day, preferably before breakfast.",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
Patient-centered mobile diabetes care195 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgevery week.,Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Kim EK, et al.196 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgcreased by 0.6%±0.7% from baseline ( P<0.0001) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Patient-centered mobile diabetes care197 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgtaneously resolved, except in one patient, who showed aggrava - tion of glucose control associated with upper respiratory tract  infection and who was requested to make an unscheduled visit  to the research clinic to adjust the insulin dose.",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Kim EK, et al.198 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgFig.",OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
Patient-centered mobile diabetes care199 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgwith a ubiquitous healthcare system using a telephone net - work-connected glucometer and short message service on  mobile phones in elderly patients showed a completion rate of  more than 90% with beneficial effects on glycemic control  [26].,Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"Kim EK, et al.200 Diabetes Metab J 2016;40:192-201 http://e-dmj.orglines: a cont trial.",Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
Patient-centered mobile diabetes care201 Diabetes Metab J 2016;40:192-201 http://e-dmj.orgMed 2009;26:628-35.,Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
Available from: http://www.emarketer.com/Article/ Worldwide-Smartphone-Usage-Grow-25-2014/1010920  (up- dated 2014 Jun 11).,Non-OADS,/arxiv_data1/oa_pdf/6d/7a/dmj-40-192.PMC4929223.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgSevere Hypoglycemia and Cardiovascular or All-Cause  Mortality in Patients with Type 2 Diabetes Seon-Ah Cha1, Jae-Seung Yun1, Tae-Seok Lim1, Seawon Hwang1, Eun-Jung Yim1, Ki-Ho Song1, Ki-Dong Y oo2, Y ong-Moon Park3,  Yu-Bae Ahn1, Seung-Hyun Ko1 Divisions of 1Endocrinology and Metabolism, 2Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea,  3Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA Background:  We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or all- cause mortality in patients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Keywords:  Cardiovascular diseases; Diabetes mellitus, type 2; Mortality; Severe hypoglycemia Corresponding author: Seung-Hyun Ko    https://orcid.org/0000-0003-3703-1479 Division of Endocrinology and Metabolism, Department of Internal  Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University  of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea E-mail: kosh@catholic.ac.kr Received: Jun.",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"The UK Prospective Diabetes Study  (UKPDS), comprising subjects with recently diagnosed diabe -Original Article Complications http://dx.doi.org/10.4093/dmj.2016.40.3.202 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:202-210",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Severe hypoglycemia and mortality203 Diabetes Metab J 2016;40:202-210 http://e-dmj.orgtes, showed that an improvement in glycemic control reduced  microvascular complication and myocardial infarction (MI)  [2].",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Cha SA, et al.204 Diabetes Metab J 2016;40:202-210 http://e-dmj.org≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or the use  of antihypertensive medications [17].",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
Severe hypoglycemia and mortality205 Diabetes Metab J 2016;40:202-210 http://e-dmj.orgfollow-up period.,Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Cha SA, et al.206 Diabetes Metab J 2016;40:202-210 http://e-dmj.orgdied from CV events.",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Severe hypoglycemia and mortality207 Diabetes Metab J 2016;40:202-210 http://e-dmj.orgDISCUSSION In this long-term, prospective observational cohort study, we  found that SH was significantly associated with increased risks  of death from both CV events and any cause in Korean pa - tients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Cha SA, et al.208 Diabetes Metab J 2016;40:202-210 http://e-dmj.orgSH and a higher frequency of subsequent macrovascular  events [22,23].",Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
Severe hypoglycemia and mortality209 Diabetes Metab J 2016;40:202-210 http://e-dmj.org358:2545-59.,Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
Available from: http://www.cdisc.,Non-OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"Cha SA, et al.210 Diabetes Metab J 2016;40:202-210 http://e-dmj.orgHanefeld M. Relationship between hypoglycemic episodes and  ventricular arrhythmias in patients with type 2 diabetes and  cardiovascular diseases: silent hypoglycemias and silent ar - rhythmias.",OADS,/arxiv_data1/oa_pdf/bc/41/dmj-40-202.PMC4929224.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgRenoprotective Effect of Gemigliptin, a Dipeptidyl  Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1  Diabetic Mice Gwon-Soo Jung1, Jae-Han Jeon1, Mi Sun Choe2, Sung-Woo Kim1, In-Kyu Lee1, Mi-Kyung Kim3, Keun-Gyu Park1 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu,  2 Department of Pathology, 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu,  Korea Background:  Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used in the treatment of patients with type 2 diabetes and  have proven protective effects on diabetic kidney disease (DKD).",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Keywords:  Diabetes mellitus, type 1; DPP-4 inhibitor; Renal fibrosis Corresponding authors: Keun-Gyu Park    http://orcid.org/0000-0002-8403-1298 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Kyungpook National University School of Medicine,   130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea E-mail: kpark@knu.ac.kr Mi-Kyung Kim    http://orcid.org/0000-0001-5750-3598 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Keimyung University School of Medicine, 56 Dalseong-ro,   Jung-gu, Daegu 41931, Korea  E-mail: mdkmk@dsmc.or.kr * Gwon-Soo Jung and Jae-Han Jeon contributed equally to this study as first  authors.",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
A number of factors important for the development Original Article Complications http://dx.doi.org/10.4093/dmj.2016.40.3.211 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:211-221,Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Jung GS, et al.212 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgof DKD, including hyperglycemia, hypertension, oxidative  stress, and inflammation [3], have been shown to lead to pro - teinuria and histological changes, such as mesangial expansion,  glomerular sclerosis, and tubulointerstitial fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Renoprotection of gemigliptin in type 1 diabetes213 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgacid Schiff (PAS), and Sirius red staining.",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Jung GS, et al.214 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgStatistical analyses Data were evaluated using analysis of variance followed by a  post hoc  least significant difference test and expressed as mean  ±standard error of mean.",OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Renoprotection of gemigliptin in type 1 diabetes215 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgGemigliptin treatment attenuates STZ-induced renal fibrosis To confirm the effects of gemigliptin on other DKD pathologic  findings, we examined the effects of gemigliptin on STZ-in - duced renal fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Jung GS, et al.216 Diabetes Metab J 2016;40:211-221 http://e-dmj.org3 2 1 0Tubular atrophydb 4 3 2 1 0Sirius red staining areada  CON STZ STZ+Gemi A Sirius red  H&ECON STZ STZ+Gemi 6 5 4 3 2 1 0Positive stain areada B2.5 2.0 1.5 1.0 0.5 0Positive stain areadb  CON STZ STZ+Gemi Fibronectin  Type I collagenCON STZ STZ+Gemi 5 4 3 2 1 0Relative type I  collagen protein levelcb  CON STZ STZ+Gemi3 2 1 0Relative type I  collagen mRNA leveldb  CON STZ STZ+Gemi 3 2 1 0Relative fibronectin  mRNA leveldb  CON STZ STZ+Gemi C3 2 1 0Relative fibronectin protein levelcb  CON STZ STZ+Gemi D Collagen (type I)CON STZ STZ+Gemi Fibronectin β-Tubulin (Continued to the next page )",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
Renoprotection of gemigliptin in type 1 diabetes217 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Jung GS, et al.218 Diabetes Metab J 2016;40:211-221 http://e-dmj.org2.5 2.0 1.5 1.0 0.5 0Relative type I collagen  mRNA leveldda Gemi (μg/mL) 100 200 400 TGF-βf2.5 2.0 1.5 1.0 0.5 0Relative fibronectin mRNA leveld da Gemi (μg/mL) 100 200 400 TGF-βf β-TubulinFibronectinCollagen (type I)p-Smad3Gemi (μg/mL) 100 200 400TGF-β A B 4 3 2 1 0Relative p-Smad3 protein levelec Gemi (μg/mL) 100 200 400 TGF-βf3 2 1 0Relative type I  collagen protein levelfa Gemi (μg/mL) 100 200 400 TGF-βff2.5 2.0 1.5 1.0 0.5 0Relative fibronectin protein levelfa Gemi (μg/mL) 100 200 400 TGF-βff C 2.5 2.0 1.5 1.0 0.5 0Relative type I collagen  mRNA levele da Gemi (μg/mL) 100 200 400 TGF-βf3 2 1 0Relative fibronectin mRNA levelfa Gemi (μg/mL) 100 200 400 TGF-βfd β-TubulinFibronectinCollagen (type I)p-Smad3Gemi (μg/mL) 100 200 400TGF-β D E 2.5 2.0 1.5 1.0 0.5 0Relative type I  collagen protein levelf fb Gemi (μg/mL) 100 200 400 TGF-βf2.5 2.0 1.5 1.0 0.5 0Relative fibronectin protein leveld fa Gemi (μg/mL) 100 200 400 TGF-βf6 5 4 3 2 1 0Relative p-Smad3 protein leveldc Gemi (μg/mL) 100 200 400 TGF-βf F (Continued to the next page )",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
Renoprotection of gemigliptin in type 1 diabetes219 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"Jung GS, et al.220 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgtive mechanism [15], the latter study showed that linagliptin  inhibited the TGF- β-induced endothelial-to-mesenchymal  transition in a GLP-1-independent manner [16].",Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
Renoprotection of gemigliptin in type 1 diabetes221 Diabetes Metab J 2016;40:211-221 http://e-dmj.orgchem Biophys Res Commun 2014;443:828-33.,Non-OADS,/arxiv_data1/oa_pdf/83/54/dmj-40-211.PMC4929225.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgAPO A2 −265T /C Polymorphism Is Associated with  Increased Inflammatory Responses in Patients with  Type 2 Diabetes Mellitus Fariba Koohdani1,2, Haleh Sadrzadeh-Y eganeh3, Mahmoud Djalali1, Mohammadreza Eshraghian4, Elham Zamani1,   Gity Sotoudeh3, Mohammad-Ali Mansournia4, Laleh Keramat1 1Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran,  2Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 3Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, 4Department of Biostatistics and Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran Background:  Apolipoprotein A2 ( APO A2 ) is the second most abundant structural apolipoprotein in high density lipoprotein.",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"Keywords:  Apolipoprotein A-II; Diabetes; Inflammatory response; Obesity; Polymorphism Corresponding author: Laleh Keramat    http://orcid.org/0000-0003-4209-2014 Department of Cellular and Molecular Nutrition, School of Nutritional  Sciences and Dietetics, Tehran University of Medical Sciences, No: 44,  Hojjat-dost Alley, Naderi St., Keshavarz Blvd, Tehran, Iran E-mail: laleh_keramat@yahoo.com Received: Mar.",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"The T to C substitution in the APO  A2 promoter (−265T>C polymorphism, rs5082) downregu - lates its expression in the liver cells, thus reducing its secretion Original Article Genetics http://dx.doi.org/10.4093/dmj.2016.40.3.222 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:222-229",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
Apolipoprotein A2 polymorphism and inflammation 223 Diabetes Metab J 2016;40:222-229 http://e-dmj.orginto plasma.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"Koohdani F, et al.224 Diabetes Metab J 2016;40:222-229 http://e-dmj.orgCRP) was measured by DBC (Diagnostics Biochem Canada  Inc., Dorchester, ON, Canada).",OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
Apolipoprotein A2 polymorphism and inflammation 225 Diabetes Metab J 2016;40:222-229 http://e-dmj.orgmajor alleles and the heterozygote alleles (TT+TC) [24].,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"Koohdani F, et al.226 Diabetes Metab J 2016;40:222-229 http://e-dmj.orgtypes and the CC genotype.",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
Apolipoprotein A2 polymorphism and inflammation 227 Diabetes Metab J 2016;40:222-229 http://e-dmj.orgXiao et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"Koohdani F, et al.228 Diabetes Metab J 2016;40:222-229 http://e-dmj.orgtaining apolipoproteins A-I and A-II (LpA-I:A-II) as markers  of coronary artery disease in men with non-insulin-depen - dent diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
Apolipoprotein A2 polymorphism and inflammation 229 Diabetes Metab J 2016;40:222-229 http://e-dmj.org28.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/dmj-40-222.PMC4929226.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgComparison of Vildagliptin and Pioglitazone in Korean  Patients with Type 2 Diabetes Inadequately Controlled  with Metformin Jong Ho Kim1,*, Sang Soo Kim1,*, Hong Sun Baek2, In Kyu Lee3, Dong Jin Chung4, Ho Sang Sohn5, Hak Y eon Bae6,   Mi Kyung Kim7, Jeong Hyun Park8, Y oung Sik Choi9, Y oung Il Kim10, Jong Ryeal Hahm11, Chang Won Lee12, Sung Rae Jo13,   Mi Kyung Park14, Kwang Jae Lee15, In Joo Kim1 1Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan,   2Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju,   3Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu,  4Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun,  5Department of Internal Medicine, Daegu Catholic University Medical Center, Catholic University of Daegu School of Medicine, Daegu,  6Department of Internal Medicine, Chosun University Hospital, Chosun University School of Medicine, Gwangju,  7Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu,  8Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan,  9Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan,  10Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan,  11Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju,  12Department of Internal Medicine, Busan St. Mary’s Hospital, Catholic University of Pusan, Busan,  13Department of Internal Medicine, Changwon Fatima Hospital, Changwon,  14Department of Internal Medicine, Dong-A Medical Center, Dong-A University College of Medicine, Busan,  15Department of Internal Medicine, Daedong Hospital, Busan, Korea Background:  We compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add- on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Keywords:  Dipeptidyl peptidase 4 inhibitor; Metformin; Thiazolidinediones Corresponding author: In Joo Kim    http://orcid.org/0000-0003-1307-6146  Division of Endocrinology and Metabolism, Department of Internal  Medicine, Pusan National University Hospital, Pusan National University  School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea E-mail: injkim@pusan.ac.kr * Jong Ho Kim and Sang Soo Kim contributed equally to this study as first  authors.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"24, 2015; Accepted: Sep. 18, 2015Original Article Others http://dx.doi.org/10.4093/dmj.2016.40.3.230 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:230-239",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Metformin, vildagliptin, pioglitazone231 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgINTRODUCTION The prevalence of diabetes continues to rapidly increase world - wide, including in Korea.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Kim JH, et al.232 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgdiabetes were eligible to participate.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Metformin, vildagliptin, pioglitazone233 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgRESULTS Patients studied The flow of the study patients from the initial screening to the  study endpoint is summarized in Fig.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Kim JH, et al.234 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgpioglitazone (8.08%±0.98%) groups at baseline (visit 1) did not  significantly differ ( P=0.389).",OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Metformin, vildagliptin, pioglitazone235 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgC, HDL-C, and non-HDL-C from baseline to week 16 were sig - nificantly different between the two groups (all P values <0.05).",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Kim JH, et al.236 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgBoth study drugs were relatively safe and well-tolerated and  there were no serious drug-related AEs or death.",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Metformin, vildagliptin, pioglitazone237 Diabetes Metab J 2016;40:230-239 http://e-dmj.org In humans, chronic treatment with metformin enhances  both basal and nutrient-induced GLP-1 secretion [13,14] al - though its acute administration does not increase circulating  levels of GLP-1 [11,13,14,25,26].",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Kim JH, et al.238 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgkamp U, Shaw JE.",OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"Metformin, vildagliptin, pioglitazone239 Diabetes Metab J 2016;40:230-239 http://e-dmj.orgsuura T, Suzuki H, Kurose T, Y amada Y , Seino Y .",Non-OADS,/arxiv_data1/oa_pdf/f8/af/dmj-40-230.PMC4929227.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgEffects of Rebamipide on Gastrointestinal Symptoms in  Patients with Type 2 Diabetes Mellitus Sejeong Park1,*, So Y oung Park2,*, Yu Jin Kim2, Soo Min Hong1,†, Suk Chon1,3, Seungjoon Oh1,3, Jeong-taek Woo1,3,   Sung-Woon Kim1,3, Y oung Seol Kim4, Sang Y oul Rhee1,3 1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul,  2Department of Endocrinology and Metabolism, College of Medicine, Kyung Hee University, Seoul, 3Research Institute of Endocrinology, Kyung Hee University, Seoul,  4Department of Internal Medicine,  Chung Hospital, Seongnam, Korea Background:  Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"Keywords:  Diabetes mellitus, type 2; Gastrointestinal diseases; Rebamipide Corresponding author: Sang Y oul Rhee    http://orcid.org/0000-0003-0119-5818 Department of Endocrinology and Metabolism, Kyung Hee University School  of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea E-mail: bard95@hanmail.net * Sejeong Park and So Y oung Park contributed equally to this study as first  authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"In effect,  GI symptoms reduce quality of life in patients with T2DM [4] Original Article Others http://dx.doi.org/10.4093/dmj.2016.40.3.240 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:240-247",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
Effects of rebamipide in T2DM241 Diabetes Metab J 2016;40:240-247 http://e-dmj.organd increase the medical cost to the public health care system  [5].,Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"Park S, et al.242 Diabetes Metab J 2016;40:240-247 http://e-dmj.orged the outpatient clinic three times during the study.",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
Effects of rebamipide in T2DM243 Diabetes Metab J 2016;40:240-247 http://e-dmj.orgRESULTS Baseline clinical characteristics Table 2 shows the baseline clinical characteristics of the pa - tients.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"Park S, et al.244 Diabetes Metab J 2016;40:240-247 http://e-dmj.orgDBSQ score Compared to before rebamipide treatment, the total DBSQ  score was significantly reduced, from 24.9±8.0 to 20.4±7.3  (P<0.001) after the treatment.",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
Effects of rebamipide in T2DM245 Diabetes Metab J 2016;40:240-247 http://e-dmj.orgimproved more in women than in men after rebamipide treat - ment (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"Park S, et al.246 Diabetes Metab J 2016;40:240-247 http://e-dmj.orgtiveness of current pharmacologic therapy, demonstrating the  efficacy of rebamipide for GI symptom control in DM is of  great significance.",Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
Effects of rebamipide in T2DM247 Diabetes Metab J 2016;40:240-247 http://e-dmj.orgtimating the prevalence of comorbid conditions and their ef - fect on health care costs in patients with diabetes mellitus in  Switzerland.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/dmj-40-240.PMC4929228.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/dd/dmj-40-248.PMC4929229.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgHyperglycemia Is Associated with Impaired Muscle  Quality in Older Men with Diabetes: The Korean  Longitudinal Study on Health and Aging ( Diabetes  Metab J  2016;40:140-6) Jun Sung Moon Department of Internal Medicine, Y eungnam University College of Medicine, Daegu, Korea Corresponding author: Jun Sung Moon    http://orcid.org/0000-0003-1569-3068 Department of Internal Medicine, Y eungnam University College of Medicine,  170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea E-mail: mjs7912@yu.ac.krEver since the introduction of the concept of sarcopenia [1],  its definition has been changed over the past two decades.",Non-OADS,/arxiv_data1/oa_pdf/1c/dd/dmj-40-248.PMC4929229.pdf
"Second, poorly controlled diabetes can lead to diabetic  complications including peripheral arterial insufficiency and Letter http://dx.doi.org/10.4093/dmj.2016.40.3.248 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:248-249",Non-OADS,/arxiv_data1/oa_pdf/1c/dd/dmj-40-248.PMC4929229.pdf
"Muscle quality in older men with diabetes 249 Diabetes Metab J 2016;40:248-249 http://e-dmj.orgneuropathy can cause lower muscle weakness [11,12].",Non-OADS,/arxiv_data1/oa_pdf/1c/dd/dmj-40-248.PMC4929229.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/74/dmj-40-250.PMC4929230.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgHyperglycemia Is Associated with Impaired Muscle  Quality in Older Men with Diabetes: The Korean  Longitudinal Study on Health and Aging   (Diabetes Metab J  2016;40:140-6)  Ji Won Yoon1,2,3, Hak Chul Jang1,2 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,  3 Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul National University College of Medicine,  Seoul, Korea Corresponding author: Hak Chul Jang     http://orcid.org/0000-0002-4188-6536 Department of Internal Medicine, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 82 Gumi-ro  173beon-gil, Bundang-gu, Seongnam 13620, Korea E-mail: janghak@snu.ac.krWe thank Dr.",Non-OADS,/arxiv_data1/oa_pdf/98/74/dmj-40-250.PMC4929230.pdf
"Among the subjects with a his - tory of myocardial infarction or angina pectoris, one (4.8%)  was in HbA1c <6.5% group, three (9.7%) were in 6.5% ≤HbA1c  <7.5% group, but no one was in 7.5%≤ HbA1c<8.5% or HbA1c Response http://dx.doi.org/10.4093/dmj.2016.40.3.250 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:250-251",Non-OADS,/arxiv_data1/oa_pdf/98/74/dmj-40-250.PMC4929230.pdf
"Muscle quality in older men with diabetes 251 Diabetes Metab J 2016;40:250-251 http://e-dmj.org≥8.5% group, in which the differences in prevalence were sta - tistically insignificant.",Non-OADS,/arxiv_data1/oa_pdf/98/74/dmj-40-250.PMC4929230.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Self-examinationTesticular neoplasmsEarly detection of cancerPractice guidelines as topic Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC4929233.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.04.006 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC4929233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC4929233.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC4929233.pdf
Retrieved from https://www.auanet.org/common/pdf/education/clinical-guidance/Mens-Health-Checklist.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC4929233.pdf
http://www.cancer.gov/types/testicular/hp/testicular-screening-pdq .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC4929233.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Measurement propertiesSelf-report physical activityAdults Validity 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/b8/main.PMC4929234.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.0032211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/b8/main.PMC4929234.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/b8/main.PMC4929234.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/c6/b8/main.PMC4929234.pdf
The German version was based on the Austrian translation(available at https://sites.google.com/site/theipaq/questionnaire_links ).,Non-OADS,/arxiv_data1/oa_pdf/c6/b8/main.PMC4929234.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Smoking cessationHospital personnelReferralEducation 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.02.002 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"To promote smoking cessation, WHO and NICE guidelines recommend that all staff be trained to support smokers who seek secondary service to quit smoking (Tobacco Free Initiative, 2015; https://www.nice.org.uk/guidance/ph48, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"NICE guidelines also mentioned that it is necessary to ensure that staff are trained to supportsmokers in quitting smoking while seeking secondary care service (https://www.nice.org.uk/guidance/ph48, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"Lung Cancer 61 (1), 13 –20.http://dx.doi.org/10.1016/j.lungcan.",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"6 (3), 447– 455. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
http://dx.doi.org/10.1159/000319937 .,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"19(1), 44 –49.http://dx.doi.org/10.1136/tc.2009.031435 .",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
http://dx.doi.org/10.1111/inr.12004 .,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
http://dx.doi.org/10.1111/ add.12680.,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
http://dx.doi.org/10.1016/ S1470-2045(08)70154-2 .,OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"BMC Public Health 10 (1), 77. http://dx.doi.org/10.1186/1471- 2458-10-77 .",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"15 (1), 1–10.http://dx.doi.org/10.1186/1471-2296-15-103 .",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"https://www.nice.org.uk/guidance/ ph48 Accessed July 4, 2015 .",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"Public Health 11 (5), 4782– 4798. http://dx.doi.org/10.3390/ijerph110504782 .",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"24, 14022. http://dx.doi.org/10.1038/npjpcrm.2014.22 .",OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
http://dx.doi.org/10.1161/ STROKEAHA.113.002342 .,Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"C ommunity Health 50 (6), 625 –630.http://dx.doi.org/10.1136/ jech.50.6.625.",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
"https://www.who.int Accessed July 4, 2015 .Table 4 The signi ﬁcant variables in ﬂuencing the willingness of referral for smoking cessation.",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/main.PMC4929235.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AgingInterventionsPhysical activity Exercise Sedentary behaviorHealth behavior 1.,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.005 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1177/1090198104263660 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"United States Department of Laber, Washington, DC ( http://www.bls.gov/news.release/atus.nr0.htm .",Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"U.S. Department of Health and Human Services, Centersfor Disease Control and Prevention, Atlanta , Georgia ( http://www.cdc.gov/brfss/ .",Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"U.S. Department of Health and Human Services, Centers for Disease Control and Preven- tion, Atlanta, Georgia ( http://www.cdc.gov/cdi/de ﬁnitions/older-adults.html .",Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"97 (3), 368– 376. http://dx.doi.org/10.1016/j.diabres.",OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
Health http://dx.doi.org/10.1123/jpah.2015-0173 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1007/s10865-014-9581-6 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"Diabetes Care 31 (4), 661– 666. http://dx.doi.org/ 10.2337/dc07-2046 .",Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"57 (1), 43–48.http://dx.doi.org/10.1016/j.ypmed.2013.04.004 .",OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.2337/ dc07-1795 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
1. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.3945/ajcn.111.019620 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1093/gerona/glt014 .242 J. Fanning et al.,OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1016/j.cct.2011.10.002 .,OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1097/JES.0b013e3181e373a2 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1093/ije/dyv191 .,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"40 (6), 1188. http://dx.doi.org/10.1249/MSS.0b013e31817057da .",Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1503/cmaj.,OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
http://dx.doi.org/10.1093/gerona/glu188 .,OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
"World Health Organization, Geneva, Switzerland ( http://www.who.int/ dietphysicalactivity/physical-activity-recommendations-18-64years.pdf .",Non-OADS,/arxiv_data1/oa_pdf/33/63/main.PMC4929237.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HungerObesityCommunity-based participatory researchConvenience foods Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/10/04/main.PMC4929238.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.008 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/10/04/main.PMC4929238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/04/main.PMC4929238.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/10/04/main.PMC4929238.pdf
"United States Department of Agriculture, Economic Research Service (Retrieved from http://econpapers.repec.",Non-OADS,/arxiv_data1/oa_pdf/10/04/main.PMC4929238.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is a heterogeneous disease characterized by  gene expression patterns or differential expression of the tu - mor markers, estrogen receptor (ER), progesterone receptor  (PR), and human epidermal growth factor receptor 2 (HER2)  [1-3].",Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"Prior research in California has shown that Southeast  Asians, Filipino, and Korean women were more likely than  white women to have the ER+/PR+/HER2+ subtype, while  Chinese, Pacific Islander, and Filipino women were less likely  to have the triple-negative subtype [11].Breast Cancer Mortality among Asian-American Women in California:  Variation according to Ethnicity and Tumor Subtype Carol Parise, Vincent Caggiano Sutter Institute for Medical Research, Sacramento, USAORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 112-121  http://dx.doi.org/10.4048/jbc.2016.19.2.112 Purpose:  Asian-American women have equal or better breast  cancer survival rates than non-Hispanic white women, but many  studies use the aggregate term “Asian/Pacific Islander” (API) or  consider breast cancer as a single disease.",Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
Variability in Breast Cancer Mortality of Asian Americans in California113 http://dx.doi.org/10.4048/jbc.2016.19.2.112  http://ejbc.krIt is unknown whether there is similar variability in mortal - ity among the Asian ethnicities within the ER/PR/HER2 sub - types.,Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.112the 2000 U.S. Census, for cases diagnosed from 2000 through  2005, and for cases diagnosed from 2006 through 2013, data  from the American Community Survey was used [18].",OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
Variability in Breast Cancer Mortality of Asian Americans in California115 http://dx.doi.org/10.4048/jbc.2016.19.2.112  http://ejbc.krTable 2.,Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.112White  (n= 93,089)Pacific  Islander  (n= 543)Southeast  Asian  (n= 3,886)Indian  Continent  (n= 1,175)Chinese  (n= 3,796)Japanese  (n= 1,736)Filipino  (n= 4,868)Korean  (n= 1,027)Total  (n= 110,120)All Asian/ Pacific Islander  Combined  (n= 17,031)  Radiation therapy    Yes 42,671 (54.2) 250 (54.0) 2,046 (47.3) 514 (56.3) 1,834 (51.7) 822 (52.6) 2,591 (46.8) 540 (47.4) 51,268 (53.4) 8,597 (49.5)    No 50,418 (45.8) 293 (46.0) 1,840 (52.7) 661 (43.7) 1,962 (48.3) 914 (47.4) 2,277 (53.2) 487 (52.6) 58,852 (46.6) 8,434 (50.5) Surgery    None   2,288 (2.5) 27 (5.0) 103 (2.7) 45 (3.8)     89 (2.3)    35 (2.0)  168 (3.5) 40 (3.9) 2,795 (2.5)  507 (3.0)    Lumpectomy 57,053 (61.3) 288 (53.0) 1,913 (49.2) 603 (51.3) 1,967 (51.8) 1,023 (58.9) 2,192 (45.0) 513 (50.0) 65,552 (59.5) 8,499 (49.9)    Mastectomy 33,748 (36.3) 228 (42.0) 1,870 (48.1) 527 (44.9) 1,740 (45.8)     678 (39.1) 2,508 (51.5) 474 (46.2) 41,773 (37.9) 8,025 (47.1) Tumor size (mm)    < 5.0 5,928 (6.4) 30 (5.5) 259 (6.7) 68 (5.8) 276 (7.3)  139 (8.0)  309 (6.3) 62 (6.0) 7,071 (6.4) 1,143 (6.7)    ≥ 5.0, < 10.0 17,319 (18.6)  64 (11.8) 609 (15.7) 141 (12.0) 608 (16.0)   305 (17.6)    628 (12.9) 122 (11.9) 19,796 (18.0) 2,477 (14.5)    ≥ 10.0, < 20.0 35,857 (38.5) 188 (34.6) 1,363 (35.1) 389 (33.1)  1,424 (37.5)   716 (41.2) 1,645 (33.8) 392 (38.2) 41,974 (38.1) 6,117 (35.9)    ≥ 20.0, < 50.0 26,752 (28.7) 192 (35.4) 1,315 (33.8) 455 (38.7) 1,204 (31.7)   469 (27.0) 1,814 (37.3) 357 (34.8) 32,558 (29.6) 5,806 (34.1)    ≥ 50.0 7,233 (7.8)  69 (12.7) 340 (8.7) 122 (10.4) 284 (7.5) 107 (6.2)   472 (9.7) 94 (9.2) 8,721 (7.9) 1,488 (8.7) ER/PR/HER2 subtype    ER+/PR+/HER2 – 57,159 (61.4) 327 (60.2) 2,147 (55.2) 644 (54.8)  2,171 (57.2) 1,072 (61.8) 2,689 (55.2) 507 (49.4) 66,716 (60.6) 9,557 (56.1)    ER+/PR+/HER2+ 7,860 (8.4) 62 (11.4)  409 (10.5) 116 (9.9) 397 (10.5) 167 (9.6) 606 (12.4) 140 (13.6)  9,757 (8.9) 1,897 (11.1)    ER+/PR –/HER2 – 8,877 (9.5) 32 (5.9) 339 (8.7) 70 (6.0) 300 (7.9) 166 (9.6)   398 (8.2) 56 (5.5) 10,238 (9.3) 1,361 (8.0)    ER+/PR –/HER2+ 2,759 (3.0) 13 (2.4) 143 (3.7) 30 (2.6) 142 (3.7) 54 (3.1)   185 (3.8) 40 (3.9) 3,366 (3.1)    607 (3.6)    ER –/PR+/HER2 – 652 (0.7) 5 (0.9) 25 (0.6) 14 (1.2) 30 (0.8) 11 (0.6) 36 (0.7)  11 (1.1)    784 (0.7)    132 (0.8)    ER –/PR+/HER2+ 267 (0.3) 0 25 (0.6) 4 (0.3) 10 (0.3) 6 (0.3) 22 (0.5)   4 (0.4)    338 (0.3)      71 (0.4)    ER –/PR–/HER2 – 10,650 (11.4) 59 (10.9) 465 (12.0) 204 (17.4) 402 (10.6) 173 (10.0) 435 (8.9) 160 (15.6) 12,548 (11.4)  1,898 (11.1)    ER –/PR–/HER2+ 4,865 (5.2) 45 (8.3) 333 (8.6) 93 (7.9) 344 (9.1) 87 (5.0) 497 (10.2) 109 (10.6) 6,373 (5.8) 1,508 (8.9) Data are presented as number (%).",Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"Variability in Breast Cancer Mortality of Asian Americans in California117 http://dx.doi.org/10.4048/jbc.2016.19.2.112  http://ejbc.krRESULTS There were 90,930 cases with incomplete data for race/eth - nicity, cause of death, AJCC stage, ER, PR, HER2, tumor  grade, treatment, or SES (Table 1).",OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.112Table 3.,Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
Variability in Breast Cancer Mortality of Asian Americans in California119 http://dx.doi.org/10.4048/jbc.2016.19.2.112  http://ejbc.krDISCUSSION The rapid recent growth in the Asian-American population  in the United States has sparked considerable interest in breast  cancer incidence and mortality [26].,Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.112ACKNOWLEDGMENTS The collection of cancer incidence data used in this study  was supported by the California Department of Public Health  as part of the statewide cancer reporting program mandated  by California Health and Safety Code Section 103885, the Na - tional Cancer Institute’s Surveillance, Epidemiology and End  Results Program, under contract N01-PC-35136 awarded to  the Northern California Cancer Center, contract N01- PC-35139, awarded to the University of Southern California,  and contract N01-PC-54404, awarded to the Public Health  Institute, and the Centers for Disease Control and Prevention’s  National Program of Cancer Registries, under agreement  1U58DP00807-01, awarded to the Public Health Institute.",Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"Variability in Breast Cancer Mortality of Asian Americans in California121 http://dx.doi.org/10.4048/jbc.2016.19.2.112  http://ejbc.krIslanders, 2016: converging incidence in males and females.",Non-OADS,/arxiv_data1/oa_pdf/52/88/jbc-19-112.PMC4929251.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Inflammation is an important component for the develop - ment of all types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"Constitutive activation of STAT3 is in -Role of STAT3 Phosphorylation in Ethanol-Mediated Proliferation of Breast  Cancer Cells Poornima devi Narayanan1, Sangeetha Kadapakkam Nandabalan2, Lakshmi Subhadra Baddireddi1,3 1Department of Biotechnology, Anna University, Chennai; 2Department of Biochemistry, University of Madras, Chennai; 3Centre for Food Technology,  Department of Biotechnology, Anna University, Chennai, IndiaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 122-132  http://dx.doi.org/10.4048/jbc.2016.19.2.122 Purpose:  In this study, we investigated the molecular mechanism  involved in ethanol (EtOH)-mediated proliferation of breast cancer  cells.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"Ethanol Mediates Breast Cancer Proliferation through STAT3 Phosphorylation 123 http://dx.doi.org/10.4048/jbc.2016.19.2.122  http://ejbc.krvolved in tumor initiation, progression, and maintenance,  marking it as a potential target for cancer therapy [9].",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.1223-phosphate dehydrogenase (GAPDH) Forward, 5 ´-CC  ACCCATGGCAAATTCCATGGCA-3 ´, Reverse, 5 ´-TC - TAGACGGCAGGTCAGGTCCACC-3 ´.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"Ethanol Mediates Breast Cancer Proliferation through STAT3 Phosphorylation 125 http://dx.doi.org/10.4048/jbc.2016.19.2.122  http://ejbc.kr(100 nM) and tyrphostin (AG490) (100 µM) in the presence/ absence of EtOH, an MTT assay was performed after 48  hours of treatment as described above.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.122cells at 800 µg/dL, (173 µM) for 48 hours (Figure 1B).",OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"Ethanol Mediates Breast Cancer Proliferation through STAT3 Phosphorylation 127 http://dx.doi.org/10.4048/jbc.2016.19.2.122  http://ejbc.krobserved at 48 hours in MCF-7 (Figure 2C, D) and MDA  MB-231 cells (Figure 2C, D), whereas a decrease in expression  of the tumor suppressor protein p53 was observed, thereby  validating the increase in cell proliferation after treatment  with EtOH.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.122crease in the expression of cyclin D1, D2, and D3; matrix me - talloproteinase (MMP)-2; and MMP-9 to about 1.8, 2.1, 1.8,  1.35, and 1.6 fold, respectively, in MCF-7 cells (Figure 5A) and  2.5, 1.79, 2.25, 2.56, and 2.43 fold, respectively, in MDA MB- 231 cells (Figure 5B) after incubation with EtOH in compari - son to untreated cells.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
Ethanol Mediates Breast Cancer Proliferation through STAT3 Phosphorylation 129 http://dx.doi.org/10.4048/jbc.2016.19.2.122  http://ejbc.krFigure 7.,Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.122Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"Ethanol Mediates Breast Cancer Proliferation through STAT3 Phosphorylation 131 http://dx.doi.org/10.4048/jbc.2016.19.2.122  http://ejbc.kring the expression of p-STAT3, and, its association with pro - liferation was probed by studying the expression of cyclin D1  by immunoblotting.",Non-OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.122Drug T argets 2011;11:451-64.,OADS,/arxiv_data1/oa_pdf/d8/f3/jbc-19-122.PMC4929252.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Cancer is a polygenic disease of the eukaryotic cell cycle, in - volving genetic and epigenetic alterations in the genes playing  a vital role in controlling the cell cycle [1].",Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
"Among the E2F family, the E2F5  gene has growth-repres -Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of  the E2F5  Gene in Breast Cancer Arshad Ali1,2,*, Farman Ullah1,2,*, Irum Sabir Ali3, Ahmad Faraz3, Mumtaz Khan3, Syed Tahir Ali Shah4, Nawab Ali2,  Muhammad Saeed1 1Cancer Genetics and Epigenetics Lab, Department of Biosciences, COMSATS Institute of Information Technology, Islamabad; 2Department of  Biotechnology & Genetic Engineering, Kohat University of Science & Technology, Kohat; 3Department of Surgical C Unit, Post Graduate Medical Institution,  Lady Reading Hospital, Peshawar; 4Department of Surgery, Divisional Headquarter Hospital, Kohat, PakistanORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 133-141  http://dx.doi.org/10.4048/jbc.2016.19.2.133 Purpose:  The promoter methylation status of cell cycle regulatory  genes plays a crucial role in the regulation of the eukaryotic cell  cycle.",Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.133sive characteristics that have been observed in solid osteosar - coma [8] and cancer of the colon [9], ovary [3], and breast  [10].",Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
Promoter Methylation and Expression of E2F5  in Breast Cancer 135 http://dx.doi.org/10.4048/jbc.2016.19.2.133  http://ejbc.krethidium bromide.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.133Table 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
"Promoter Methylation and Expression of E2F5  in Breast Cancer 137 http://dx.doi.org/10.4048/jbc.2016.19.2.133  http://ejbc.krthat changes in the methylation status (∆meth) are signifi - cantly related to both tissue types ( p< 0.001) (Tables 1, 2,  Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.133(43.8%) compared to patients at an advanced stage (Stage II,  50%; Stage III, 66.7%).",Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
Promoter Methylation and Expression of E2F5  in Breast Cancer 139 http://dx.doi.org/10.4048/jbc.2016.19.2.133  http://ejbc.krTable 4.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.133tissues (48% of all cases), compared to the control samples  (80%).",Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
Promoter Methylation and Expression of E2F5  in Breast Cancer 141 http://dx.doi.org/10.4048/jbc.2016.19.2.133  http://ejbc.krstable sporadic colorectal carcinomas.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/jbc-19-133.PMC4929253.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The S100 protein family consists of over 20 family members  of low molecular weight calcium binding proteins [1].",Non-OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
"S100A8 and S100A9  are known to be associated with high grade and basal-type Hornerin Is Involved in Breast Cancer Progression Jinhyuk Choi*, Dong-Il Kim1,*, Jinkyoung Kim, Baek-Hui Kim, Aeree Kim Department of Pathology, Korea University Guro Hospital, Seoul; 1Green Cross Reference Laboratory, Y ongin, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 142-147  http://dx.doi.org/10.4048/jbc.2016.19.2.142 Purpose:  The S100 gene family, which comprises over 20 mem - bers, including S100A1, S100A2, S100A8, S100A9, profilaggrin,  and hornerin encodes low molecular weight calcium-binding  proteins with physiological and pathological roles in keratiniza - tion.",Non-OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
Hornerin Is Involved in Breast Cancer Progression143 http://dx.doi.org/10.4048/jbc.2016.19.2.142  http://ejbc.krbreast cancer [8-10].,Non-OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.142statistically significant when the p-value was less than 0.050.,OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
Hornerin Is Involved in Breast Cancer Progression145 http://dx.doi.org/10.4048/jbc.2016.19.2.142  http://ejbc.krcer progression.,Non-OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.142lymph nodes of the same patients.,Non-OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
Hornerin Is Involved in Breast Cancer Progression147 http://dx.doi.org/10.4048/jbc.2016.19.2.142  http://ejbc.kr11.,Non-OADS,/arxiv_data1/oa_pdf/aa/8e/jbc-19-142.PMC4929254.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is a heterogeneous and complex genetic dis - ease that is characterized by altered expression of several cod - ing and noncoding genes.",Non-OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"Partic -Aberrant Expression of Breast Development-Related MicroRNAs, miR-22,  miR-132, and miR-212, in Breast Tumor Tissues Zahra Damavandi, Safoora Torkashvand1,2, Mohammad Vasei3, Bahram M. Soltani, Mahmood Tavallaei4,   Seyed Javad Mowla Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran; 1Department of Genetics, Faculty of Biological Sciences, Science  and Research Branch, Islamic Azad University, Tehran; 2Razi Drug Research Center, Iran University of Medical Sciences, Tehran; 3Pathology Laboratory,  Shariati Hospital, Tehran University of Medical Sciences, Tehran; 4Human Genetic Research Center, Baqiyatallah University of Medical Sciences, Tehran,  IranORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 148-155  http://dx.doi.org/10.4048/jbc.2016.19.2.148 Purpose:  MicroRNAs (miRNAs) are a major class of small en - dogenous RNA molecules that posttranscriptionally regulate the  expression of most genes in the human genome.",OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"miR-22, miR-132, and miR-212 Expression Alterations in Breast cancer149 http://dx.doi.org/10.4048/jbc.2016.19.2.148  http://ejbc.krularly, in several LOH studies, a high frequency of deletions in  two distinct regions of 17p (17p13.1 and 17p13.3) have been  reported.",Non-OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.148Diego, USA).",Non-OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"miR-22, miR-132, and miR-212 Expression Alterations in Breast cancer151 http://dx.doi.org/10.4048/jbc.2016.19.2.148  http://ejbc.krsingle, sharp melting curves, and direct DNA sequencing  (Figure 1).",OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.148in tumor samples were normalized to those of nontumor  specimens obtained from the same patient.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"miR-22, miR-132, and miR-212 Expression Alterations in Breast cancer153 http://dx.doi.org/10.4048/jbc.2016.19.2.148  http://ejbc.krFigure 4.  miR-22 expression in tumor versus nontumor breast tissue samples.",OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.148result of using samples with different stages or grades of ma - lignancy.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"miR-22, miR-132, and miR-212 Expression Alterations in Breast cancer155 http://dx.doi.org/10.4048/jbc.2016.19.2.148  http://ejbc.kr1215-20.",Non-OADS,/arxiv_data1/oa_pdf/17/ba/jbc-19-148.PMC4929255.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common malignancy in women,  and invasive carcinoma of no special type is the most com - mon form of breast cancer [1,2].",Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
"Further, a recent study High Expression of Urokinase-Type Plasminogen Activator Is Associated with  Lymph Node Metastasis of Invasive Ductal Carcinoma of the Breast Eun Y oung Kim*, Sung-Im Do1,*, Keehoon Hyun, Y ong Lai Park, Dong-Hoon Kim1, Seoung Wan Chae1, Jin Hee Sohn1,  Chan Heun Park Departments of Surgery and 1Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 156-162  http://dx.doi.org/10.4048/jbc.2016.19.2.156 Purpose:  In the present study, we evaluated the levels of uroki - nase-type plasminogen activator (uPA) and plasminogen activ- ator inhibitor 1 (PAI-1) by performing immunohistochemical stain - ing to determine whether they were reliable prognostic markers  in patients with breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
High Expression of Urokinase-Type Plasminogen Activator157 http://dx.doi.org/10.4048/jbc.2016.19.2.156  http://ejbc.krdiscussed the role of tumor uPA and PAI-1 levels in a making  decision for using adjuvant therapy for treating early breast  cancer [10].,Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.156of data on DFS and OS.,OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
High Expression of Urokinase-Type Plasminogen Activator159 http://dx.doi.org/10.4048/jbc.2016.19.2.156  http://ejbc.krTable 2.  uPA and PAI-1 expression in DCIS and IDC patients TotaluPA PAI-1 Low High p-value Low High p-value DCIS* 80  51 (63.8) 29 (36.2) 0.182 14 (17.5)  66 (82.5) 0.003 IDC* 214 118 (55.2) 96 (44.8) 75 (35.1) 139 (64.9) Data are presented as number (%).,Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.156DISCUSSION Malignant tumors degrade the extracellular matrix, which  is crucial for their invasion and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
"High Expression of Urokinase-Type Plasminogen Activator161 http://dx.doi.org/10.4048/jbc.2016.19.2.156  http://ejbc.krtastasis of some cancers by inhibiting uPA–Urokinase-type  plasminogen activator receptor (uPAR) [16-18], it promotes  the growth and angiogenesis of some cancers [18,19].",Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.156al.,Non-OADS,/arxiv_data1/oa_pdf/ff/3f/jbc-19-156.PMC4929256.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION According to the American Joint Committee on Cancer  (AJCC) TNM staging system, breast cancer presenting with  positive nodes at the apex of the axilla (level III) and/or 10 or  more metastatic lymph nodes (LN) is categorized as pN3  (pathological lymph node status 3) [1].",Non-OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
"N3 was defined  according to the AJCC seventh TNM staging system as ≥ 10  axillary nodes on pathology reports and/or ipsilateral supra/ infraclavicular LN (SCN/ICN) metastasis and/or ipsilateral  internal mammary LN (IMLN) metastasis, as shown by imag -Prognostically Distinctive Subgroup in Pathologic N3 Breast Cancer Yun Y eong Kim, Heung Kyu Park, Kyung Hee Lee, Kwan Il Kim, Y ong Soon Chun Department of Surgery, Breast Cancer Center, Gachon University Gill Medical Center, Incheon, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 163-168  http://dx.doi.org/10.4048/jbc.2016.19.2.163 Purpose:  The aim of this retrospective study was to investigate  whether there are prognostically different subgroups among pa - tients with pathologic N3 (pN3) breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.163ing modalities or needle biopsy.,Non-OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
"165 http://dx.doi.org/10.4048/jbc.2016.19.2.163  http://ejbc.krtant metastasis as the first event, and both were found in 19  patients (8.6%) (Table 2).",OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.163cant factor of recurrence (Wald test = 13.131, highest among  significant factors mentioned above).",OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
"167 http://dx.doi.org/10.4048/jbc.2016.19.2.163  http://ejbc.krcrine therapy, which was administered to all patients as indi - cated.",Non-OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.163REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/71/38/jbc-19-163.PMC4929257.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Although the percentage of patients with breast cancer di - agnosed at an early stage has increased as a result of promoted  awareness, early detection campaigns, and screening tools  such as mammography, up to 30% of breast cancer patients  still present with advanced disease at initial diagnosis [1].",Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
"Over the last few decades, the development of multimodal - ity treatments consisting of radical surgery, adjuvant chemo - therapy, and adjuvant radiotherapy (RT) with or without ad -Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast  Cancer Patients with 10 or More Axillary Nodes Sang-Won Kim, Doo Ho Choi1, Seung Jae Huh1, Won Park1, Seok Jin Nam2, Seok Won Kim2, Jeong Eon Lee2,   Y oung-Hyuck Im3, Jin Seok Ahn3, Y eon Hee Park3 Department of Radiation Oncology, Ajou University School of Medicine, Suwon; Departments of 1Radiation Oncology, 2Surgery, and 3Division of  Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 169-175  http://dx.doi.org/10.4048/jbc.2016.19.2.169 Purpose:  We analyzed the association of lymph node ratio (LNR)  wth locoregional control (LRC) in breast cancer patients with  ≥ 10 involved axillary lymph nodes who underwent multimodality  treatment.",Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.169juvant endocrine therapy, has resulted in favorable clinical  outcomes in patients with ≥ 10 involved ALNs [9,10].",Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
"LNR Effect on LRC in Patients with ≥10 Axillary LNs171 http://dx.doi.org/10.4048/jbc.2016.19.2.169  http://ejbc.krdian age was 43 years (range, 29–77 years).",OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.169was carried out in eight patients before systemic therapy; sur - gery was performed in six patients and RT was performed in  two patients with IMN recurrence.,Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
"LNR Effect on LRC in Patients with ≥10 Axillary LNs173 http://dx.doi.org/10.4048/jbc.2016.19.2.169  http://ejbc.krTo reduce the rate of LRR and eventually to improve sur - vival rate, the role of adjuvant RT has been investigated.",Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.169tions prescribed elective irradiation to axillary lymph nodes  area in patients with ≥ 3 positive ALNs after axillary lymph  node dissection.,Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
LNR Effect on LRC in Patients with ≥10 Axillary LNs175 http://dx.doi.org/10.4048/jbc.2016.19.2.169  http://ejbc.krnodes in breast cancer recurrence and survival in patients with one to  three positive axillary lymph nodes.,Non-OADS,/arxiv_data1/oa_pdf/1e/93/jbc-19-169.PMC4929258.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Radiotherapy is an important adjuvant treatment for pa - tients with breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
"Therefore, it remains unclear whether this Predictive Value of Molecular Subtyping for Locoregional Recurrence in  Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy Ge Wen1,2,*, Jin-Shan Zhang2,*, Yu-Jing Zhang1, Yu-Jia Zhu1, Xiao-Bo Huang1, Xun-Xing Guan1 1Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation  Center of Cancer Medicine, Guangdong; 2Department of Radiation Oncology, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou,  ChinaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 176-184  http://dx.doi.org/10.4048/jbc.2016.19.2.176 Purpose:  This study was designed to investigate the relationship  between molecular subtype and locoregional recurrence (LRR) in  patients with early-stage breast cancer with 1–3 positive axillary  lymph nodes (ALNs) and improve the individualized indications  for postmastectomy radiotherapy (PMRT).",Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
Molecular Subtyping Predict Locoregional Recurrence in Early Breast Cancer 177 http://dx.doi.org/10.4048/jbc.2016.19.2.176  http://ejbc.krsubgroup of patients should receive PMRT.,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.176positively stained tumor cell nuclei in the weak intensity cate - gory [1+] × 1)+(percentage of positively stained tumor cell  nuclei in the intermediate intensity category [2+] × 2)+(per - centage of positively stained tumor cell nuclei in the strong in - tensity category [3+] × 3).,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
Molecular Subtyping Predict Locoregional Recurrence in Early Breast Cancer 179 http://dx.doi.org/10.4048/jbc.2016.19.2.176  http://ejbc.krPostoperative adjuvant therapy All patients who received adjuvant radiotherapy were ex - cluded from this study.,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.176tion, the 5-year and 10-year LRR rates were 9.1% and 13.5%,  respectively; the 5-year and 10-year LRFS rates were 86.3%  and 77.5%, respectively; and the 5-year and 10-year BCSS  rates were 91.2% and 84.0%, respectively.",OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
"Molecular Subtyping Predict Locoregional Recurrence in Early Breast Cancer 181 http://dx.doi.org/10.4048/jbc.2016.19.2.176  http://ejbc.krof LRR ( p= 0.002 each), lower LRFS ( p= 0.001 each), and  lower BCSS ( p= 0.002 and p= 0.001, respectively) (Table 3,  Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.176rates than the patients with non-triple-negative breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
Molecular Subtyping Predict Locoregional Recurrence in Early Breast Cancer 183 http://dx.doi.org/10.4048/jbc.2016.19.2.176  http://ejbc.krcases in which the HER2 IHC score was 2+.,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
http://www.nccn.org/profes - sionals/physician_gls/PDF/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.17621.,Non-OADS,/arxiv_data1/oa_pdf/5e/23/jbc-19-176.PMC4929259.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast screening programs such as mammography or biop - sy have resulted in the increase in the detection of ductal car - cinoma in situ  (DCIS) [1,2].",Non-OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
"This is the first multigene assay that Predictors of Recurrent Ductal Carcinoma In Situ  after Breast-Conserving  Surgery Jung Y eon Kim, Kyeongmee Park, Guhyun Kang, Hyun-Jung Kim, Geumhee Gwak1, Y oung-Joo Shin2 Departments of Pathology, 1Surgery, and 2Radiation Oncology, Inje University Sanggye Paik Hospital, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 185-190  http://dx.doi.org/10.4048/jbc.2016.19.2.185 Purpose:  Local recurrence is a major concern in patients who  have undergone surgery for ductal carcinoma in situ  (DCIS).",Non-OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.185generates individualized estimates for the 10-year risk of any  local recurrence.,OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
"Predictors of Recurrence of Ductal Carcinoma In Situ  187 http://dx.doi.org/10.4048/jbc.2016.19.2.185  http://ejbc.krof cardiovascular disease or systemic disease, and poor per - formance status.",Non-OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.185(41.7%) was ER−/PR−/HER2+ and the second most common  initial subtype (33.3%) was ER+/PR+/HER2+.,OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
"Predictors of Recurrence of Ductal Carcinoma In Situ  189 http://dx.doi.org/10.4048/jbc.2016.19.2.185  http://ejbc.krmined via the symptomatic nonscreen detection method;  however, no associations were found between nuclear grade,  comedonecrosis, tumor size, multifocality, hormonal status,  or HER2 positivity and tumor recurrence.",Non-OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.18520.,Non-OADS,/arxiv_data1/oa_pdf/da/16/jbc-19-185.PMC4929260.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Internal mammary lymph nodes (IMLNs) are a secondary  lymphatic drainage area in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
"As the role of MRI in evaluating pa -Breast Magnetic Resonance Imaging for Assessment of Internal Mammary  Lymph Node Status in Breast Cancer Hyung Won Lee, Sung Hun Kim  Division of Radiology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 191-198  http://dx.doi.org/10.4048/jbc.2016.19.2.191 Purpose:  The purpose of this study was to assess magnetic res - onance imaging (MRI) features of malignant internal mammary  lymph nodes (IMLNs) and benign IMLNs in breast cancer pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.191tients with breast cancer expands, a better understanding of  MRI ﬁndings of IMLNs is needed to enable correct preoper - ative diagnosis and appropriate management.",Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
MRI Features of Malignant and Benign Internal Mammary Lymph Node193 http://dx.doi.org/10.4048/jbc.2016.19.2.191  http://ejbc.krchi-square test.,Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.191Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
MRI Features of Malignant and Benign Internal Mammary Lymph Node195 http://dx.doi.org/10.4048/jbc.2016.19.2.191  http://ejbc.krFigure 3.,Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.191peak.,Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
MRI Features of Malignant and Benign Internal Mammary Lymph Node197 http://dx.doi.org/10.4048/jbc.2016.19.2.191  http://ejbc.krwas 4.78 ± 3.32.,Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.1912001;19:3516-23.,Non-OADS,/arxiv_data1/oa_pdf/5d/7c/jbc-19-191.PMC4929261.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Lobular carcinoma in situ  (LCIS), a noninvasive prolifera - tion of lobular cells within a terminal-duct lobular unit, in - volves multicentric lobules and both the breasts in 85% and  30% to 67% of patients, respectively [1,2].",Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
"Between 2005 and 2013, a total of 21,270 Features of Pure Lobular Carcinoma In Situ  on Magnetic Resonance Imaging  Associated with Immediate Re-Excision after Lumpectomy A Jung Chu1,2, Nariya Cho1, In-Ae Park3, Seong Whi Cho2 1Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; 2Department of Radiology, Kangwon  National University Graduate School, Chuncheon; 3Department of Pathology, Seoul National University Hospital, Seoul National University College of  Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2016 June; 19(2): 199-205  http://dx.doi.org/10.4048/jbc.2016.19.2.199 Purpose:  To evaluate imaging features of pure lobular carcinoma  in situ  (LCIS) on magnetic resonance imaging (MRI) in patients  who underwent immediate re-excision after lumpectomy.",Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.199consecutive patients underwent image-guided percutaneous  breast biopsy at our hospital.,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
"MRI Features of LCIS Associated Re-Excision201 http://dx.doi.org/10.4048/jbc.2016.19.2.199  http://ejbc.krversion 19.0 (IBM Corp., Armonk, USA) was used for all sta - tistical analyses and two-tailed p-values of < 0.05 were con - sidered to indicate a statistical significance.",OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.199Table 3.,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
"MRI Features of LCIS Associated Re-Excision203 http://dx.doi.org/10.4048/jbc.2016.19.2.199  http://ejbc.krdelayed persistent kinetics (42.9%, 12/28).",Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.199margin did not affect subsequent local recurrence [8,9].",OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
http://www.nccn.org/professionals/ physician_gls/PDF/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
MRI Features of LCIS Associated Re-Excision205 http://dx.doi.org/10.4048/jbc.2016.19.2.199  http://ejbc.krcology/American Society for Radiation Oncology consensus guideline.,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/jbc-19-199.PMC4929262.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Opioid receptors are involved in tumor growth and pro - gression [1-3].",Non-OADS,/arxiv_data1/oa_pdf/ef/1a/jbc-19-206.PMC4929263.pdf
"The  present study was conducted to confirm the effects of the dif - ferential distribution of the OPRM1  A118G SNP on breast  cancer in Korean women.Study protocol was reviewed and approved by the Institu - tional Review Board of Konkuk University Medical Center,  Seoul, South Korea (KUH1160085), and the study was regis - tered at https://cris.nih.go.kr (KCT0001558).",Non-OADS,/arxiv_data1/oa_pdf/ef/1a/jbc-19-206.PMC4929263.pdf
"Results for each genotype  were confirmed in randomly selected women by performing Mu-Opioid Receptor Polymorphisms and Breast Cancer in a Korean Female  Adult Population: A Retrospective Study Chung-Sik Oh1, Seung-Hyun Lee2, Y oung-Bum Y oo3, Jung-Hyun Y ang3, Seong-Hyop Kim1,4 1Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul; 2Department of  Microbiology, Konkuk University School of Medicine, Seoul; 3Department of Surgery, Konkuk University Medical Center, Konkuk University School of  Medicine, Seoul; 4Institute of Biomedical Science and Technology, Konkuk University School of Medicine, Seoul, KoreaBRIEF COMMUNICATIONJ Breast Cancer 2016 June; 19(2): 206-209  http://dx.doi.org/10.4048/jbc.2016.19.2.206 Distribution of A118G single nucleotide polymorphism (SNP) in  the mu-opioid receptor 1 gene ( OPRM1 ) differs with ethnicity.",Non-OADS,/arxiv_data1/oa_pdf/ef/1a/jbc-19-206.PMC4929263.pdf
Opioid Receptor Polymorphism and Breast Cancer207 http://dx.doi.org/10.4048/jbc.2016.19.2.206  http://ejbc.krdirect sequencing.,Non-OADS,/arxiv_data1/oa_pdf/ef/1a/jbc-19-206.PMC4929263.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.206G allele of the OPRM1  A118G SNP and breast cancer in  Caucasian women, which was consistent with that observed  in their study (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/ef/1a/jbc-19-206.PMC4929263.pdf
Opioid Receptor Polymorphism and Breast Cancer209 http://dx.doi.org/10.4048/jbc.2016.19.2.206  http://ejbc.krnucleotide polymorphism of human mu-opioid receptor gene influ - ences pain perception and patient-controlled intravenous morphine  consumption after intrathecal morphine for postcesarean analgesia.,Non-OADS,/arxiv_data1/oa_pdf/ef/1a/jbc-19-206.PMC4929263.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Angiogenesis plays a major role in the development and  progression of cancer, including breast cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/e1/2e/jbc-19-210.PMC4929264.pdf
"The parameters of SMI were as follows: less An Innovative Ultrasound Technique for Evaluation of Tumor Vascularity in  Breast Cancers: Superb Micro-Vascular Imaging Ah Y oung Park, Bo Kyoung Seo, Sang Hoon Cha, Suk Keu Y eom, Seung Wha Lee, Hwan Hoon Chung Department of Radiology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, KoreaBRIEF COMMUNICATIONJ Breast Cancer 2016 June; 19(2): 210-213  http://dx.doi.org/10.4048/jbc.2016.19.2.210 Tumor vascularity is an important indicator for differential diag - nosis, tumor growth, and prognosis.",Non-OADS,/arxiv_data1/oa_pdf/e1/2e/jbc-19-210.PMC4929264.pdf
"Superb Micro-vascular Imaging in Breast Cancer211 http://dx.doi.org/10.4048/jbc.2016.19.2.210  http://ejbc.krthan 1.5-scale region of interest size, a range of 4 to 7 frame  average, and as high gain as possible.",Non-OADS,/arxiv_data1/oa_pdf/e1/2e/jbc-19-210.PMC4929264.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.210mean number of vessels within the tumor was 2.48 ( ± 2.4) on  color Doppler, 2.81 ( ±3.0) on power Doppler imaging, and  7.24 ( ± 3.0) on SMI.",OADS,/arxiv_data1/oa_pdf/e1/2e/jbc-19-210.PMC4929264.pdf
Superb Micro-vascular Imaging in Breast Cancer213 http://dx.doi.org/10.4048/jbc.2016.19.2.210  http://ejbc.krand in eight tumors (38.1%) on power Doppler imaging.,Non-OADS,/arxiv_data1/oa_pdf/e1/2e/jbc-19-210.PMC4929264.pdf
https://medical.toshiba.com/products/ultrasound/aplio-platinum/ technology.php .,Non-OADS,/arxiv_data1/oa_pdf/e1/2e/jbc-19-210.PMC4929264.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Brain metastasis from breast cancer is less common than  metastasis to the bone, lung, and liver.",Non-OADS,/arxiv_data1/oa_pdf/ec/3d/jbc-19-214.PMC4929265.pdf
"CASE REPORTS Case 1 MBT were found during first-line palliative chemotherapy  (docetaxel plus capecitabine) in a 43-year-old woman with  breast cancer with metastasis to the lung and the mediastinal Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from  Breast Cancer: Two Case Reports Kyung-Do Byun, Sung Gwe Ahn1, Hyung Joo Baik, Anbok Lee, Ki Beom Bae, Min Sung An, Kwang Hee Kim, Jae Ho Shin,  Ha Kyoung Park, Heunglae Cho2, Joon Jeong1, Tae Hyun Kim Breast Center, Department of Surgery, Inje University Busan Paik Hospital, Busan; 1Department of Surgery, Gangnam Medical Research Center, Gangnam  Severance Hospital, Y onsei University College of Medicine, Seoul; 2Department of Radiation Oncology, Inje University Busan Paik Hospital, Busan, KoreaCASE REPORTJ Breast Cancer 2016 June; 19(2): 214-217  http://dx.doi.org/10.4048/jbc.2016.19.2.214 The prognosis associated with brain metastasis arising from  breast cancer is very poor.",Non-OADS,/arxiv_data1/oa_pdf/ec/3d/jbc-19-214.PMC4929265.pdf
"Eribulin with Local Treatment Regressed Brain Metastasis from Breast Cancer215 http://dx.doi.org/10.4048/jbc.2016.19.2.214  http://ejbc.krnodes, in Inje University Busan Paik Hospital in June 2013.",Non-OADS,/arxiv_data1/oa_pdf/ec/3d/jbc-19-214.PMC4929265.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.214she was postmenopausal, we initiated treatment with an aro - matase inhibitor (letrozole) in December 2014.",Non-OADS,/arxiv_data1/oa_pdf/ec/3d/jbc-19-214.PMC4929265.pdf
"Eribulin with Local Treatment Regressed Brain Metastasis from Breast Cancer217 http://dx.doi.org/10.4048/jbc.2016.19.2.214  http://ejbc.krDISCUSSION The clinical regression, without symptoms, of MBT from  breast cancer was sustained for 24 and 18 months in case 1  and case 2, respectively, using multimodality therapies that in - cluded surgery, SRT, WBRT, chemotherapy, and endocrine  therapy.",Non-OADS,/arxiv_data1/oa_pdf/ec/3d/jbc-19-214.PMC4929265.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Germline mutations in the tumor suppressor genes BRCA1   and BRCA2  account for 3% to 5% of all breast cancer cases  and 10% to 15% of ovarian cancer cases [1].",Non-OADS,/arxiv_data1/oa_pdf/45/b8/jbc-19-218.PMC4929266.pdf
"She had no past medical history and was in Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA   Mutation Carrier Yurina Maeshima, Kumiko Oseto, Ryohei Katsuragi, Yukiko Y oshimoto, Sachiko Takahara, Akira Y amauchi Department of Breast Surgery, Kitano Hospital Breast Center, The Tazuke Kohukai Medical Research Institute, Osaka, JapanCASE REPORTJ Breast Cancer 2016 March; 19(2): 218-221  http://dx.doi.org/10.4048/jbc.2016.19.2.218 Women with BRCA1/2  mutations have a high risk of breast can - cer and may opt for risk-reducing mastectomy (RRM).",Non-OADS,/arxiv_data1/oa_pdf/45/b8/jbc-19-218.PMC4929266.pdf
Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA  Mutation Carrier219 http://dx.doi.org/10.4048/jbc.2016.19.2.218  http://ejbc.krgood health.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/jbc-19-218.PMC4929266.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.218risks associated with surgeries.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/jbc-19-218.PMC4929266.pdf
"Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA  Mutation Carrier221 http://dx.doi.org/10.4048/jbc.2016.19.2.218  http://ejbc.krsearch is limited to undertaking observation studies, which  intrinsic methodological limitation.",Non-OADS,/arxiv_data1/oa_pdf/45/b8/jbc-19-218.PMC4929266.pdf
http://www.nccn.org/professionals/physician_gls/ pdf/genetics_screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/jbc-19-218.PMC4929266.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.MOLECULAR ROADMAP , FROM PROGENITOR  TO MATURE CELLS, IN THE NORMAL HUMAN  MAMMARY GLAND Recent studies have shown that normal breast tissue is com - posed of epithelial and nonepithelial cells with different pro - files reflecting their maturation and differentiation [1].",Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
"These cells are located in the ducts, Molecular Portrait of the Normal Human Breast Tissue and Its Influence on  Breast Carcinogenesis Madalin Marius Margan, Andreea Adriana Jitariu1, Anca Maria Cimpean1, Cristian Nica2, Marius Raica1 Department XII-Obstetrics and Gynecology, Neonatology and Perinatal Care, 1Department of Microscopic Morphology/Histology,   Angiogenesis Research Center, and  2Department of Surgery, Victor Babes University of Medicine and Pharmacy, Timisoara, RomaniaREVIEW ARTICLEJ Breast Cancer 2016 June; 19(2): 99-111  http://dx.doi.org/10.4048/jbc.2016.19.2.99 Normal human breast tissue consists of epithelial and nonepi - thelial cells with different molecular profiles and differentiation  grades.",Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.99lobules, and various other regions, wherein a certain hierarchy  is present [5-7].",Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
"Normal Breast Gene Expression Profile and Carcinogenesis101 http://dx.doi.org/10.4048/jbc.2016.19.2.99  http://ejbc.krof these molecular changes is a BRCA1  gene mutation, specifi - cally occurring through chromosomal loss [19-21].",Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.99sion [36].,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
"Normal Breast Gene Expression Profile and Carcinogenesis103 http://dx.doi.org/10.4048/jbc.2016.19.2.99  http://ejbc.krfetal mammary tissue, Bcl2 appears to regulate the patterning  behavior of mammary cells [58].",Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.99Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
Normal Breast Gene Expression Profile and Carcinogenesis105 http://dx.doi.org/10.4048/jbc.2016.19.2.99  http://ejbc.krTable 1.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.99proper management and predict patient outcome is necessary.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
Normal Breast Gene Expression Profile and Carcinogenesis107 http://dx.doi.org/10.4048/jbc.2016.19.2.99  http://ejbc.kr11.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.9943.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
Normal Breast Gene Expression Profile and Carcinogenesis109 http://dx.doi.org/10.4048/jbc.2016.19.2.99  http://ejbc.krtential pitfalls in distinguishing intralymphatic carcinoma from in situ  carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
Epub 2016 Mar 22. http://dx.doi.org/10.18632/ oncotarget.8250.,OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2016.19.2.99lation of EMT factors by steroid nuclear receptors in breast cancer: a  review and in silico investigation.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
Epub 2016 Feb 5. http://dx.doi.org/10.1159/000444451.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
Normal Breast Gene Expression Profile and Carcinogenesis111 http://dx.doi.org/10.4048/jbc.2016.19.2.99  http://ejbc.kr142.,Non-OADS,/arxiv_data1/oa_pdf/ca/3c/jbc-19-99.PMC4929267.pdf
She wasContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.06.002 2211-7539/ &2016 International Society for Human and Animal Mycology.,OADS,/arxiv_data1/oa_pdf/d7/b2/main.PMC4929340.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/8b/main.PMC4929341.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.06.029 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e3/8b/main.PMC4929341.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2016.06.029 .",OADS,/arxiv_data1/oa_pdf/e3/8b/main.PMC4929341.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/37/main.PMC4929342.pdf
"E-mail addresses: xiaqw@utexas.edu (Q. Paulson), edouglass@seton.org (E. Douglass), alejandro.moreno@austin.utexas.edu (A. Moreno), jdaydelotte@seton.org (J. Aydelotte).Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr http://dx.doi.org/10.1016/j.idcr.2016.02.008 2214-2509/ /C2232016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/37/main.PMC4929342.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/37/main.PMC4929342.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/04/main.PMC4929343.pdf
"At  the  patient’s  request,  fat  injection  for  lateral  vol- ume  loss  was  performed  twice  in  the  plastic  surgery  department http://dx.doi.org/10.1016/j.ijscr.2016.06.017 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/84/04/main.PMC4929343.pdf
"7 (2012)  53,  http://dx.doi.org/10.1186/1746-1596-7-53 .",Non-OADS,/arxiv_data1/oa_pdf/84/04/main.PMC4929343.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/4c/main.PMC4929344.pdf
During http://dx.doi.org/10.1016/j.ijscr.2016.06.019 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/07/4c/main.PMC4929344.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2016, 11: 32088 - http://dx.doi.org/10.3402/ljm.v11.32088 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32088 - http://dx.doi.org/10.3402/ljm.v11.32088",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"in Libya Citation: Libyan Journal of Medicine 2016, 11: 32088 - http://dx.doi.org/10.3402/ljm.v11.32088 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"4 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32088 - http://dx.doi.org/10.3402/ljm.v11.32088",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"in Libya Citation: Libyan Journal of Medicine 2016, 11: 32088 - http://dx.doi.org/10.3402/ljm.v11.32088 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"2012; 7: 19852, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"2012; 7: e48165, doi: http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"6 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32088 - http://dx.doi.org/10.3402/ljm.v11.32088",Non-OADS,/arxiv_data1/oa_pdf/68/d9/LJM-11-32088.PMC4929352.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"After overnight coupling andblocking (with 1% (w/v) BSA in PBS for 2 h at room temperature (RT)), the bound material was labelled withProteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"All other graphs were generated using GraphPad Prism version 5.01 for Windows (GraphPad Software,Proteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"A proportion was also analysed by nanoparticle tracking to examine the size distribution of particles in the ﬁnal sample, and the histogram mean and mode is shown (based on triplicate measurements) (d).Proteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"Some of the identifica- tions reported with a low signal, for example, with anProteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"A bespoke sample collection was initiated, aiming to collect plasma and urine from prostate cancer patients who were either newly diagnosed with multipleProteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"The data set is shown in Supplementary Table 3A.Proteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"Inplasma isolates, a number of elevated proteins known asmarkers of prostate cancer or of disease progression wereProteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/ 2.,Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2014;33:657 /C171, doi: http://dx.doi.org/10.1007/ s10555-013-9470-4 4.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2002;2:569 /C179, doi: http://dx.doi.org/10.1038/nri8555.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2012;10:e1001450, doi: http://dx.doi.org/10.1371/journal.pbio.1001450 6.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2007;9:654 /C19, doi: http://dx.doi.org/10.1038/ncb1596 7.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2014;24:766 /C19, doi: http://dx.doi.org/10.1038/cr.2014.44 8.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"Cancer Res.2006;66:4795 /C1801, doi: http://dx.doi.org/10.1158/0008-5472.can- 05-4579 9.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2010;9:1085/C199, doi: http://dx.doi.org/10.1074/mcp.M900381-MCP200 10.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2005;118:3631 /C18, doi: http://dx.doi.org/10.1242/jcs.02494 11.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;40:27 /C134, doi: http://dx.doi.org/10.1016/j.semcdb.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2005;17:879 /C187, doi: http://dx.doi.org/ 10.1093/intimm/dxh267 13.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"Proc NatlAcad Sci USA 2004;101:13368 /C173, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2008;31:1059 /C162, doi: http://dx.doi.org/10.1248/bpb.31.1059 15.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2011;59:823/C131, doi: http://dx.doi.org/10.1016/j.eururo.2010.12.031 17.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2008;110:13 /C121, doi: http://dx.doi.org/10.1016/ j.ygyno.2008.04.033 19.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2006;70:1847 /C157, doi: http://dx.doi.org/10.1038/sj.ki.5001874 20.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;2015:657086, doi: http://dx.doi.org/10.1155/2015/657086 21.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"16 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2013;13:3354 /C164, doi: http://dx.doi.org/10.1002/pmic.201300282 22.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2014;3:23430, doi: http://dx.doi.org/10.3402/jev.v3.23430 24. de Menezes-Neto A, Fidalgo Sa ´ez MJ, Lozano-Ramos I, Segui-Barber J, Martin-Jaular L, Estanyol Ullate JM, et al.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2010;5:e15004, doi: http://dx.doi.org/ 10.1371/journal.pone.0015004 26.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2014;13:1050 /C164, doi: http://dx.doi.org/ 10.1074/mcp.M113.032136 27.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2013;2:19861, doi: http://dx.doi.org/10.3402/jev.v2i0.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2014;3:e201, doi:http://dx.doi.org/10.1038/mtna.2014.49 30.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;15:2597 /C1601, doi: http://dx.doi.org/10.1002/ pmic.201400515 31.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;4:27269, doi: http://dx.doi.org/10.3402/jev.v4.27269 32.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2009;378:433 /C18, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2012;26:4160 /C173, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2012;1:19179, doi: http://dx.doi.org/10.3402/jev.v1i0.19179 36.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2009;20: 363/C179, doi: http://dx.doi.org/10.1681/asn.2008040406 39.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2012;12:329/C138, doi: http://dx.doi.org/10.1002/pmic.201100477 40.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2009;7:4, doi: http://dx.doi.org/10.1186/1479-5876-7-4 41.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"J Immunol Methods.2008;338:21 /C130, doi: http://dx.doi.org/10.1016/j.jim.2008.07.007 42.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;4:27031, doi: http://dx.doi.org/10.3402/jev.v4.27031 43.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;10:e0145686, doi: http://dx.doi.org/10.1371/journal.pone.0145686 44.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;4:27369, doi: http://dx.doi.org/10.3402/jev.v4.27369 45.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2014;3:26913, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2008;123:633 /C140, doi: http://dx.doi.org/10.1002/ ijc.23490 48.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;3:87 /C192, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"Candidate serum biomarkers forprostate adenocarcinoma identiﬁed by mRNA differences inProteomics of biofluid exosomes in prostate cancer Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2012;58:599 /C1609, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2001;95:51 /C15, doi: http://dx.doi.org/10.1002/1097-0215(20010120)95:1 B51:: AID-IJC1009 /C213.0.CO;2-J 51.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2013;190:2271 /C17, doi: http://dx.doi.org/10.1016/ j.juro.2013.05.004 52.",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2015;141:627 /C131, doi: http://dx.doi.org/10.1007/ s00432-014-1848-3 53.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"2009;28:2756 /C165, doi: http://dx.doi.org/ 10.1038/onc.2009.132 54.",Non-OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"18 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31209 - http://dx.doi.org/10.3402/jev.v5.31209",OADS,/arxiv_data1/oa_pdf/fd/a4/JEV-5-31209.PMC4929354.pdf
"   Case Rep Gastroenterol   DOI: 10.1159/000442663    © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2f/0b/crg-0010-0057.PMC4929358.pdf
"   Case Rep Gastroenterol 2016;10:81 –87  DOI: 10.1159/000444275   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/09/55/crg-0010-0081.PMC4929359.pdf
"   Case Rep Gastroenterol 2016;10:157 –160  DOI: 10.1159/000445868   Published online: May 9, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/14/91/crg-0010-0157.PMC4929360.pdf
"   Case Rep Gastroenterol 2016;10:108 –114  DOI: 10.1159/000444011   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Crea tive Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/da/57/crg-0010-0108.PMC4929361.pdf
"   Case Rep Gastroenterol 2016;10:95 –98  DOI: 10.1159/000444443   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ce/75/crg-0010-0095.PMC4929362.pdf
"   Case Rep Gastroenterol 2016;10:88 –94  DOI: 10.1159/000444442   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.",Non-OADS,/arxiv_data1/oa_pdf/42/89/crg-0010-0088.PMC4929363.pdf
"   Case Rep Gastroenterol 2016;10:44 –49  DOI: 10.1159/000444013   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (C C BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/crg-0010-0044.PMC4929364.pdf
"   Case Rep Gastroenterol 2016;10:99 –107  DOI: 10.1159/000444444   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommerci al 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/96/9e/crg-0010-0099.PMC4929365.pdf
"   Case Rep Gastroenterol 2016;10:24 –29  DOI: 10.1159/000442664    © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2a/d8/crg-0010-0024.PMC4929366.pdf
"   Case Rep Gastroenterol 2016;10:63 –67  DOI: 10.1159/000444413   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/20/45/crg-0010-0063.PMC4929367.pdf
"   Case Rep Gastroenterol 2016;10:181 –192  DOI: 10.1159/000445373   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1a/19/crg-0010-0181.PMC4929368.pdf
"   Case Rep Gastroenterol 2016;10:146 –150  DOI: 10.1159/000445737   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenA ccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2e/67/crg-0010-0146.PMC4929369.pdf
"   Case Rep Gastroenterol 2016;10:36 –43  DOI: 10.1159/000442972   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International  License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/29/cd/crg-0010-0036.PMC4929370.pdf
"   Case Rep Gastroenterol 2016;10:127 –131  DOI: 10.1159/000445185   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed u nder the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/67/33/crg-0010-0127.PMC4929371.pdf
"   Case Rep Gastroenterol 2016;10:1 –6  DOI: 10.1159/000443268   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/dc/d4/crg-0010-0001.PMC4929372.pdf
"   Case Rep Gastroenterol 2016;10:199 –206  DOI: 10.1159/000445976   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e9/f7/crg-0010-0199.PMC4929373.pdf
"   Case Rep Gastroenterol 2016;10:161 –167  DOI: 10.1159/000444441   Published online: May 4, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Cr eative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/66/8a/crg-0010-0161.PMC4929374.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/8e/ehw052.PMC4929376.pdf
Lo ¨nnberg G. VIP 1990-2014. http://public.tableau .com/views/VHU1990- 2014/Kolesterol?,Non-OADS,/arxiv_data1/oa_pdf/08/8e/ehw052.PMC4929376.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/f8/ehw125.PMC4929377.pdf
European Dietary Guidelines ..http://www.euﬁc.org/ article/en/expid/food-based-dietary-guidelines-in-europe/ (28 Novem- ber 2012) .,Non-OADS,/arxiv_data1/oa_pdf/e3/f8/ehw125.PMC4929377.pdf
"Cambridge University Press, 2004. http://journals.cambridge.org/action/displayAbstract?fromPage= online&aid=607988&ﬁleId=S0954422404000022 (30 July 2015) .",Non-OADS,/arxiv_data1/oa_pdf/e3/f8/ehw125.PMC4929377.pdf
http://www.srl.cam.ac.uk/epic/nutmethod/FFQii .shtml (30 July 2015) .,Non-OADS,/arxiv_data1/oa_pdf/e3/f8/ehw125.PMC4929377.pdf
"National Can- cer Institute, 2015. http://epi.grants.cancer.gov/diet/usualintakes/ffq .html?&url=/diet/usualintakes/ffq.html (30 July 2015) .",Non-OADS,/arxiv_data1/oa_pdf/e3/f8/ehw125.PMC4929377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/bc/ehw152.PMC4929379.pdf
https://www.nice.org.uk/guidance/cg181/evidence/lipid- modiﬁcation-update-full-guideline-243786637 (24 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/cd/bc/ehw152.PMC4929379.pdf
"   Case Rep Gastroenterol 2016;10:168 –173  DOI: 10.1159/000443269   Published online: May 9, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/32/ff/crg-0010-0168.PMC4929380.pdf
"   Case Rep Gastroenterol 2016;10:75 –80  DOI: 10.1159/000444249   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/66/22/crg-0010-0075.PMC4929381.pdf
"   Case Rep Gastroenterol 2016;10:132 –138  DOI: 10.1159/000445183   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercia l 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/91/ee/crg-0010-0132.PMC4929382.pdf
"   Case Rep Gastroenterol 2016;10:68 –74  DOI: 10.1159/000444276   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e5/9d/crg-0010-0068.PMC4929383.pdf
"   Case Rep Gastroenterol 2016;10:121 –126  DOI: 10.1159/000444519   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/3f/d5/crg-0010-0121.PMC4929384.pdf
"   Case Rep Gastroenterol 2016;10:139 –145  DOI: 10.1159/000445186   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/10/3d/crg-0010-0139.PMC4929385.pdf
"   Case Rep Gastroenterol 2016;10:30 –35  DOI: 10.1159/000442971   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/76/7d/crg-0010-0030.PMC4929386.pdf
"   Case Rep Gastroenterol 2016;10:115 –120  DOI: 10.1159/000444445   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/cf/1a/crg-0010-0115.PMC4929387.pdf
"   Case Rep Gastroenterol 2016;10:193 –198  DOI: 10.1159/000446017   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f7/4d/crg-0010-0193.PMC4929390.pdf
"   Case Rep Gastroenterol 2016;10:7 –16  DOI: 10.1159/000442707   Published online: May 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/cf/fd/crg-0010-0007.PMC4929392.pdf
"   Case Rep Gastroenterol 2016;10:174 –180  10.1159/000445867   Published online: May 2, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662 -0631/16/0101 –0174$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/3f/d8/crg-0010-0174.PMC4929393.pdf
"   Case Rep Gastroenterol 2016;10:151 –156  10.1159/000445738   Published online: May 2, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662 -0631/16/0101 –0151$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAcces sLicense).",Non-OADS,/arxiv_data1/oa_pdf/54/21/crg-0010-0151.PMC4929394.pdf
"   Case Rep Gastroenterol 2016;10:17 –23  DOI: 10.1159/000443267    © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c7/f2/crg-0010-0017.PMC4929395.pdf
"33 To determine whether hSH3BGRL has somatic mutations in tumors, we searched the publically available COSMIC database (http://www.sanger.ac.uk; http://www.cbioportal.org/public-portal/ cross_cancer) and noted that hSH3BGRL has natural mutations invarious tumors (Supplementary Tables 1 and 2), indicating that mutation of tumor suppressor hSH3BGRL reversely endorses it a metastatic driver.",Non-OADS,/arxiv_data1/oa_pdf/f0/7b/onc2015391a.PMC4929482.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Species-speci ﬁci nﬂuence of SH3BGRL in cancer metastasis H Wang et al 3313 © 2016 Macmillan Publishers Limited Oncogene (2016) 3303 –3313",Non-OADS,/arxiv_data1/oa_pdf/f0/7b/onc2015391a.PMC4929482.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Molecular dynamics of the p53 tetramer MD ’Abramo et al 3281 © 2016 Macmillan Publishers Limited Oncogene (2016) 3272 –3281",Non-OADS,/arxiv_data1/oa_pdf/fc/79/onc2015388a.PMC4929483.pdf
Available at: http://www.cdc.gov/drugresistance/threat- report-2013/index.html .,OADS,/arxiv_data1/oa_pdf/64/e9/ofw112.PMC4929486.pdf
Available at: http://www.who.int/drugresistance/documents/surveillancereport/ en/.,OADS,/arxiv_data1/oa_pdf/64/e9/ofw112.PMC4929486.pdf
Available at: http://www.who.int/drugresistance/documents/ baselinesurveynov2015/en/ .,Non-OADS,/arxiv_data1/oa_pdf/64/e9/ofw112.PMC4929486.pdf
Available at: http://www.bls.gov/cps/ .,Non-OADS,/arxiv_data1/oa_pdf/64/e9/ofw112.PMC4929486.pdf
Available at: https://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/64/e9/ofw112.PMC4929486.pdf
Available at: http://www.census.,OADS,/arxiv_data1/oa_pdf/64/e9/ofw112.PMC4929486.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000674/WC500053462.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/78/ofw119.PMC4929487.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/d1/ofw115.PMC4929488.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/3b/ofw110.PMC4929489.pdf
We identified 17 patients in the literature with HT treated withFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Clinical outcome and characterization of local field potentials Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Clinical outcome and characterization of local field potentials Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Clinical outcome and characterization of local field potentials Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Clinical outcome and characterization of local field potentials Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/5e/af/tre-06-388-7522-1.PMC4929492.pdf
Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/40/82/srep12896.PMC4929682.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/40/82/srep12896.PMC4929682.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.How to cite this article: Lee, E., Pandey, N.B.",Non-OADS,/arxiv_data1/oa_pdf/d9/2a/srep05853.PMC4929683.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5853 | DOI: 10.1038/srep05853 11",Non-OADS,/arxiv_data1/oa_pdf/d9/2a/srep05853.PMC4929683.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3827 | DOI: 10.1038/srep03827 7",Non-OADS,/arxiv_data1/oa_pdf/e0/69/srep03827.PMC4929687.pdf
"The computations were performed on the NIH Biowulf Cluster System (http://biowulf.nih.gov)and the Dell Blade Cluster System at the Institute of Psychology, Chinese Academy ofSciences.",OADS,/arxiv_data1/oa_pdf/01/ca/srep05549.PMC4929688.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/srep05549.PMC4929688.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5549 | DOI: 10.1038/srep05549 12",Non-OADS,/arxiv_data1/oa_pdf/01/ca/srep05549.PMC4929688.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)S-adenosylmethionine as novel asthma therapeutics S-Y Yoon et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/28/c5/emm201635a.PMC4929690.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/RBP2 induces cancer stem cells by EMT DZ h o u et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/19/ee/emm201637a.PMC4929691.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/PLC-β3a n dE Cf u n c t i o n JM Ha et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/fa/20/emm201639a.PMC4929692.pdf
Off-target prediction is based on‘Optimized CRISPR Design (http://crispr.mit.edu/) ’of the zhang Lab.,Non-OADS,/arxiv_data1/oa_pdf/54/71/emm201643a.PMC4929693.pdf
"(http://www.ncbi.nlm.nih.gov/geo, accession number GSE68766).",Non-OADS,/arxiv_data1/oa_pdf/54/71/emm201643a.PMC4929693.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)One-step generation of gene-corrected iPSC B-Y Kim et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/54/71/emm201643a.PMC4929693.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)SOCS1 inhibits C/EBP βin chondrocytes Y-J Ha et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/5e/20/emm201647a.PMC4929694.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/Somatic mutations disrupting brain connectivity JH Lee 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/0e/ae/emm201653a.PMC4929695.pdf
CROI http://www.croiconference.org/sessions/ sofosubuvir-simeprevir-ribavirin-hcv-protease-inhibitor- experienced-patients.,Non-OADS,/arxiv_data1/oa_pdf/ee/20/CCR3-4-653.PMC4929798.pdf
"Rare forms of HH and ferroportin disease The rare forms of HH (reviewed in Mayr et al, 2Camaschella and Poggiali,10and Brissot et al11), generally classi ﬁed as Rare Hereditary Hemochromatosis (http://www.orpha.net/consor/cgi-bin/Disease_- Search_Simple.php) comprise the non-HFE-related HH forms suchas juvenile hemochromatosis, associated with variants in the hemo- juvelin ( HFE2 orHJV)o rh e p c i d i n( HAMP ) genes, and hemochroma- tosis of adult onset resulting from variants in the gene for transferrinreceptor 2 ( TFR2 ).",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
"For most issues addressed, the quality of evidence and strength of recommendations had been already assessedelsewhere 9,28according to the system developed by the Grading of Recommendations Assessment, Development and Evaluation (short GRADE) Working Group (http://www.gra deworkinggroup.org/index.htm).",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
"ACKNOWLEDGEMENTS We wish to thank Prof. David Barton, Chair of the Management Board of the European Molecular Quality Network (http://www.emqn.org) for promoting the revision of the guidelines, for funding and facilitating the BPM and forfunding topublish the manuscript as an open access document.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
36 GRADE Working Group: http://www.gradeworkinggroup.org/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
37 EMQN Quality in the world of Molecular Genetics: http://www.cmgs.org/BPGs/ Best_Practice_Guidelines.htm.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
38 Swiss Society of Medical Genetics: http://www.sgmg.ch/view_page_professional.php?,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
39 Deutsche Gesellschaft für Humangenetik: http://www.gfhev.de/en/documents/index.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
40 The European Molecular Genetics Quality Network: http://www.emqn.org.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
41 Eurogentest: http://www.eurogentest.org/documents/.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
42 Centre de référence des surcharges en fer rare d'origine génétique: http://www.centre- reference-fer-rennes.org/.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
44 Haute Autorité de Santé: http://www.has-sante.fr/portail/upload/docs/application/pdf/ haemochromatosis_abstract.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
"45 British Committee for Standards in Haematology http://www.bcshguidelines.com/ documents/haemochromotosis_2000.pdf, 2000.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
"46 Leitlinien zur molekular genetischen Diagnostik der HH: http://www.gfhev.de/de/ leitlinien/LL_und_Stellungnahmen/ 2008-12-Haemochromatose.pdf, 2008.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
2012. http://www.acgs.uk.com/.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
172 Human Genome Variation Society: http://www.hgvs.org/rec.html.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
173 Practice guidelines for the Interpretation and Reporting of Unclassi ﬁed Variants (UVs) in Clinical Molecular Genetics: http://cmgsweb.shared.hosting.zen.co.uk/BPGs/pdfs% 20current%20bpgs/UV%20GUIDELINES%20rati ﬁed.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
174 The Human Gene Mutation Database: http://www.hgmd.cf.ac.uk/ac/index.php.175 OECD Guidelines for Quality Assurance in Molecular Genetic Testing.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Hereditary hemochromatosis guidelines GP o r t o et al 495 European Journal of Human Genetics,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/ejhg2015128a.PMC4929861.pdf
"To view a copy of this license, visit http://creativecommons.o rg/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Y-chromosome in Sicilian and Calabrian Arbereshe SS a r n o et al 606 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ejhg2015138a.PMC4929864.pdf
"The frequency in general populations was determined based on the Database of Single Nucleotide Variants (dbSNP, http://www.ncbi.nlm.nih.gov/ snp/), 1000 genomes sequencing project (http://www.1000genomes.org/),the National Heart Lung and Blood Institute Exome Variant Server database (EVS, http://evs.gs.washington.edu/EVS/) and the ExAC browser (http://exac.",OADS,/arxiv_data1/oa_pdf/20/95/ejhg2015155a.PMC4929874.pdf
"22Conﬁrmed variants were submitted to the LOVD 3.0 shared installation databases: (http://databases.lovd.nl/shared/genes/PAX6 (patient ID 37525), http://databases.lovd.nl/shared/genes/otx2 (patient ID 37524) and http://databases.lovd.nl/shared/genes/ndp(patient ID 37523)).",OADS,/arxiv_data1/oa_pdf/20/95/ejhg2015155a.PMC4929874.pdf
The variant has not beenpreviously reported based on searches of the scienti ﬁc literature and the Leiden Open Variation Database (LOVD) (http://lsdb.hgu.mrc.ac.uk/home.php?select_db =PAX6).,Non-OADS,/arxiv_data1/oa_pdf/20/95/ejhg2015155a.PMC4929874.pdf
"The alignment utilized KALIGN (http://www.ebi.ac.uk/Tools/msa/kalign) and the following reference sequences: AAK95849.1 (human PAX6), AFE78491.1 ( Rhesus Pax6), AAI16039.1 (cow Pax6), AAH36957.1 (mouse Pax6), AAI28742.1 (rat Pax6), BAA23004.1 (chicken Pax6), NP_571379.1 and AAC96095.1 (zebra ﬁsh pax6a and pax6b, correspondingly; only one HD sequence is shown because it is identical between the two homologs), NM_079889.3 (eyeless (ey);Drosophila melanogaster ), AAF59395.4 (twin of eyeless (toy), D. melanogaster ), AAA82991.1 (mab-18, Caenorhabditis elegans ).",OADS,/arxiv_data1/oa_pdf/20/95/ejhg2015155a.PMC4929874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)PAX6, OTX2 andNDP in anophthalmia, microphthalmia and coloboma BD e m l et al 541 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/20/95/ejhg2015155a.PMC4929874.pdf
"Additionally, reclassi ﬁcation tables were constructed using various classiﬁers in PredictABEL in R. All analyses were performed in PLINK: Whole genome Association Analysis Toolset,15and R version 3.1.0 –‘Spring Dance ’ (http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/e0/db/ejhg2015162a.PMC4929880.pdf
Data are available at http://www.gwascentral.org/study/HGVST1831 RESULTS BMI is strongly associated with CAD case –control status General population characteristics by case –control status are provided in Table 1.,OADS,/arxiv_data1/oa_pdf/e0/db/ejhg2015162a.PMC4929880.pdf
"These data are available at http://www.gwascentral.org/study/ HGVST1831 DISCUSSION Here, we have performed a large Mendelian randomization study to assess the contribution of genetic risk for obesity to CAD in a population without diabetes mellitus and when controlling for other TRFs highly associated with obesity including plasma TGs and HDLc.",Non-OADS,/arxiv_data1/oa_pdf/e0/db/ejhg2015162a.PMC4929880.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Genetic risk for obesity and CAD CB Cole et al 591 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/e0/db/ejhg2015162a.PMC4929880.pdf
"2–4Close to 2000 unique variations have been identi ﬁed so far in the CFTR gene (http://www.genet.sickkids.on.ca), either in CF, in CFTR - related disorders (CFTR-RD), or in asymptomatic individuals.",Non-OADS,/arxiv_data1/oa_pdf/9e/53/ejhg201599a.PMC4929885.pdf
"NOMENCLATURE S i n c et h ed i s c o v e r yo ft h e CFTR gene in 1989, the CF scienti ﬁc community developed its own nomenclature system (Cystic FibrosisMutation Database, (http://www.genet.sickkids.on.ca/)).",OADS,/arxiv_data1/oa_pdf/9e/53/ejhg201599a.PMC4929885.pdf
See the HGVS nomencla ture website (http://www.hgvs.org/ mutnomen/recs.html) for detailed descriptions of sequence variants and signi ﬁcance of punctuation symbols.,Non-OADS,/arxiv_data1/oa_pdf/9e/53/ejhg201599a.PMC4929885.pdf
"Box 3 Internet resources CF-Network EQA —External Quality Assessment process http://www.cfnetwork.be United Kingdom National External Quality Assessment Service for Molecular Genetics (UKNEQAS) http://www.ukneqas-molgen.org.uk EuroGentest http://www.eurogentest.org/web/qa/basic/xhtml HGVS nomenclature http://www.hgvs.org/mutnomen/ European Molecular Genetics Quality Network (EMQN) http://www.emqn.org/emqn/Best+Practice Cystic Fibrosis Mutation Database http://www.genet.sickkids.on.ca/ CFTR2 http://www.cftr2.org Testing guidelines for molecular diagnosis of cystic ﬁbrosis (2008) www.acgs.uk.com/media/774379/cfbp26may.pdf Orphanet www.orpha.net OCDE guidelines for quality assurance in molecular genetic testing http://www.oecd.org/sti/biotech/38839788.pdf University of California Santa Cruz (UCSC) genome browser http://genome.ucsc.edu Table 3 Main indications for CFTR testing Newborn screening for CF Diagnostic testing Typical CF clinical presentations (including newborns with meconium ileus) Atypical clinical presentations and/or borderline or negative sweat test Male infertility with CBAVD CFTR-Related Disorder in adults Fetuses with bowel hyperechogenicity and/or loop dilatation in the second trimester of pregnancy (risk of CF estimated as 3%) Carrier testing Individuals with a family history of CF ( ‘cascade testing ’) Individuals without a family history (essentially for preconception carrier screening) Partner of a CF patient Partner of a CBAVD patient Infertile couples seeking for IVF (not usually recommended among European genetic societies, as the risk of carrying a CF variant is not signi ﬁcantly higher than that of the general population).",Non-OADS,/arxiv_data1/oa_pdf/9e/53/ejhg201599a.PMC4929885.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/Guidelines for CF-PGD AG i r a r d e t et al 478 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/9e/53/ejhg201599a.PMC4929885.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Blood and Lymphatic Cancer: Targets and Therapy 2016:6 1–6Blood and Lymphatic Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BLCTT .S7353 0idelalisib therapy of indolent B-cell malignancies:  chronic lymphocytic leukemia and small  lymphocytic or follicular lymphomas Yazan F Madanat1 Mitchell R Smith2 Alexandru Almasan3 Brian T Hill2 1Department of internal Medicine,   2Department of Hematology and  Medical Oncology, Taussig Cancer  institute, 3Department of Cancer  Biology, Lerner Research institute,   Cleveland Clinic, Cleveland, OH, USA Correspondence: Yazan F Madanat   Department of internal Medicine,  Cleveland Clinic, 9500 euclid Ave,  Cleveland, OH 44195, USA   T el +1 216 333 2425   email madanay@ccf.or g     Brian T Hill   Department of Hematology and Medical  Oncology, Taussig Cancer institute,  Cleveland Clinic, 9500 euclid Ave,  Cleveland, OH 44195, USA   email hillb2@ccf.or gAbstract:  Chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular  lymphoma are indolent B-cell lymphoproliferative disorders that mainly affect an older popu - lation.",Non-OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
"Avail - able from: http://www.targetedonc.com/publications/targeted-therapies- cancer/2015/april-2015/a-tale-of-two-isoforms-pi3k-delta-and-gamm a.  Accessed November 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
"Available from: http://www.gilead.com/ ∼/media/Files/pdfs/ medicines / oncology/zydelig/zydelig_pi.pd f. Accessed November 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
"Blood and Lymphatic Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/blood-and-lymphatic-cancer-targets-and-therapy-journa lBlood and Lymphatic Cancer: Targets and Therapy is an international,  peer-reviewed, open access journal focusing on blood and lymphatic  cancer research, identification of therapeutic targets and the optimal  use of preventative and integrated treatment interventions to achieve  improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/ae/blctt-6-001.PMC4929980.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/  for details.,Non-OADS,/arxiv_data1/oa_pdf/44/71/nihms-713917.PMC4930070.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1507/-/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/44/71/nihms-713917.PMC4930070.pdf
Available from http://www.diabetesleadershipinitiative.com/assets/high-cost-of-complications- white-paper.pdf .,Non-OADS,/arxiv_data1/oa_pdf/44/71/nihms-713917.PMC4930070.pdf
Available from https://www.cdc.gov/ brfss/ .,OADS,/arxiv_data1/oa_pdf/44/71/nihms-713917.PMC4930070.pdf
Available from http://ftp.cdc.gov/pub/Data/Brfss/2010_Summary_Data_Quality_Report.pdf .,OADS,/arxiv_data1/oa_pdf/44/71/nihms-713917.PMC4930070.pdf
Available from http://www.cdc.gov/diabetes/pubs/factsheet11.htm .,Non-OADS,/arxiv_data1/oa_pdf/44/71/nihms-713917.PMC4930070.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/d9/f5/nihms-767719.PMC4930103.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Merry L Lindsey Mississippi Center for Heart Research, Department of Physiology and Biophysics, School of  Medicine, University of Mississippi Medical Center, University of Mississippi, 2500 North State Street, Jackson, MS 39216 4505,  USA, Tel +1 601 815 1329, Fax +1 601 984 1817, mllindsey@umc.edu.",Non-OADS,/arxiv_data1/oa_pdf/d9/f5/nihms-767719.PMC4930103.pdf
"Keywords Bayesian networks; belief networks; causal inference; expert knowledge; knowledge elicitation;  probabilistic graphical models This manuscript version is made available under the CC-BY-NC-ND 4.0 license: http://creativecommons.org/licenses/by-nc-nd/4.0/ bCorresponding author:  Dr. Anthony Constantinou, anthony@constantinou.info.",Non-OADS,/arxiv_data1/oa_pdf/fe/0d/emss-69016.PMC4930146.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/77/hyw023.PMC4930148.pdf
"For a certificate, please see: http://www.textcheck.com/certificate/eyybQJ.",Non-OADS,/arxiv_data1/oa_pdf/fa/77/hyw023.PMC4930148.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/b9/tcrm-12-1023.PMC4930221.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1023–1028Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1023ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10572 2 syncope as a presentation of acute pulmonary  embolism Bülent Altınsoy Fatma erboy Hakan Tanrıverdi Fırat Uygur Tacettin Örnek Figen atalay Meltem T or Department of Pulmonary Medicine,   school of Medicine, Bulent ecevit  University, Kozlu, Zonguldak, T urkeyPurpose:  Syncope is an atypical presentation for acute pulmonary embolism (APE).",Non-OADS,/arxiv_data1/oa_pdf/3c/b9/tcrm-12-1023.PMC4930221.pdf
"This study  was performed to determine the clinical and prognostic characteristics in patients  with syncope in APE.Correspondence: Bülent Altınsoy Bülent Ecevit Universitesi Tıp Fakültesi,  Gög ˘üs Hastalıkları AD Esenköy, Kozlu,  Zonguldak 67600, Turkey Tel +90 505 268 1060 Fax +90 372 261 0155 email altinsoyb@ymail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Altınsoy et al Running head recto: Syncope and pulmonary embolism DOI: http://dx.doi.org/10.2147/TCRM.S105722",Non-OADS,/arxiv_data1/oa_pdf/3c/b9/tcrm-12-1023.PMC4930221.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3c/b9/tcrm-12-1023.PMC4930221.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/b9/tcrm-12-1023.PMC4930221.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/dddt-10-2081.PMC4930222.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2081–2086Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10927 1 Dietary arginine silicate inositol complex increased  bone healing: histologic and histomorphometric  study Ferhan Yaman1 izzet acikan1 serkan Dundar2 sercan simsek3 Mehmet gul4 i˙brahim hanifi Ozercan3 James Komorowski5 Kazim sahin6 1Department of Oral-Maxillofacial  surgery, Faculty of Dentistry, Dicle  University, Diyarbakir, T urkey;   2Department of Periodontology,   Faculty of Dentistry, Firat University,   elazig, T urkey; 3Department of  Pathology, Faculty of Medicine, Firat  University, elazig, T urkey; 4Department  of Periodontology, Faculty of  Dentistry, Dicle University, Diyarbakir,   T urkey; 5nutrition 21, llc, Purchase,   nY, Usa; 6Department of animal  nutrition, Faculty of Veterinary  Medicine, Firat University, elazig,   T urkeyBackground:  Arginine silicate inositol complex (ASI; arginine 49.5%, silicon 8.2%, and  inositol 25%) is a novel material that is a bioavailable source of silicon and arginine.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/dddt-10-2081.PMC4930222.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/dddt-10-2081.PMC4930222.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/c2/dddt-10-2081.PMC4930222.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/90/1e/cmar-8-083.PMC4930224.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/90/1e/cmar-8-083.PMC4930224.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research Cancer Management and Research 2016:8 83Dovepress submit your manuscript | www.dovepress.com Dovepress  Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/90/1e/cmar-8-083.PMC4930224.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 83 ERRATUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S115369Reappraisal of the role of dolasetron in prevention and treatment of  nausea and vomiting associated with surgery or chemotherapy [Erratum] Roberts SM, Bezinover DS, Janicki PK.",Non-OADS,/arxiv_data1/oa_pdf/90/1e/cmar-8-083.PMC4930224.pdf
The correct DOI is: 10.2147/CMAR.S15545.Journal name: Cancer Management and Research Article Designation: ERRATUMY ear: 2016V olume: 8Running head verso: Roberts et alRunning head recto:DOI: http://dx.doi.org/10.2147/CMAR.S115369,Non-OADS,/arxiv_data1/oa_pdf/90/1e/cmar-8-083.PMC4930224.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/a7/ndt-12-1581.PMC4930225.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1581–1585Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1581OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10754 7 cortisol awakening response in drug-naïve  panic disorder Katarzyna Jakuszkowiak- Wojten Jerzy landowski Mariusz s Wiglusz Wiesław Jerzy Cubała Department of Psychiatry, Medical  University of Gdańsk, Gdańsk, PolandBackground:  It is unclear whether hypothalamic–pituitary–adrenal axis is involved in the  pathophysiology of panic disorder (PD).",Non-OADS,/arxiv_data1/oa_pdf/3d/a7/ndt-12-1581.PMC4930225.pdf
"Salivary cortisol levels behave in nonlinear pattern to serum levels in  response to a challenge or under conditions that affect cortisol-binding protein such  as oral contraceptives, pregnancy, or menstrual cycle.3  It was suggested that CAR is under hippocampus control, and reduced hippocampus  volume was associated with the blunted CAR.2 It seems that acute stressors lead to correspondence: Katarzyna  Jakuszkowiak-Wojten Department of Psychiatry, Medical  University of Gdańsk, Dębinki St 7  build 25, 80-952 Gdańsk, Poland Tel +48 58 349 2650 Fax +48 58 349 2748 email k.jakuszkowiak@gumed.edu.p l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Jakuszkowiak-Wojten et al Running head recto: Cortisol awakening response in drug-naïve panic disorder DOI: http://dx.doi.org/10.2147/NDT.S107547",Non-OADS,/arxiv_data1/oa_pdf/3d/a7/ndt-12-1581.PMC4930225.pdf
statistical analysis The statistical analysis was performed using StatsDirect  v.2.7.9 ( http://www.statsdirect.co m).,OADS,/arxiv_data1/oa_pdf/3d/a7/ndt-12-1581.PMC4930225.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3d/a7/ndt-12-1581.PMC4930225.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/a7/ndt-12-1581.PMC4930225.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2a/ad/ott-9-3873.PMC4930226.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3873–3878OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3873Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10219 9 relationship between serum carcinoembryonic  antigen level and epidermal growth factor  receptor mutations with the influence on the  prognosis of non-small-cell lung cancer patients Zuxun cai Department of Thoracic surgery,   henan Provincial chest hospital,   Zhengzhou city, People’s  republic of chinaObjective:  To investigate the relationship between serum carcinoembryonic antigen (CEA)  level and epidermal growth factor receptor (EGFR) gene mutations in non-small-cell lung  cancer (NSCLC) patients and to analyze the influence of CEA level on postoperative survival  time in lung cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2a/ad/ott-9-3873.PMC4930226.pdf
"Although chemoradiotherapy techniques  and traditional operation methods have greatly improved, the survival rate of NSCLC  patients is still ,20%.1,2 At present, in the clinical diagnosis and treatment of NSCLC,  molecular targeting therapy using epidermal growth factor receptor (EGFR) as the target correspondence: Zuxun cai Department of Thoracic surgery, henan  Provincial chest hospital, no 1, Weiwu  road, Zhengzhou city 450003, People’s  republic of china email petercai886@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cai Running head recto: Relationship between CEA level and EGFR mutations in NSCLC patients DOI: http://dx.doi.org/10.2147/OTT.S102199",Non-OADS,/arxiv_data1/oa_pdf/2a/ad/ott-9-3873.PMC4930226.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2a/ad/ott-9-3873.PMC4930226.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/ad/ott-9-3873.PMC4930226.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/eb/aabc-9-001.PMC4930227.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Advances and Applications in Bioinformatics and Chemistry Advances and Applications in Bioinformatics and Chemistry 2016:9 1–11Dove press submit your manuscript | www.dovepress.co m Dove press   Molecular docking as a popular tool in drug  design, an in silico travel Jerome de Ruyck Guillaume Brysbaert Ralf Blossey Marc F Lensink University Lille, CNRS UMR8576  UGSF , Lille, France Correspondence: Jerome de Ruyck   University Lille, UGSF – UMR8576,  Campus CNRS Haute-Borne, 50 Avenue  de Halley, BP 70478, 59658 Villeneuve  d’Ascq Cedex, France   T el +33 3 62 53 17 32   Fax +33 3 62 53 17 01   Email jerome.de-ruyck@univ-lille1.f rAbstract:  New molecular modeling approaches, driven by rapidly improving computational  platforms, have allowed many success stories for the use of computer-assisted drug design  in the discovery of new mechanism- or structure-based drugs.",Non-OADS,/arxiv_data1/oa_pdf/32/eb/aabc-9-001.PMC4930227.pdf
"Advances and Applications in Bioinformatics and Chemistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com /advances-and-applications-in-bioinformatics-and-chemistry-journalAdvances and Applications in Bioinformatics and Chemistry is an inter - national, peer-reviewed open-access journal that publishes articles in  the following fields: Computational biomodeling; Bioinformatics; Com - putational genomics; Molecular modeling; Protein structure modeling  and structural genomics; Systems Biology; Computational Biochemistry; Computational Biophysics; Chemoinformatics and Drug Design; In silico  ADME/Tox prediction.",Non-OADS,/arxiv_data1/oa_pdf/32/eb/aabc-9-001.PMC4930227.pdf
Visit http://www.dovepress.com/testimonials.,Non-OADS,/arxiv_data1/oa_pdf/32/eb/aabc-9-001.PMC4930227.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/66/opth-10-1187.PMC4930228.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1187–1197Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1187Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10332 4 secondary glaucoma in CAPN5 -associated  neovascular inflammatory vitreoretinopathy abdourahman Cham1,2 Mayank Bansal3 himanshu K Banda4 Y oung Kwon1 Paul s Tlucek1 alexander g Bassuk5 stephen h Tsang6,7 Warren M sobol8 James C Folk1 steven Yeh4 Vinit B Mahajan1,2 1Department of Ophthalmology and  Visual sciences, 2Omics laboratory,   University of iowa, iowa City, ia,   Usa; 3rajendra Prasad Centre  for Ophthalmic sciences, all india  institute of Medical sciences,   new Delhi, india; 4Department of  Ophthalmology, emory University  school of Medicine, atlanta, ga,   5Department of Pediatrics, University  of iowa, iowa City, ia, 6Barbara and  Donald Jonas laboratory of stem  Cells and regenerative Medicine and  Bernard and shirlee Brown glaucoma  laboratory, Department of Pathology  and Cell Biology, institute of human  nutrition, College of Physicians  and surgeons, Columbia University,   7edward s harkness eye institute,   new Y ork-Presbyterian hospital,   new Y ork, nY, 8retina Physicians &  surgeons, inc., Dayton, Oh, UsaObjective:  The objective of this study was to review the treatment outcomes of patients with  secondary glaucoma in cases of autosomal dominant neovascular inflammatory vitreoretinopathy  (ADNIV), a hereditary autoimmune uveitis due to mutations in CAPN5 .",Non-OADS,/arxiv_data1/oa_pdf/c0/66/opth-10-1187.PMC4930228.pdf
"Correspondence: Vinit B Mahajan Department of Ophthalmology and Visual  sciences, University of iowa, 200 hawkins  Drive, iowa City, ia 52242, Usa Tel +1 319 467 5151 Fax +1 319 356 0363 email mahajanlab@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cham et al Running head recto: Secondary glaucoma in ADNIV DOI: http://dx.doi.org/10.2147/OPTH.S103324",Non-OADS,/arxiv_data1/oa_pdf/c0/66/opth-10-1187.PMC4930228.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c0/66/opth-10-1187.PMC4930228.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/66/opth-10-1187.PMC4930228.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/47/ndt-12-1587.PMC4930229.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1587Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f3/47/ndt-12-1587.PMC4930229.pdf
"Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s 1587CorrigeNDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11396 1 Parkinson’s disease managing reversible neurodegeneration  [Corrigendum]Journal name: Neuropsychiatric Disease and Treatment Article Designation: Corrigendum Y ear: 2016 Volume: 12 Running head verso: Hinz et al Running head recto: Parkinson’s disease managing reversible neurodegeneration DOI: http://dx.doi.org/10.2147/NDT.S113961 Hinz M, Stein A, Cole T, McDougall B, Westaway M.  Neuropsychiatric Disease and Treatment .",Non-OADS,/arxiv_data1/oa_pdf/f3/47/ndt-12-1587.PMC4930229.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/8f/ppa-10-1161.PMC4930230.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1161–1167Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1161OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10560 0 Association between patients’ beliefs and oral  antidiabetic medication adherence in a chinese  type 2 diabetic population Ping Wu1 naifeng liu2 1Department of clinical Pharmacy,   school of Basic Medical sciences  and clinical Pharmacy, china  Pharmaceutical University, 2institute  of cardiovascular Disease, southeast  University Medical school, nanjing,   People’s republic of chinaPurpose:  The objective of this study was to identify, using the theory of planned behavior (TPB),  patients’ beliefs about taking oral antidiabetic drugs (OADs) as prescribed, and to measure the  correlations between beliefs and medication adherence.",Non-OADS,/arxiv_data1/oa_pdf/08/8f/ppa-10-1161.PMC4930230.pdf
"A study in Australia showed that 59.6% of  patients omitted their hypoglycemic drugs 3  months before the study interview.4 Another  study, in the US, found that overall adherence to oral medications for military veterans  with diabetes ranged from 42.5% to 54.1%.5 Since treatment regimens will not work  effectively if medications are not taken as prescribed, it is essential to pinpoint the correspondence: naifeng liu institute of cardiovascular Disease,  southeast University Medical school,  nanjing 210000, People’s republic  of china Tel +86 25 8327 2002 email liunf@seu.edu.c n Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wu and Liu Running head recto: Association between patients’ beliefs and OAD adherence DOI: http://dx.doi.org/10.2147/PPA.S105600",Non-OADS,/arxiv_data1/oa_pdf/08/8f/ppa-10-1161.PMC4930230.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/08/8f/ppa-10-1161.PMC4930230.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/21/39/idr-9-143.PMC4930231.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/21/39/idr-9-143.PMC4930231.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 143–148Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 143 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S108325An exploratory study to evaluate Clostridium  difficile polymerase chain reaction ribotypes and  infection outcomes Abrar K Thabit1,2 David P Nicolau1,3 1Center for Anti-Infective Research  and Development, Hartford Hospital,   Hartford, CT, USA; 2Faculty of  Pharmacy, King Abdulaziz University,  Jeddah, Saudi Arabia;  3Division of  Infectious Diseases, Hartford Hospital,  Hartford, CT, USABackground: Clostridium difficile infection ranges from mild to severe prolonged diarrhea  with systemic symptoms.",Non-OADS,/arxiv_data1/oa_pdf/21/39/idr-9-143.PMC4930231.pdf
"3Correspondence: David P Nicolau Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USATel +1 860 972 3941Fax +1 860 545 3992Email david.nicolau@hhchealth.orgJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Thabit and NicolauRunning head recto: C. difficile ribotypes and severityDOI: http://dx.doi.org/10.2147/IDR.S108325",Non-OADS,/arxiv_data1/oa_pdf/21/39/idr-9-143.PMC4930231.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/21/39/idr-9-143.PMC4930231.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 148 Thabit and Nicolau  7.,Non-OADS,/arxiv_data1/oa_pdf/21/39/idr-9-143.PMC4930231.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/cf/ott-9-3861.PMC4930232.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3861–3871OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3861Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10551 4 The clinical significance of γ -catenin  in acute  myeloid leukemia Jiadai Xu1 Wei Wu1 Wenyi shen1 Peng liu2 1Department of Hematology, The First  Affiliated Hospital of Nanjing Medical  University, Nanjing, 2Department of  Hematology, Zhongshan Hospital,   Fudan University, Shanghai, People’s  Republic of ChinaAbstract:  Dysregulation of γ -catenin  may function as an oncogenic factor in various  malignancies.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/ott-9-3861.PMC4930232.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/ott-9-3861.PMC4930232.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/ott-9-3861.PMC4930232.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/ae/dddt-10-1947.PMC4930233.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1947–1959Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1947Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10144 9a novel imidazopyridine derivative, X22, attenuates  sepsis-induced lung and liver injury by inhibiting  the inflammatory response in vitro and in vivo Xiangting ge1,2,* Zhiguo Feng1,* Tingting Xu2 Beibei Wu3 hongjin chen1 Fengli Xu3 lili Fu1 Xiaoou shan3 Yuanrong Dai2 Yali Zhang1 guang liang1 1chemical Biology research  center, school of Pharmaceutical  sciences, 2Department of Pulmonary  Medicine, The 2nd affiliated hospital,   3Department of Pediatrics, The  2nd affiliated hospital, Wenzhou  Medical University, Wenzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Sepsis remains a leading cause of death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ab/ae/dddt-10-1947.PMC4930233.pdf
"Keywords:  LPS, imidazopyridine derivative, sepsis, acute lung injury, inflammation Introduction Sepsis, a whole-body inflammatory response triggered by an infection, remains a  critical health problem and a major cause of death even in many modern intensive  care units.1,2 Research efforts in the field of sepsis have focused primarily on the  innate immune system, and typically have conceptually viewed sepsis as a syndrome  of hyperinflammation.3,4 Reports pointed out cercal ligation and puncture (CLP) and  lipopolysaccharide (LPS) were used for the establishment of sepsis animal model.5–7  Although CLP may greatly mimic the progression and characteristics of human sepsis,  the high consistency and reproducibility of CLP-induced septic animal were seriously  influenced by the little different procedures of CLP.6,8 However, Gram-negative bacteria  are among the most important pathogens of sepsis and their LPS content is regarded  as an important stimulator of the mammalian innate immune system that triggers the  systemic inflammatory reaction.9 In sepsis, the large amount of cytokines produced  causes edema, cellular metabolic stress, and, ultimately, tissue necrosis.10,11 Cytokines  also induce vasodilatation and transient increase in capillary permeability producing  extravasation of plasma proteins.12 The proinflammatory cytokines, such as tumor  necrosis factor (TNF)- α and interleukin (IL)-6, are primarily involved in promoting  inflammatory processes and play an important role in sepsis.10,13 The inhibitory targeting  of cytokines has been identified as an important potential strategy for treating sepsis.correspondence: Yali Zhang chemical Biology research center,  school of Pharmaceutical sciences,  Wenzhou Medical University, University  Town, Wenzhou, Zhejiang 325035,  People’s republic of china Tel +86 577 8669 9892 email ya-li000@163.co m  Yuanrong Dai Department of Pulmonary Medicine, The  2nd Affiliated Hospital, Wenzhou Medical  University, Wenzhou, Zhejiang 325035,  People’s republic of china email daiyr@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ge et al Running head recto: X22 attenuated inflammatory response in vivo and in vitro DOI: http://dx.doi.org/10.2147/DDDT.S101449",Non-OADS,/arxiv_data1/oa_pdf/ab/ae/dddt-10-1947.PMC4930233.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ab/ae/dddt-10-1947.PMC4930233.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/ae/dddt-10-1947.PMC4930233.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijwh-8-233.PMC4930234.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 233–242International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  233OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9163 2The contribution of maternal psychological  functioning to infant length of stay in the neonatal  Intensive care Unit amanda s cherry1 Melissa r Mignogna1 angela roddenberry Vaz1 carla Hetherington2 Mary anne Mccaffree2 Michael P anderson3 stephen r gillaspy1 1section of general and community  Pediatrics, Department of Pediatrics,   University of Oklahoma Health  sciences center, Oklahoma city,   OK, 2neonatal Perinatal Medicine,   Department of Pediatrics, University  of Oklahoma, college of Medicine,   Oklahoma city, OK, 3Department  of Biostatistics and epidemiology,   University of Oklahoma Health  sciences center, college of Public  Health, Oklahoma city, OK, UsaObjective:  Assess maternal psychological functioning within the Neonatal Intensive Care Unit  (NICU) and its contribution to neonate length of stay (LOS) in the NICU.",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijwh-8-233.PMC4930234.pdf
"An increasing body of  literature suggests that postpartum depression (PPD) and several related psychosocial  variables, such as anxiety, social support, and stress associated with the NICU environ - ment, are significantly related to both infant and parental outcomes.6 Parents of NICU infants commonly experience high levels of stress and feelings  of helplessness; which often reflect a lack of knowledge of how to parent, interact,  and care for their neonates during the NICU stay.7–9 More specifically, mothers of  premature and low-birth-weight infants have been reported to experience more con - siderable levels of psychological distress, and to be at greater risk for relationship  difficulties, family stress, and financial stress, when compared with mothers of term  infants.10 Much of the psychological distress mothers of NICU infants experience  is related to concerns about the long-term outcomes and/or survival of the infant; correspondence: amanda s cherry section of general and community  Pediatrics, Department of Pediatrics,  University of Oklahoma Health sciences  center, 1200 children’s ave suite 12400,  Oklahoma city, OK 73104, Usa Tel +1 405 271 4407 Fax +1 405 271 8709 email a manda-cherry@ouhsc.ed u Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Cherry et al Running head recto: Maternal functioning and infant length of stay DOI: http://dx.doi.org/10.2147/IJWH.S91632",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijwh-8-233.PMC4930234.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijwh-8-233.PMC4930234.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijwh-8-233.PMC4930234.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/73/ijwh-8-225.PMC4930235.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 225–231International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  225OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9663 6amniotic membrane can be a valid source for  wound healing Hossam elHeneidy1 eman Omran1 ahmed Halwagy1 Hesham al-Inany1 Mirvat al-ansary2 amr gad3 1Department of Obstetrics &  gynecology, 2Department of clinical  Pathology, 3Department of surgery,   Faculty of Medicine, cairo University,   cairo, egyptAbstract:  Amniotic membrane (AM) can promote proper epithelialization with suppression of  excessive fibrosis by creating a supportive milieu for regeneration of chronic ulcer bed.",Non-OADS,/arxiv_data1/oa_pdf/3f/73/ijwh-8-225.PMC4930235.pdf
"Human AM was used for 2,308 ophthalmologic  reconstructions in Germany 2008.1 Its special success in ophthalmology may be due  to the immune privileged properties of the AM.2 The anti-inflammatory property of AM seems to be a result of production of anti- inflammatory proteins and reduction of expression of transforming growth factor B and  pro-inflammatory cytokines, such as interleukin 10.3,4 Also, AM produces B defensins,  elastase inhibitors, elastin, and lactoferrin that contribute to its anti-inflammatory correspondence: eman Omran Department of Obstetrics & gynecology;  cairo University, 10 el-ekhsheed street,  Manial, cairo 11555, egypt email omraneman9@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: ElHeneidy et al Running head recto: Amniotic membrane for wound healing DOI: http://dx.doi.org/10.2147/IJWH.S96636",Non-OADS,/arxiv_data1/oa_pdf/3f/73/ijwh-8-225.PMC4930235.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/3f/73/ijwh-8-225.PMC4930235.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/73/ijwh-8-225.PMC4930235.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/af/e0/imcrj-9-159.PMC4930236.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/af/e0/imcrj-9-159.PMC4930236.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 159–162International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 159 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S106861Digital necrosis with squamous cell carcinoma of  the tonsil Vinod Warrier1 Ali Ahmad1 Yaqoub Alshatti1 Ali  Jafar2 1Department of Internal Medicine,   Mubarak Al-Kabeer Hospital, Jabriya,   Kuwait; 2Department of Surgical and  Interventional Sciences, University College London, Royal Free Hospital,  London, UKBackground: Digital necrosis is a rare phenomenon of paraneoplastic syndrome associated  with squamous cell carcinoma of the tonsil.",Non-OADS,/arxiv_data1/oa_pdf/af/e0/imcrj-9-159.PMC4930236.pdf
"Correspondence: Ali Ahmad Department of Internal Medicine, Mubarak Al-Kabeer Hospital, Jabriya, KuwaitEmail ali_ashkanani5@hotmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Warrier et alRunning head recto: Digital necrosis with squamous cell carcinoma of the tonsilDOI: http://dx.doi.org/10.2147/IMCRJ.S106861",Non-OADS,/arxiv_data1/oa_pdf/af/e0/imcrj-9-159.PMC4930236.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/af/e0/imcrj-9-159.PMC4930236.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 162 Warrier et al Conclusion To date, acronecrosis as a paraneoplastic manifestation has  been rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/af/e0/imcrj-9-159.PMC4930236.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/ed/ott-9-3841.PMC4930237.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3841–3848OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3841Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147OTT .S10430 7 The efficacy and safety of postoperative adjuvant  transarterial embolization and radiotherapy in  hepatocellular carcinoma patients with portal  vein tumor thrombus Tao Bai1,2,* Jie chen1,2,* Zhi-Bo Xie3 Fei-Xiang Wu1,2 si-Da Wang2,4 Jun-Jie liu2,4 le-Qun li1,2 1Department of hepatobiliary surgery,   affiliated Tumor hospital of guangxi  Medical University, 2guangxi liver  cancer Diagnosis and Treatment  engineering and Technology research  center, nanning, 3Department of  Pancreatic surgery, Pancreatic Disease  institute, huashan hospital, shanghai  Medical college, Fudan University,   shanghai, 4Department of Ultrasound  Diagnosis, affiliated T umor hospital of  guangxi Medical University, nanning,   People’s republic of china *These authors contributed equally  to this workObjective:  This study aims to find out the safety and efficiency of postoperative adjuvant  transarterial chemoembolization (TACE) and radiotherapy (RT) in hepatocellular carcinoma  (HCC) patients with portal vein tumor thrombus (PVTT).",Non-OADS,/arxiv_data1/oa_pdf/a7/ed/ott-9-3841.PMC4930237.pdf
"According to the Barcelona Clinic Liver Cancer group, HCC patients with  PVTT are often defined as Barcelona Clinic Liver Cancer stage C. Sorafenib used  to be recommended to these patients.5–7 However, median survival in patients  with sorafenib is only ~6.5 months.8 Nevertheless, many studies have figured out   that surgery could significantly prolong OS in HCC patients with PVTT.9,10 The high correspondence: le-Qun li Department of hepatobiliary surgery,  Affiliated Tumor Hospital of Guangxi  Medical University, 71 hedi road,  nanning, guangxi Zhuang  autonomous region 530021, People’s  republic of china Tel +86 771 533 0855 Fax +86 771 531 2000 email lilequngx@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Bai et al Running head recto: TACE and RT in HCC patients with PVTT DOI: http://dx.doi.org/10.2147OTT.S104307",Non-OADS,/arxiv_data1/oa_pdf/a7/ed/ott-9-3841.PMC4930237.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a7/ed/ott-9-3841.PMC4930237.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/ed/ott-9-3841.PMC4930237.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b3/8d/ndt-12-1571.PMC4930238.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1571–1579Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1571OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11120 8 Mental toughness, sleep disturbances, and physical  activity in patients with multiple sclerosis compared  to healthy adolescents and young adults Dena sadeghi Bahmani1 Markus gerber2 Nadeem Kalak1 sakari lemola3 Peter J clough4 Pasquale calabrese5 Vahid shaygannejad6 Uwe Pühse2 edith holsboer-Trachsler1 serge Brand1,2 1Psychiatric clinics of the University  of Basel, center for affective, stress  and sleep Disorders, 2Department  of sport, exercise and health, sport  science section, University of Basel,   Basel, switzerland; 3Department of  Psychology, University of Warwick,   coventry, 4Department of Psychology,    Manchester Metropolitan University,   Manchester, UK; 5Division  of  Molecular and cognitive  Neuroscience, University of Basel,   Basel, switzerland; 6Department of  Neurology and isfahan Neurosciences  research center, isfahan University of  Medical sciences, isfahan, iranBackground:  Multiple sclerosis (MS) is the most common chronic autoimmune demyelinating  and inflammatory disease of the central nervous system, afflicting both the body and mind.",Non-OADS,/arxiv_data1/oa_pdf/b3/8d/ndt-12-1571.PMC4930238.pdf
"Demyelination in association with axonal  damage results in slowing of nerve signals, leading to typical MS symptoms such as  feeling tired (fatigue), pain, visual problems, paresthesia, and problems of movement  and balance.8 MS is associated with several comorbidities including an increase in correspondence: Dena sadeghi Bahmani Psychiatric clinics of the University  of Basel, center for affective,  stress and sleep Disorders,  Wilhelm Klein-strasse 27, 4012 Basel,  switzerland Tel +41 61 3255 114  Fax +41 61 3255 513 email dena.sadeghibahmani@upkbs.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Sadeghi Bahmani et al Running head recto: Mental toughness and multiple sclerosis DOI: http://dx.doi.org/10.2147/NDT.S111208",Non-OADS,/arxiv_data1/oa_pdf/b3/8d/ndt-12-1571.PMC4930238.pdf
"The  IPAQ questionnaires (short and long versions), including  definitions of moderate and vigorous activity, are available  at http://www.ipaq.ki.s e. sleep disturbances SD were assessed with the Insomnia Severity Index.52 This  questionnaire is a seven-item screening measure for insom - nia and an outcome measure for use in treatment research.",Non-OADS,/arxiv_data1/oa_pdf/b3/8d/ndt-12-1571.PMC4930238.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b3/8d/ndt-12-1571.PMC4930238.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/8d/ndt-12-1571.PMC4930238.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2016:7 77–87Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  77 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S79060Epilepsy: addressing the transition from pediatric  to adult care Seetha Rajendran   Anand Iyer Department of Paediatric Neurology,   Neurosciences Unit, Alder Hey Children’s NHS Foundation Trust,  Liverpool, UKAbstract:  Adolescence is a period of rapid change, both physical and psychosocial for any  young person.",Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
"4Correspondence: Anand Iyer   Department of Paediatric Neurology,  Neurosciences Unit, Alder Hey Children’s NHS Foundation Trust, Eaton Road, Liverpool L12 2AP, UK   Tel +44 151 252 5163   Fax +44 151 252 5152   Email drasiyer@gmail.comJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Rajendran and IyerRunning head recto: Transition in epilepsyDOI: http://dx.doi.org/10.2147/AHMT.S79060",Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available from: http://www.bacdis.org.uk/policy/documents/transition_moving-on-well.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available from: https://www.gov.uk/government/ publications/assessing-fitness-to-drive-a-guide-for-medical-professionals.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4132149.pdf.,OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available from:  http://www.bacdis.org.uk/policy/documents/transition_moving-on-well.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available at: https://www.unil.ch/euteach/en/home.html.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available from: http://www.rcpch.ac.uk/ahp.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Available from: https://www.gov.uk/government/publications/assessing-fitness-to-drive-a-guide-for-medical-professionals.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
"Adolescent Health, Medicine and Therapeutics 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/ahmt-7-077.PMC4930239.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/b5/ott-9-3879.PMC4930240.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3879–3882OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3879PersPecTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10651 9 internal mammary sentinel lymph node biopsy:  abandon or persist?",Non-OADS,/arxiv_data1/oa_pdf/6b/b5/ott-9-3879.PMC4930240.pdf
"Interest in  metastases to IMLN culminated with the extended radical mastectomy,3 but this radi - cal surgical procedure was abandoned due to its extra complications, longer operation  time, and lack of survival benefit.4 Imaging techniques, such as ultrasound, magnetic  resonance imaging, and positron emission tomography/computed tomography, could  usually detect metastatic lesions larger than 5 mm, but due to the deep anatomical  location and small size of IMLN, the sensitivity of current imaging techniques cannot correspondence: Yong-sheng Wang Breast cancer center, shandong cancer  Hospital and institute, 440 Jiyan road,  Jinan, shandong, 250117, People’s  republic of china Tel +86 531 6762 6211 Fax +86 531 6762 6211 email wangysh2008@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Perspectives Y ear: 2016 Volume: 9 Running head verso: Qiu et al Running head recto: Internal mammary sentinel lymph node biopsy DOI: http://dx.doi.org/10.2147/OTT.S106519",Non-OADS,/arxiv_data1/oa_pdf/6b/b5/ott-9-3879.PMC4930240.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/b5/ott-9-3879.PMC4930240.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/b5/ott-9-3879.PMC4930240.pdf
Available from:  http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/b5/ott-9-3879.PMC4930240.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/72/ott-9-3849.PMC4930241.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3849–3860OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3849Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10178 2 Downregulation of human Wnt3 in gastric cancer  suppresses cell proliferation and induces apoptosis hai-sheng Wang,1,* Xiaobo  nie,2,* rui-Bing Wu,1 hong- Wei Yuan,1 Yue-hong Ma,1  Xiu-lan liu,1 Jian-Yu Zhang,1  Xiu-ling Deng,1 Qin na,1  hai-Yan Jin,1 Yan-chao Bian,1  Yu-Min gao,3 Yan-Dong  Wang,4 Wei-Dong chen,1,2 1Key laboratory of Molecular Pathology,   school of Basic Medical science, inner  Mongolia Medical University, hohhot,   2Key laboratory of receptors-Mediated  gene regulation and Drug Discovery,   school of Medicine, henan University,   Kaifeng, 3epidemiology section,   Public health school, inner Mongolia  Medical University, hohhot, 4state Key  laboratory of chemical resource  engineering, college of life science  and Technology, Beijing University of  chemical Technology, Beijing, People’s  republic of china *These authors contributed equally  to this workAbstract:  Aberrant activation of Wnt/ β-catenin signaling pathways is closely involved in the  occurrence and progression of several types of human malignancies.",Non-OADS,/arxiv_data1/oa_pdf/e7/72/ott-9-3849.PMC4930241.pdf
"Named for Drosophila  wingless and mouse homolog Int-1 (Wnt1),4 Wnt gene  family encodes a group of glycoproteins which are evolutionarily conserved across correspondence: Wei-Dong chen Key laboratory of Molecular Pathology,  school of Basic Medical science,  inner Mongolia Medical University,  Jinshan Development Zone, hohhot,  inner Mongolia, 010110, People’s  republic of china email wdchen666@163.co m  Yan-Dong Wang state Key laboratory of chemical resource  engineering, college of life science and  Technology, Beijing University of chemical  Technology, 15 Beisanhuandonglu, chaoyang  District, Beijing, 100029, People’s republic  of china email ydwangbuct2009@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Wnt3 downregulation suppresses cancer cell proliferation DOI: http://dx.doi.org/10.2147/OTT.S101782",Non-OADS,/arxiv_data1/oa_pdf/e7/72/ott-9-3849.PMC4930241.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e7/72/ott-9-3849.PMC4930241.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/72/ott-9-3849.PMC4930241.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2308-2314,DOI:http://dx.doi.org/10.19082/ 2308 Corresponding author: Assistant Professor Dr. Farhad Baghe rian, Clinical Research D evelopment Center, Shahid Beheshti Hospital, Babol University of Medical Sciences,  Babol, Iran .",Non-OADS,/arxiv_data1/oa_pdf/87/e4/epj-08-2308.PMC4930248.pdf
Trial registration: The trial was registered at the Iranian Clinical Trial Registry (http://www.irct.ir) with the IRCT identification number IRCT2013070413865N1.,Non-OADS,/arxiv_data1/oa_pdf/87/e4/epj-08-2308.PMC4930248.pdf
"http://www.ephysician.ir Page2310trocar in the r ight flank in line with the gallbladder fundus; the extraction hole created by the trocar in the epigastric region was opened to remove the ruptured gallbladders that had severe inflammation and friability using a plastic bag and positional peritoneal irri gation without any drain, and 3 -0, non-absorbable, monofilament sutures were used in the other incisions.",Non-OADS,/arxiv_data1/oa_pdf/87/e4/epj-08-2308.PMC4930248.pdf
"http://www.ephysician.ir Page2312association between intraoperative gallbladder rupture and SSI (p = 0.001), whereas many reports have indicated that wound infections were not related to rupture of the gallbladder (5, 35).",Non-OADS,/arxiv_data1/oa_pdf/87/e4/epj-08-2308.PMC4930248.pdf
Trial registration: The trial was registered at the Iranian Clinical Trial Registry (http://www.irct.ir) w ith the IRCT identification number IRCT2013070413865N1.,Non-OADS,/arxiv_data1/oa_pdf/87/e4/epj-08-2308.PMC4930248.pdf
"http://www.ephysician.ir Page231428)Yan RC, Shen SQ, Chen ZB, Lin FS, Riley J.",Non-OADS,/arxiv_data1/oa_pdf/87/e4/epj-08-2308.PMC4930248.pdf
"Electronic Physic ian (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2315-2324,DOI:http://dx.doi.org/10.19082/ 2315 Corresponding author: Dr. Fateme Mehrzad, Department of Psychiatry, School of Medicine, Ka shan University of Medical Science, Kashan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
Clinical trial registration: The trial was registered at the Iranian Registry of Clin ical Trials (http://www.irct.ir) with the IRCT ID: IRCT2014070318338N1.,Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
"http://www.ephysician.ir Page2316According to studies, the amount of sexual activity in one person and also the number of orgasms during intercourse are associated with one's satisfaction with sex (7, 8).",Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
http://www.ephysician.ir Page23183.,Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
http://www.ephysician.ir Page2320Table 5.Comparison of sexual f unction scores in treatment groups during treatment Subscale Time Group CBT Mean (SD) Sildenafil Mean (SD) Desire Before treatment 3.06 (1.27) 2.89 (1.12) 4 weeks 3.59 (1.44) 3.32 (1.26) 8weeks 3.88 (1.43) 3.6 (1.33) 12 weeks 4.54 (1.29) 3.9 (1.39) p-value <0.001 <0.001 Arousal Before treatment 2.07 (1.17) 2.13 (1.14) 4 weeks 2.7 (1.1) 3.24 (1.09) 8weeks 3.03 (1.14) 3.86 (1.18) 12 weeks 3.28 (1.12) 3.97 (1.21) <0.001 p-value <0.001 Lubrication Before treatment 2.08 (1.38) 2.25 (1.24) 4 weeks 1.66 (1.4) 2.96 (1.17) 8weeks 3.9 (1.34) 3.75 (0.98) 12 weeks 3.7 (1.35) 4.25 (0.94) p-value <0.001 <0.001 Orgasm Before treatment 1.29 (0.97) 1.54 (0.9) 4 weeks 1.62 (0.98) 2.43 (1.02) 8weeks 2.04 (1.14) 3.02 (1.12) 12 weeks 2.86 (1.09) 3.39 (1.19) p-value <0.001 <0.001 Satisfaction Before treatment 2.3 (0.64) 2.16 (0.64) 4 weeks 2.65 (0.77) 2.58 (0.77) 8weeks 3.27 (0.9) 3.01 (0.86) 12 weeks 3.71 (0.98) 3.2 (0.94) p-value <0.001 <0.001 Pain Before treatment 4.21 (1.61) 3.89 (1.56) 4 weeks 4.54 (1.5) 4.16 (1.48) 8weeks 4.72 (1.45) 4.45 (1.49) 12 weeks 4.91 (1.35) 4.67 (1.42) p-value 4.Discussion Sexual desire has an undeniable impact on quality of life of a person and her/his sexual partner.,Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
"http://www.ephysician.ir Page2322In this study, it was found that cognitive -behavioral therapy in women with sexual dysfunction may improve sexual satisfaction, marital satisfaction, and sexual performance in all subscales under question.",Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
Clinical trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the IRCT ID: IRCT2014070318338N1.,Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
http://www.ephysician.ir Page232424)Safarinejad MR.,Non-OADS,/arxiv_data1/oa_pdf/77/ef/epj-08-2315.PMC4930249.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2325-2332,DOI:http://dx.doi.org/10.19082/ 2325 Corresponding author: Assistant Professor Dr. Ebrahim Jaafaripooyan, Department of Management Sciences and Health Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ad/6d/epj-08-2325.PMC4930250.pdf
"http://www.ephysician.ir Page2326healing process (3).Sports -related injuries are the main cause of time lost in athletes and teams, and they have a significant effect on society in terms of health care resources, personal disability, and restricted activity.",Non-OADS,/arxiv_data1/oa_pdf/ad/6d/epj-08-2325.PMC4930250.pdf
http://www.ephysician.ir Page2328 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/6d/epj-08-2325.PMC4930250.pdf
"http://www.ephysician.ir Page2330the rest was not strong enough in terms of population and effect size to support the efficac y of PRP in pain reduction (p=0.663) or function improvement (p=0.820).Although this systematic review and meta -analysis showed that PRP was as effective as other comparators in pain reduction, its results were inconsistent with Malavolta et al.",OADS,/arxiv_data1/oa_pdf/ad/6d/epj-08-2325.PMC4930250.pdf
http://www.ephysician.ir Page2332autologous blood injections versus platelet -rich plasma injections.,Non-OADS,/arxiv_data1/oa_pdf/ad/6d/epj-08-2325.PMC4930250.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2333-2339,DOI:http://dx.doi.org/10.19082/ 2333 Correspondin g author: Assistant Professor Dr. Mahnaz Samadbeik, Department of Health Information Technology, School of Allied Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/epj-08-2333.PMC4930251.pdf
http://www.ephysician.ir Page23345).,Non-OADS,/arxiv_data1/oa_pdf/7c/ed/epj-08-2333.PMC4930251.pdf
"http://www.ephysician.ir Page2336in all reviewed studies in the current study, to some extent, are subgroups of WHO’s policy levers (what to buy, whom to buy from, whom to buy, how to pay, with what price) (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/epj-08-2333.PMC4930251.pdf
"http://www.ephysician.ir Page2338was placed in the structural and organizational characteristics of purchaser institutions, which will be the executives of strategic purchasing (15, 16).",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/epj-08-2333.PMC4930251.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2340-2345,DOI:http://dx.doi.org/10.19082/ 2345 Corresponding author: Associate Professor Dr. Maryam Ghasempour.",Non-OADS,/arxiv_data1/oa_pdf/f4/6a/epj-08-2340.PMC4930252.pdf
http://www.ephysician.ir Page23424)Tri-modal: Having three preferences 5)Quad-modal: Having all of the four preferences (3) 2.3.,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/epj-08-2340.PMC4930252.pdf
"http://www.ephysician.ir Page2344and having or not having one of the visual, aural, r eading-writing, and kinesthetic learning styles.",Non-OADS,/arxiv_data1/oa_pdf/f4/6a/epj-08-2340.PMC4930252.pdf
Available from: http://www.vark -learn.com.,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/epj-08-2340.PMC4930252.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephys ician.ir May2016, Volume: 8, Issue:5, Pages:2346-2354,DOI:http://dx.doi.org/10.19082/ 2346 Corresponding author: Assistant Professor Dr. Sharareh Rostam Niakan Kalhori, Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sc iences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ee/f0/epj-08-2346.PMC4930253.pdf
http://www.ephysician.ir Page23482.2.,Non-OADS,/arxiv_data1/oa_pdf/ee/f0/epj-08-2346.PMC4930253.pdf
http://www.ephysician.ir Page2350difference between students receiving social skills training and the control gro up in terms of overall drug avoidance self-efficacy.,Non-OADS,/arxiv_data1/oa_pdf/ee/f0/epj-08-2346.PMC4930253.pdf
"http://www.ephysician.ir Page2352Students training to play preventive role could influence positiv ely on behavioral factors, including drug avoidance self-efficacy (32).",Non-OADS,/arxiv_data1/oa_pdf/ee/f0/epj-08-2346.PMC4930253.pdf
"http://www.ephysician.ir Page235423)Inderbitzen HM, Foster SL.",Non-OADS,/arxiv_data1/oa_pdf/ee/f0/epj-08-2346.PMC4930253.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2355-2360,DOI:http://dx.doi.org/10.19082/ 2355 Corresponding author: Mahdiyeh Aziznezhad, Department of Pedodontics, Faculty of Dentistry, Babol University of Medical science, Babol,Iran.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/epj-08-2355.PMC4930254.pdf
"http://www.ephysician.ir Page2356restorative materials, the products of this Company include various colors, i.e., blue, silver, pink, green, lemon, and gold.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/epj-08-2355.PMC4930254.pdf
"http://www.ephysician.ir Page2358and content of filler also are factors that affect the transmission of light and, as a result, the degree of polymerization (6).",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/epj-08-2355.PMC4930254.pdf
"http://www.ephysician.ir Page236015)Mowafyo EL, Badrawy W, Wasef M, Omar H. Kermanshahi S. Efficacy of New LED light -curing unites in hardening of class composite Restoration s. J can Dent Assoce.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/epj-08-2355.PMC4930254.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2361-2365,DOI:http://dx.doi.org/10.19082/ 2361 Corresponding author: Dr. Ali Mellat, Department of Neurology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1e/88/epj-08-2361.PMC4930255.pdf
http://www.ephysician.ir Page2362fluid (CSF) (12).,Non-OADS,/arxiv_data1/oa_pdf/1e/88/epj-08-2361.PMC4930255.pdf
http://www.ephysician.ir Page2364CSCTs in the upper limbs were normal (19).,Non-OADS,/arxiv_data1/oa_pdf/1e/88/epj-08-2361.PMC4930255.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2366-2370,DOI:http://dx.doi.org/10.19082/ 2366 Corresponding author: Zahra Esmaeili Abdar, Alborz University of Medical Sciences, Karaj, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b4/88/epj-08-2366.PMC4930256.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/88/epj-08-2366.PMC4930256.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/88/epj-08-2366.PMC4930256.pdf
Available from: http://www.ebd.ada.org/en/about 5)New Zealand Dental Association practice guidelines on evidence -based dentistry.,Non-OADS,/arxiv_data1/oa_pdf/b4/88/epj-08-2366.PMC4930256.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2371-2377,DOI:http://dx.doi.org/10.19082/ 2371 Corresponding author: Dr. Morteza Khaki, Department of Internal Medicine, Gh aem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mash had, Iran.",Non-OADS,/arxiv_data1/oa_pdf/c3/64/epj-08-2371.PMC4930257.pdf
"http://www.ephysician.ir Page2372as diabetes, and heart diseases can be associated with an increased prevalence (3 -5).",Non-OADS,/arxiv_data1/oa_pdf/c3/64/epj-08-2371.PMC4930257.pdf
http://www.ephysician.ir Page2374associated with chronic kidney disease.,Non-OADS,/arxiv_data1/oa_pdf/c3/64/epj-08-2371.PMC4930257.pdf
http://www.ephysician.ir Page2376recipients: a cross -sectional survey from Sudan.,OADS,/arxiv_data1/oa_pdf/c3/64/epj-08-2371.PMC4930257.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2378-2387,DOI:http://dx.doi.org/10.19082/ 2378 Corresponding author: Mehdi Raadabadi: Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/d6/f4/epj-08-2378.PMC4930258.pdf
http://www.ephysician.ir Page2380the traffic plan and had access to the major highways of the city.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/epj-08-2378.PMC4930258.pdf
http://www.ephysician.ir Page2382Table 2.Demographic characteristics of pat ients Variables n (%) Variables n (%) Age Group (year)10-20 46 (13.2) Insurance TypeEmployed in Armed Forces 55 (15.8) 21-30 120 (34.48) Retired from Armed Forces 35 (10.06) 31-40 77 (22.13) Armed Forces Family 70 (20.11) 41-50 46 (13.22) Employed in Other Armed Forces58 (16.67) 51-60 38 (10.92) Armed Forces2 Family 38 (10.92) 61-70 7 (201.),Non-OADS,/arxiv_data1/oa_pdf/d6/f4/epj-08-2378.PMC4930258.pdf
"http://www.ephysician.ir Page2384facilities;"" ""having trust in the clinic physicians;"" and ""adornment and good behavior of staff"" had the next priorities.",Non-OADS,/arxiv_data1/oa_pdf/d6/f4/epj-08-2378.PMC4930258.pdf
"http://www.ephysician.ir Page238614)van Empel IW, Dancet EA, Koolman XH, Nelen WL, Stolk EA, Sermeus W, et al.",OADS,/arxiv_data1/oa_pdf/d6/f4/epj-08-2378.PMC4930258.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2388-2394,DOI:http://dx.doi.org/10.19082/ 2388 Corresponding author: Associate Professor Dr. Mojtaba Mousavi Bazaz, Department Of Community Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/24/53/epj-08-2388.PMC4930259.pdf
http://www.ephysician.ir Page23903)Transportation behavior: Data on self -reported adherence t o fastening the seatbelt and obeying the speed limits among eligible participants (drivers were asked about obeying the speed limit) at all times were obtained.,Non-OADS,/arxiv_data1/oa_pdf/24/53/epj-08-2388.PMC4930259.pdf
http://www.ephysician.ir Page2392people in cluster 3 were smokers despite the fact that there were no smokers in clusters 1 and 2.,Non-OADS,/arxiv_data1/oa_pdf/24/53/epj-08-2388.PMC4930259.pdf
"http://www.ephysician.ir Page23943)Hendricks KM, Herbold N, Fung T. Diet and other lifestyle beh aviours in young college women.",Non-OADS,/arxiv_data1/oa_pdf/24/53/epj-08-2388.PMC4930259.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2395-2404,DOI:http://dx.doi.org/10.19082/ 2395 Corresponding author: Associate Professor Dr. Monir Nobahar, Nursing Care Research Center, Faculty of Nursing andAllied Health , Semnan University of Medi cal Sciences, Semnan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/be/62/epj-08-2395.PMC4930260.pdf
http://www.ephysician.ir Page2396development and professional growth are associated with improved quality of nursing care (3).,Non-OADS,/arxiv_data1/oa_pdf/be/62/epj-08-2395.PMC4930260.pdf
http://www.ephysician.ir Page2398 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/be/62/epj-08-2395.PMC4930260.pdf
http://www.ephysician.ir Page24003.2.1.11 Precision and concentration: Two essential aspects of the clinical skills of ICCU nurses are precision and concentration.,Non-OADS,/arxiv_data1/oa_pdf/be/62/epj-08-2395.PMC4930260.pdf
http://www.ephysician.ir Page24025.,Non-OADS,/arxiv_data1/oa_pdf/be/62/epj-08-2395.PMC4930260.pdf
"http://www.ephysician.ir Page240441)Thomas EJ, Sexton JB, Helmreich RL.",Non-OADS,/arxiv_data1/oa_pdf/be/62/epj-08-2395.PMC4930260.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2405-2409,DOI:http://dx.doi.org/10.19082/2405 Corresponding author: Kobra Kahnouji, Health Information Management Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.",Non-OADS,/arxiv_data1/oa_pdf/e2/7d/epj-08-2405.PMC4930261.pdf
"http://www.ephysician.ir Page2406education and research, and it has a serious task in scoring this subject (3) .",Non-OADS,/arxiv_data1/oa_pdf/e2/7d/epj-08-2405.PMC4930261.pdf
http://www.ephysician.ir Page2408subject doesn’t have an impor tant role.,Non-OADS,/arxiv_data1/oa_pdf/e2/7d/epj-08-2405.PMC4930261.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2410-2415,DOI:http://dx.doi.org/10.19082/ 2410 Corresponding author: Dr. Mahin Dianat, Physiology Research Center and Department of Physiolog y, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/e1/31/epj-08-2410.PMC4930262.pdf
http://www.ephysician.ir Page24122.5.,Non-OADS,/arxiv_data1/oa_pdf/e1/31/epj-08-2410.PMC4930262.pdf
"http://www.ephysician.ir Page24147)Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo MK, Saitoh Y, Aozuka Y, et al.",OADS,/arxiv_data1/oa_pdf/e1/31/epj-08-2410.PMC4930262.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2416-2424,DOI:http://dx.doi.org/10.19082/ 2416 Corresponding author: Seyed Abbas Mirmalek, Medical Research Center, Azad University of Medica l Sciences, Attarimoqaddam Ave, Haqani Ave, Dr. Shariati St, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ca/f5/epj-08-2416.PMC4930263.pdf
"http://www.ephysician.ir Page2418discovery of the BRCA1 gene (16), and a similar gene on chromosome 13 was discovered the next year and was named BRCA2, which increases susceptibility to breast cancer (17).",Non-OADS,/arxiv_data1/oa_pdf/ca/f5/epj-08-2416.PMC4930263.pdf
http://www.ephysician.ir Page24202.7.,Non-OADS,/arxiv_data1/oa_pdf/ca/f5/epj-08-2416.PMC4930263.pdf
http://www.ephysician.ir Page242214)Gralow JR.,Non-OADS,/arxiv_data1/oa_pdf/ca/f5/epj-08-2416.PMC4930263.pdf
http://www.ephysician.ir Page242457)Yarden Y.,Non-OADS,/arxiv_data1/oa_pdf/ca/f5/epj-08-2416.PMC4930263.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2425-2431,DOI:http://dx.doi.org/10.19082/2425 Corresponding author: Dr.Omar Atef Tolba ,Cairo University Children's Hospital, Depart ment of Pediatrics, Cairo University, Egypt .",Non-OADS,/arxiv_data1/oa_pdf/b7/69/epj-08-2425.PMC4930264.pdf
http://www.ephysician.ir Page2426that may have occ urred (7).,Non-OADS,/arxiv_data1/oa_pdf/b7/69/epj-08-2425.PMC4930264.pdf
http://www.ephysician.ir Page2428was 47.2% (range: –1.2-69.1%) with DFX compared to 50.3% (range: –7.7-61.2%) with DFO (p = 0.315).,OADS,/arxiv_data1/oa_pdf/b7/69/epj-08-2425.PMC4930264.pdf
"http://www.ephysician.ir Page24309)Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, e t al.",Non-OADS,/arxiv_data1/oa_pdf/b7/69/epj-08-2425.PMC4930264.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2432-2435,DOI:http://dx.doi.org/10.19082/2432 Corresponding author: Associate Profess or Dr. Amir Masoud Hashemian, Department of Emergency, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/a8/d5/epj-08-2432.PMC4930265.pdf
Clinical trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the IRCT ID: IRCT2013100214872N1 Funding: The authors received no financial support f or the research or for the publication of this article.,Non-OADS,/arxiv_data1/oa_pdf/a8/d5/epj-08-2432.PMC4930265.pdf
http://www.ephysician.ir Page24342.6.,Non-OADS,/arxiv_data1/oa_pdf/a8/d5/epj-08-2432.PMC4930265.pdf
Clinical trial registration: The trial was regi stered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the IRCT ID: IRCT2013100214872N1.,Non-OADS,/arxiv_data1/oa_pdf/a8/d5/epj-08-2432.PMC4930265.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2436-2442,DOI:http://dx.doi.org/10.19082/ 2436 Corresponding author: Assiastant Professor Dr.",Non-OADS,/arxiv_data1/oa_pdf/88/0a/epj-08-2436.PMC4930266.pdf
Clinical trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the Irct ID: IRCT201509042388/N1.,Non-OADS,/arxiv_data1/oa_pdf/88/0a/epj-08-2436.PMC4930266.pdf
http://www.ephysician.ir Page24382.3.,Non-OADS,/arxiv_data1/oa_pdf/88/0a/epj-08-2436.PMC4930266.pdf
http://www.ephysician.ir Page2440 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/88/0a/epj-08-2436.PMC4930266.pdf
"http://www.ephysician.ir Page24427)Giorgi VS, Peracoli MT, Peracoli JC, Witkin SS, Bannwart -Castro CF.",Non-OADS,/arxiv_data1/oa_pdf/88/0a/epj-08-2436.PMC4930266.pdf
"Electronic Physician (ISSN: 2008-5842)                       http://www.ephysician.ir  May 2016, Volume: 8, Issue: 5, Pages: 2443-2451, DOI: http://dx.doi.org/10.19082/2443   Corresponding author:   Saeedeh Badieyan, Department of Biomedical Engineering and Medical Physics, Shahid Beheshti University of  Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/e0/58/epj-08-2443.PMC4930267.pdf
"http://www.ephysician.ir  Page 244܁Many promising methods have been proposed for image segmentation, such as region merging-based methods (6-7),  graph-based methods (8-11), and active contour model (ACM)-based methods (12, 13).",Non-OADS,/arxiv_data1/oa_pdf/e0/58/epj-08-2443.PMC4930267.pdf
http://www.ephysician.ir  Page 244ࠁ2.5.,Non-OADS,/arxiv_data1/oa_pdf/e0/58/epj-08-2443.PMC4930267.pdf
http://www.ephysician.ir  Page 244ँFigure 2 .,Non-OADS,/arxiv_data1/oa_pdf/e0/58/epj-08-2443.PMC4930267.pdf
http://www.ephysician.ir  Page 240ଁcontour and the threshold of the energy function are based on visual assessment.,OADS,/arxiv_data1/oa_pdf/e0/58/epj-08-2443.PMC4930267.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir May2016, Volume: 8, Issue:5, Pages:2452-2457,DOI:http://dx.doi.org/10.19082/2 542 Corresponding author: Dr. Nasrollah Naghdi, Ilam University of Medical Sciences, Ilam, Iran.",Non-OADS,/arxiv_data1/oa_pdf/05/49/epj-08-2452.PMC4930268.pdf
http://www.ephysician.ir Page2454Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/05/49/epj-08-2452.PMC4930268.pdf
http://www.ephysician.ir Page2456Table1.FCC Limits for Maximum Permissible Exposure (MPE).,Non-OADS,/arxiv_data1/oa_pdf/05/49/epj-08-2452.PMC4930268.pdf
2012; 3(3): 38-9.http://www.nepjol.info/index.php/HP/article/view/7274.,Non-OADS,/arxiv_data1/oa_pdf/05/49/epj-08-2452.PMC4930268.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/7a/ott-9-3883.PMC4930270.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3883–3891OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3883Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10399 6 association between pretreatment glasgow  prognostic score and gastric cancer survival  and clinicopathological features: a meta-analysis chun-Xiao Zhang* shu-Yi Wang* shuang-Qian chen shuai-long Yang lu Wan Bin Xiong Department of Oncology, Zhongnan  hospital of Wuhan University, hubei  Key laboratory of T umor Biological  Behaviors and hubei cancer clinical  study center, Wuhan, hubei, People’s  republic of china *These authors contributed equally  to this workBackground:  Glasgow prognostic score (GPS) is widely known as a systemic inflammatory- based marker.",Non-OADS,/arxiv_data1/oa_pdf/39/7a/ott-9-3883.PMC4930270.pdf
"It is increasingly recognized that variations within clinical outcomes in  cancer patients were influenced by not only clinicopathological characteristics but also correspondence: Bin Xiong Department of Oncology, Zhongnan  hospital of Wuhan University, hubei Key  laboratory of Tumor Biological Behaviors  and hubei cancer clinical study center,  no 169 Donghu road, Wuchang District,  Wuhan 430071, hubei Province, People’s  republic of china Tel +86 027 6781 3152 Fax +86 027 6781 2829 email binxiong1961@whu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: GPS and GC survival and clinicopathological features DOI: http://dx.doi.org/10.2147/OTT.S103996",Non-OADS,/arxiv_data1/oa_pdf/39/7a/ott-9-3883.PMC4930270.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/39/7a/ott-9-3883.PMC4930270.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/7a/ott-9-3883.PMC4930270.pdf
"Intriguingly, the Bhlhb5::flpo  allele also genetically labels numerous  other regions of the nervous system that process sensory input, including the dorsal horn, the  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/2b/67/nihms795579.PMC4930277.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.ydbio.2016.04.028 .,OADS,/arxiv_data1/oa_pdf/2b/67/nihms795579.PMC4930277.pdf
"Key Words:  Sponges, Pharmacokinetics, Antitumor, Antiviral, Pathogenesis, MicrobesAbstractReview Biomol  Ther 24(4), 347-362 (2016) *Corresponding Author E-mail: shams1327@yahoo.com, Hassan13@zju.edu.cn Tel: +86-15695712713, Fax: +86-15695712713Received  Mar 24, 2016  Revised  Apr 28, 2016  Accepted  May 19, 2016 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2016.067 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"348 http://dx.doi.org/10.4062/biomolther.2016.067ara-C used in the treatment of lymphoma and leukemia, a part  of this one of its fluorinated derivative also permitted for the  treatment of lung, pancreatic (Momparler, 2013), breast and  bladder cancer (Schwartsmann, 2000).",Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"350 http://dx.doi.org/10.4062/biomolther.2016.067variabilis , was found to be an antibiotic (Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"352 http://dx.doi.org/10.4062/biomolther.2016.067some of the antimicrobial compounds have been derived from  sponges (Table  4, Fig.",OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"354 http://dx.doi.org/10.4062/biomolther.2016.067brane by the mechanism of preventing the phospholipase A2  enzyme from the binding to the membrane of phospholipid,  the reason is that it increases the concentration of intracellular  arachidonic acid that results in the upregulation of the inflam- mation mediators synthesis as a leukotrienes and prostaglan - dins.",Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
356 http://dx.doi.org/10.4062/biomolther.2016.067(Fig.,Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"358 http://dx.doi.org/10.4062/biomolther.2016.067 CONCLUSION Sponge-derived substances span a wide range of chemis- try (e.g., alkaloid, peptide, terpenoid and polyketides) with an  equally variety of biotechnological properties (e.g., Antibacte- rial, antifungal, antiviral, immunosuppressive, cardiovascular  and anti-parasitic) (Ang et al., 2001; Torres et al., 2002).",OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
Available from: http://www.funasa.gov.br/.,Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"360 http://dx.doi.org/10.4062/biomolther.2016.067Kobayashi, J. and Ishibashi, M. (1993) Bioactive metabolites of symbi- otic marine microorganisms.",OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
Available from:  http://www.earthlife.net/inverts/porifera.html/.,Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
362 http://dx.doi.org/10.4062/biomolther.2016.067Study on bioactivity of extracts from marine sponges in Chinese  Sea.,Non-OADS,/arxiv_data1/oa_pdf/61/58/bt-24-347.PMC4930278.pdf
"Key Words:  Cardiac progenitor cell, Hyperglycemia, Fasentin, Mitochondrial dynamics, Diabetic cardiomyopathyAbstractOriginal Article Biomol  Ther 24(4), 363-370 (2016) Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2016.097 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/a3/bt-24-363.PMC4930279.pdf
364 http://dx.doi.org/10.4062/biomolther.2016.097is potential for the use of hCPCs in cell therapies.,Non-OADS,/arxiv_data1/oa_pdf/87/a3/bt-24-363.PMC4930279.pdf
366 http://dx.doi.org/10.4062/biomolther.2016.097networks after hCPCs were treated with 25 mM D-glucose for  24 h or with 15 mM or 25 mM D-glucose for 72 h (Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/a3/bt-24-363.PMC4930279.pdf
368 http://dx.doi.org/10.4062/biomolther.2016.097cally blocking glucose uptake rescued hCPC viability and tube  formation.,Non-OADS,/arxiv_data1/oa_pdf/87/a3/bt-24-363.PMC4930279.pdf
"370 http://dx.doi.org/10.4062/biomolther.2016.097Kajstura, J.",OADS,/arxiv_data1/oa_pdf/87/a3/bt-24-363.PMC4930279.pdf
"Further work has suggested that this protec- tion may involve interference with multiple factors associated  with intracellular reactive oxygen species (ROS), ER stress Original Article Biomol  Ther 24(4), 371-379 (2016) *Corresponding Author E-mail: huanglan260@126.com Tel: +86-02368755601, Fax: +86-02368755601Received  Aug 17, 2015  Revised  Nov 9, 2015  Accepted  Nov 17, 2015 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.130 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/bt-24-371.PMC4930280.pdf
"372 http://dx.doi.org/10.4062/biomolther.2015.130Biomol  Ther 24(4), 371-379 (2016) and mitochondrial dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/bt-24-371.PMC4930280.pdf
"374 http://dx.doi.org/10.4062/biomolther.2015.130Biomol  Ther 24(4), 371-379 (2016) Western blot analysis After the various treatments were performed, proteins were  extracted from EPCs using a lysis buffer (RIPA) containing  phenylmethanesulfonyl fluoride (PMSF).",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/bt-24-371.PMC4930280.pdf
"376 http://dx.doi.org/10.4062/biomolther.2015.130Biomol  Ther 24(4), 371-379 (2016) CRP78/BIP were up-regulated by H 2O2 stimulation compared  with that of the control group.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/bt-24-371.PMC4930280.pdf
"378 http://dx.doi.org/10.4062/biomolther.2015.130Biomol  Ther 24(4), 371-379 (2016) tween chronic kidney disease and cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/bt-24-371.PMC4930280.pdf
"Silymarin has been used for Original Article *Corresponding Author E-mail: jjb0403@anu.ac.kr Tel: +82-54-820-7757, Fax: +82-54-820-6252Received  Sep 23, 2015  Revised  Nov 22, 2015  Accepted  Dec 11, 2015 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.154 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/38/bt-24-380.PMC4930281.pdf
"382 http://dx.doi.org/10.4062/biomolther.2015.154Biomol  Ther 24(4), 380-386 (2016) RESUL TS Downregulation of β-catenin by silymarin treatment To test whether silymarin affects the protein levels of  β-catenin, we performed Western blot in HCT116 and SW480  cells treated with 0, 50 and 100 μM of silymarin.",Non-OADS,/arxiv_data1/oa_pdf/77/38/bt-24-380.PMC4930281.pdf
"384 http://dx.doi.org/10.4062/biomolther.2015.154Biomol  Ther 24(4), 380-386 (2016) dependent activity, we performed a luciferase reporter assay  using TOP-FLASH (wild-type TCF binding site) or FOP-FLASH  (Mutated TCF binding site) in HCT116 and SW480 cells, re-spectively.",Non-OADS,/arxiv_data1/oa_pdf/77/38/bt-24-380.PMC4930281.pdf
"386 http://dx.doi.org/10.4062/biomolther.2015.154Biomol  Ther 24(4), 380-386 (2016) 1423-1432.",Non-OADS,/arxiv_data1/oa_pdf/77/38/bt-24-380.PMC4930281.pdf
"Complex TLRs signaling and its associated Original Article Biomol  Ther 24(4), 387-394 (2016) *Corresponding Author E-mail: sunmee@skku.edu Tel: +82-31-290-7712, Fax: +82-31-292-8800Received  Oct 30, 2015  Revised  Nov 26, 2015  Accepted  Dec 2, 2015 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.176 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/f7/bt-24-387.PMC4930282.pdf
"388 http://dx.doi.org/10.4062/biomolther.2015.176Biomol  Ther 24(4), 387-394 (2016) downstream regulators involved in pathogenesis and devel - opment of sepsis.",Non-OADS,/arxiv_data1/oa_pdf/f9/f7/bt-24-387.PMC4930282.pdf
"390 http://dx.doi.org/10.4062/biomolther.2015.176Biomol  Ther 24(4), 387-394 (2016) Results are presented as mean ± standard error of the mean  (SEM).",OADS,/arxiv_data1/oa_pdf/f9/f7/bt-24-387.PMC4930282.pdf
"392 http://dx.doi.org/10.4062/biomolther.2015.176Biomol  Ther 24(4), 387-394 (2016) vial inflammation in collagen-induced arthritis mouse model  (Nasu et al., 2008) and allergen-induced airway inflammation  in mouse asthma model (Choi et al., 2005).",Non-OADS,/arxiv_data1/oa_pdf/f9/f7/bt-24-387.PMC4930282.pdf
"394 http://dx.doi.org/10.4062/biomolther.2015.176Biomol  Ther 24(4), 387-394 (2016) organ failure.",Non-OADS,/arxiv_data1/oa_pdf/f9/f7/bt-24-387.PMC4930282.pdf
"Emodin also induced osteoblast  differentiation and increased the area of new bone formation  395Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2016.020 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/3d/bt-24-395.PMC4930283.pdf
"396 http://dx.doi.org/10.4062/biomolther.2016.020by inducing BMP-2 through activation of the MAP kinase-NF- κB signaling pathway in MC3T3-El cells (Kim et al., 2014).",OADS,/arxiv_data1/oa_pdf/90/3d/bt-24-395.PMC4930283.pdf
"398 http://dx.doi.org/10.4062/biomolther.2016.020Statistical analysis The experiments were repeated at least three times, and  all data were summarized as the mean ± SEM.",OADS,/arxiv_data1/oa_pdf/90/3d/bt-24-395.PMC4930283.pdf
400 http://dx.doi.org/10.4062/biomolther.2016.020formation.,OADS,/arxiv_data1/oa_pdf/90/3d/bt-24-395.PMC4930283.pdf
"Key Words:  4-methyl-2,6-bis(1-phenylethyl)phenol, Apoptotis, Anti-cancer activity, Cordyceps BassianaAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: jhkim1@chonbuk.ac.kr (Kim JH), jaecho@skku.edu (Cho JY) Tel: +82-63-270-2563 (Kim JH), +82-31-290-7868 (Cho JY)Fax: +82-63-270-3780 (Kim JH), +82-31-290-7870 (Cho JY) †The first three authors contributed equally to this work.Received  Oct 13, 2015  Revised  Nov 14, 2015  Accepted  Nov 24, 2015 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.166 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/e5/bt-24-402.PMC4930284.pdf
404 http://dx.doi.org/10.4062/biomolther.2015.1666 h and washed twice with PBS then fixed to the cover slips by  incubating in 3.7% formaldehyde for 10 min.,Non-OADS,/arxiv_data1/oa_pdf/8e/e5/bt-24-402.PMC4930284.pdf
"406 http://dx.doi.org/10.4062/biomolther.2015.166phosphate, 1 mM sodium orthovanadate, 1 mM dithiothreitol,  1% Triton X-100, 10% glycerol, 10 μg/ml aprotinin, 10 μg/ml  pepstatin, 1 mM benzimide, and 2 mM PMSF) for 1 hour, with rotation, at 4°C.",Non-OADS,/arxiv_data1/oa_pdf/8e/e5/bt-24-402.PMC4930284.pdf
408 http://dx.doi.org/10.4062/biomolther.2015.166that the activity of those proteins was blocked by KTH-13-Me.,Non-OADS,/arxiv_data1/oa_pdf/8e/e5/bt-24-402.PMC4930284.pdf
"Key Words:  Flavonoids, Quercetin, Quercetin glycosides, α7 nAChRAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: synah@konkuk.ac.kr (Nah SY), smlee@konkuk.ac.kr (Lee SM) Tel: +82-2-450-4154 (Nah SY), +82-2-450-3716 (Lee SM)Fax: +82-2-450-3037 (Nah SY), +82-2-450-3037 (Lee SM)Received  Sep 21, 2015  Revised  Dec 28, 2015  Accepted  Jan 22, 2016 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.153 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/8a/bt-24-410.PMC4930285.pdf
"412 http://dx.doi.org/10.4062/biomolther.2015.153Biomol  Ther 24(4), 410-417 (2016)  1.8 mM CaCl 2, and 5 mM HEPES, pH 7.5) supplemented with  50 μg/ml gentamicin.",Non-OADS,/arxiv_data1/oa_pdf/f1/8a/bt-24-410.PMC4930285.pdf
"414 http://dx.doi.org/10.4062/biomolther.2015.153Biomol  Ther 24(4), 410-417 (2016)  3.7 and 63.1 ± 4.6% at 3, 10, 30, 100, and 300 μM in oocytes  expressing α7 AChRs, respectively.",Non-OADS,/arxiv_data1/oa_pdf/f1/8a/bt-24-410.PMC4930285.pdf
"416 http://dx.doi.org/10.4062/biomolther.2015.153Biomol  Ther 24(4), 410-417 (2016)  present study, we found that quercetin glycosides inhibited IACh  and furthermore, Rutin and Rham1 could attenuate the quer- cetin-induced enhancement of I ACh.",Non-OADS,/arxiv_data1/oa_pdf/f1/8a/bt-24-410.PMC4930285.pdf
"*Corresponding Author E-mail: daiyueyue888@163.com Tel: +86-577-88816173, Fax: +86-577-88816255Received  Oct 15, 2015  Revised  Jan 25, 2016  Accepted  Mar 24, 2016 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.168 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/ba/bt-24-418.PMC4930286.pdf
"420 http://dx.doi.org/10.4062/biomolther.2015.168Biomol  Ther 24(4), 418-425 (2016)  A Inhibition(%) 100 Time(min)20 40 60 8060 4020 0 0 Saline POG (1mg/kg) POG (3mg/kg) POG (10mg/kg) POG (30mg/kg) Indometacin (10mg/kg) B %InhibitionbyAUC10-90m in Dose (mg)11 060 40 20 0 0 100E=56.6% ED =1.9 mgmax 50 C Flinchtimes/min 100 Time(min)20 40 60 806040 20 0 0D Normalizedlatencies Post formalin injection (min)121.5 1.0 0.5 0 0 5  4Saline (10ml/kg) POG (100 mg/kg) Indomethacin (10mg/kg) 3Saline (10ml/kg/day) POG (10mg/kg )/day Fig.",Non-OADS,/arxiv_data1/oa_pdf/cc/ba/bt-24-418.PMC4930286.pdf
422 http://dx.doi.org/10.4062/biomolther.2015.168decreased spinal COX-2 protein dose-dependently compared  with indomethacin (p<0.05 one-way ANOVA).,OADS,/arxiv_data1/oa_pdf/cc/ba/bt-24-418.PMC4930286.pdf
ACKNOWLEDGMENTS We thank LetPub (http://www.letpub.com) for its linguistic  assistance during the preparation of this manuscript.,Non-OADS,/arxiv_data1/oa_pdf/cc/ba/bt-24-418.PMC4930286.pdf
424 http://dx.doi.org/10.4062/biomolther.2015.168CONFLICT OF INTEREST The authors declare no conflict of interest.,Non-OADS,/arxiv_data1/oa_pdf/cc/ba/bt-24-418.PMC4930286.pdf
"A pre- *Corresponding Author E-mail: hbinpark@gnu.ac.kr Tel: +82-55-750-8688, Fax: +82-55-754-0477Received  Oct 21, 2015  Revised  Jan 6, 2016  Accepted  Jan 11, 2016 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.169 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/8f/bt-24-426.PMC4930287.pdf
"428 http://dx.doi.org/10.4062/biomolther.2015.169Biomol  Ther 24(4), 426-432 (2016) was done by SPSS 17.0 for Windows (SPSS, Chicago, Illi- nois, USA).",OADS,/arxiv_data1/oa_pdf/96/8f/bt-24-426.PMC4930287.pdf
"430 http://dx.doi.org/10.4062/biomolther.2015.169Biomol  Ther 24(4), 426-432 (2016) Arany et al., 2004).",OADS,/arxiv_data1/oa_pdf/96/8f/bt-24-426.PMC4930287.pdf
"432 http://dx.doi.org/10.4062/biomolther.2015.169Biomol  Ther 24(4), 426-432 (2016) Olson, J. M. and Hallahan, A. R. (2004) p38 MAP kinase: a conver- gence point in cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/96/8f/bt-24-426.PMC4930287.pdf
"Key Words:  Salvia miltiorrhiza, Ethanol, Synaptic plasticity, NMDA receptorAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: drchoism@gmail.com (Choi SM), mose79@dau.ac.kr (Kim DH) Tel: +82-62-220-6135 (Choi SM), +82-51-200-7583 (Kim DH)Fax: +82-62-228-3461 (Choi SM), +82-51-200-7583 (Kim DH)Received  Nov 24, 2015  Revised  Jan 21, 2016  Accepted  Mar 23, 2016 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.184 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/c6/bt-24-433.PMC4930288.pdf
"434 http://dx.doi.org/10.4062/biomolther.2015.184and Use Committee of Dong-A University, Busan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/91/c6/bt-24-433.PMC4930288.pdf
"436 http://dx.doi.org/10.4062/biomolther.2015.184SM blocks ethanol-induced L TP impairment To test the effect of SM on ethanol-induced memory im- pairment, we next examined LTP, which has been previously  reported to be impaired by ethanol (Hicklin et al., 2011; Izumi  et al., 2005).",OADS,/arxiv_data1/oa_pdf/91/c6/bt-24-433.PMC4930288.pdf
"Key Words:  Cyperi Rhizoma, Scirpusin A, Scirpusin B, Neuroprotection, Bioactivity-guided fractionationAbstractOriginal Article Biomol  Ther 24(4), 438-445 (2016) Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2016.091 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/6a/bt-24-438.PMC4930289.pdf
440 http://dx.doi.org/10.4062/biomolther.2016.091Measurement of ABTS radical cation scavenging activity ABTS solution of 7.4 mM was added to 2.6 mM potassium  persulfate for 1 day before starting the experiment in the dark.,Non-OADS,/arxiv_data1/oa_pdf/83/6a/bt-24-438.PMC4930289.pdf
"442 http://dx.doi.org/10.4062/biomolther.2016.091(5) (Miyase and Ueno, 1993), p-coumaric acid (6) (Swislocka  et al., 2012), ferulic acid (7) (Yoshioka et al., 2004), pinellic  acid (8) (Hong and Oh, 2012), and fulgidic acid (9) (Kurashina  et al., 2011) by spectroscopic (1H NMR, 13C NMR, 2D NMR,  and MS) measurements and comparison with published val- ues (Fig.",OADS,/arxiv_data1/oa_pdf/83/6a/bt-24-438.PMC4930289.pdf
"444 http://dx.doi.org/10.4062/biomolther.2016.091dicinal chemist working in this field in a challenging situation  (Decker, 2011).",Non-OADS,/arxiv_data1/oa_pdf/83/6a/bt-24-438.PMC4930289.pdf
"Key Words:  Chrysin, Caffeine, Drug interaction, Pharmacokinetics, in vivoAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: taecheon@ynu.ac.kr (Jeong TC), hgjeong@cnu.ac.kr (Jeong HG) Tel: +82-53-810-2819 (Jeong TC), +82-42-821-5936 (Jeong HG)Fax: +82-53-810-4654 (Jeong TC), +82-42-825-4936 (Jeong HG)Received  Dec 4, 2015  Revised  Dec 26, 2015  Accepted  Dec 29, 2015 Published Online  Jul 1, 2016http://dx.doi.org/10.4062/biomolther.2015.197 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/33/bt-24-446.PMC4930290.pdf
448 http://dx.doi.org/10.4062/biomolther.2015.197mentioned above.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/bt-24-446.PMC4930290.pdf
450 http://dx.doi.org/10.4062/biomolther.2015.197statistically significant.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/bt-24-446.PMC4930290.pdf
452 http://dx.doi.org/10.4062/biomolther.2015.197tification of caffeine and its three primary metabolites in rat plasma  by liquid chromatography-tandem mass spectrometry.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/bt-24-446.PMC4930290.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16093 EditorialJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/73/f8/jnm-22-351.PMC4930291.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16094 EditorialJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/72/d2/jnm-22-353.PMC4930292.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15150 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/9c/3e/jnm-22-355.PMC4930293.pdf
Available from URL: http://www.medscape.org/ viewarticle/702505_5 (accessed 1 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/9c/3e/jnm-22-355.PMC4930293.pdf
Available from URL: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor - PatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm190787.htm (accessed 29 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/9c/3e/jnm-22-355.PMC4930293.pdf
Available from URL:  http://www.fda.gov/Drugs/DrugSafety/ucm231161.htm (accessed 29 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/9c/3e/jnm-22-355.PMC4930293.pdf
Available from URL: http://www.fda.gov/Safety/MedW atch/SafetyIn-formation/ucm225843.htm (accessed 29 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/9c/3e/jnm-22-355.PMC4930293.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16023 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e5/ef/jnm-22-367.PMC4930294.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15185 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a1/e3/jnm-22-383.PMC4930295.pdf
2010. http://www.g-i-n.net (accessed Jul 13 2010).,Non-OADS,/arxiv_data1/oa_pdf/a1/e3/jnm-22-383.PMC4930295.pdf
2014. http://www.uptodate.com/contents/magnesium-oxide-drug-information?source=search_result &search=magnesium +oxide&selectedTitle=1~18 (accessed 5 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/a1/e3/jnm-22-383.PMC4930295.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16004 Meta-analysisJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/67/6a/jnm-22-412.PMC4930296.pdf
Available from URL: http://www.drugs.com/cdi/ polyethylene-glycol-3350-powder-for-oral-solution.html (accessed 21 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/67/6a/jnm-22-412.PMC4930296.pdf
Available from URL: http://handbook.cochrane.org/  (accessed 21 April 2016).,OADS,/arxiv_data1/oa_pdf/67/6a/jnm-22-412.PMC4930296.pdf
Available from URL: http://tech.cochrane.org/revman/download/ windows64 (accessed 21 April 2016).,OADS,/arxiv_data1/oa_pdf/67/6a/jnm-22-412.PMC4930296.pdf
Available from: URL: http://ims.cochrane.org/revman/ other-resources/gradepro/download (accessed 21 April 2016).,OADS,/arxiv_data1/oa_pdf/67/6a/jnm-22-412.PMC4930296.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16060 Technique ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ea/de/jnm-22-423.PMC4930297.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15166 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a7/b2/jnm-22-436.PMC4930298.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15192 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/75/jnm-22-444.PMC4930299.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16013 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/2b/7f/jnm-22-452.PMC4930300.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15174 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/91/0f/jnm-22-459.PMC4930301.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15159 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/0f/6f/jnm-22-470.PMC4930302.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15123 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ad/61/jnm-22-477.PMC4930303.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15128 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/51/1d/jnm-22-483.PMC4930304.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15157 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5d/24/jnm-22-490.PMC4930305.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15089 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/c5/ee/jnm-22-497.PMC4930306.pdf
"Supplementary Materials   Note: T o access the supplementary tables mentioned in this  article, visit the online version of Journal of Neurogastroenterology  and Motility  at http://www.jnmjournal.org/ and at http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c5/ee/jnm-22-497.PMC4930306.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15167 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d3/bb/jnm-22-509.PMC4930307.pdf
Available from URL: http://www.fda.gov/down - loads/Drugs/.../Guidances/UCM205269.pdf (accessed 20 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/d3/bb/jnm-22-509.PMC4930307.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15181 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/0c/11/jnm-22-517.PMC4930308.pdf
"Supplementary Materials   Note: T o access the supplementary videos mentioned in this  article, visit the online version of Journal of Neurogastroenterology  and Motility  at http://www.jnmjournal.org/ and at http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0c/11/jnm-22-517.PMC4930308.pdf
"3   July,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15194 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7b/73/jnm-22-529.PMC4930309.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.05.018,Non-OADS,/arxiv_data1/oa_pdf/4a/f0/main.PMC4930332.pdf
MALDI-TOF MS Spectrum Accession Number The MALDI-TOF-MS spectrum of this strain is available at http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/4a/f0/main.PMC4930332.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,4 3 –44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/f0/main.PMC4930332.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.003,Non-OADS,/arxiv_data1/oa_pdf/66/4b/main.PMC4930333.pdf
MALDI-TOF Spectrum MALDI-TOF spectrum of ‘Bacteroides mediterraneensis ’Strain Marseille-P2644Tis available at http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database .,Non-OADS,/arxiv_data1/oa_pdf/66/4b/main.PMC4930333.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,4 8 –50 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/66/4b/main.PMC4930333.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,4 8 –50 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/66/4b/main.PMC4930333.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/e9/main.PMC4930337.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.06.003 2213-2244/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/05/e9/main.PMC4930337.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/e5/main.PMC4930338.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/e5/main.PMC4930338.pdf
http://dx.doi.org/10.1016/j.eucr.2016.06.003Urology Case Reports 8 (2016) 31 e33,Non-OADS,/arxiv_data1/oa_pdf/b5/e5/main.PMC4930338.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/main.PMC4930340.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.06.012 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/main.PMC4930340.pdf
21 (5) (2007 May) 581 e590 http://www.ncbi.nlm.nih.gov/ pubmed/17447970 .,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/main.PMC4930340.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.005,Non-OADS,/arxiv_data1/oa_pdf/9e/29/main.PMC4930344.pdf
MALDI-TOF spectrum The MALDI-TOF spectrum of ‘Marseilla massiliensis ’strain Marseille-P2475Tis available at http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database .,Non-OADS,/arxiv_data1/oa_pdf/9e/29/main.PMC4930344.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,4 5 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/9e/29/main.PMC4930344.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,4 5 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/9e/29/main.PMC4930344.pdf
This  is  an  open  access  article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/07/main.PMC4930355.pdf
"At  the moment  of  the  admission,  the  subject  had  a  chest  radiograph  with http://dx.doi.org/10.1016/j.ijscr.2016.05.046 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/9d/07/main.PMC4930355.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ee/0a/134_2015_Article_4009.PMC4930457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"* pB0.05 ( t-test): ENS versus ECS.$pB0.05 (Chi2): ENS versus ECS.Narghile-use and periodontal bone height Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"4 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"Clinical and radiological data of the study groups: exclusive narghile smokers (ENS, n/C3060) and exclusive cigarette smokers (ECS, n/C3060) ENS ECS p Plaque index classes 0 /C11 4 (6.7) 8 (13.3) 0.386 1/C12 26 (43.3) 37 (61.7) 2/C13 30 (50.0) 15 (25.0) Bone loss Yes 7 (11.7) 9 (15.0) 0.631 No 53 (88.3) 51 (85.0) Qualitative data: number (percentage).$pB0.05 (Chi2): ENS versus ECS.Narghile-use and periodontal bone height Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"6 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"Significant differences: *ENS versus ECS;$ENS versus Non-S;%ENS versus MS.Narghile-use and periodontal bone height Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
2. WHO report on the global tobacco epidemic (2011) Warning about the dangers of tobacco [downloaded 2016 May 30].Available from: http://apps.who.int/iris/bitstream/10665/70680/ 1/WHO_NMH_TFI_11.3_eng.pdf [cited 5 July 2011].,Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"2015; 10: 27760, doi: http://dx.doi.org/10.3402/ ljm.v10.27760 12.",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"8 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"2015; 10: 30001, doi: http://dx.doi.org/10.3402/ljm.v10.30001 15.",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"2015; 23: 329 /C155.Narghile-use and periodontal bone height Citation: Libyan Journal of Medicine 2016, 11: 31689 - http://dx.doi.org/10.3402/ljm.v11.31689 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/61/51/LJM-11-31689.PMC4930549.pdf
"Around age 40, he developed onset of slowly progressive insuppressible facial twitching, which resulted in dysarthria and dysphagia.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/61/36/tre-06-405-7522-1.PMC4930628.pdf
"While reading, the patient’s speech is frequently interrupted by synchronous myoclonus involving the neck, orbicularis oculi, and vocal musculature.Isaacs DA, Hedera P Speech-activated Myoclonus Mimicking Stuttering Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/61/36/tre-06-405-7522-1.PMC4930628.pdf
"doi: 10.1002/1531-8249(199911)46:5 ,794: AID-ANA19 .3.0.CO;2-2.Speech-activated Myoclonus Mimicking Stuttering Isaacs DA, Hedera P Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/61/36/tre-06-405-7522-1.PMC4930628.pdf
"2010;  available at: http://www.who.int/hrh/nursing_midwifery/en/   (accessed 4 April, 2016).",Non-OADS,/arxiv_data1/oa_pdf/cf/3f/pharmpract-14-680.PMC4930853.pdf
"Available at  http://www.ahrq.gov/professionals/quality -patient -safety/pharmhealthlit/index.htm l (accessed December 1, 2014   13.",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/pharmpract-14-686.PMC4930855.pdf
"Available  at http://plato.stanford.edu/entries/mental - imagery/theories -memory.html  (accessed February 14, 2016)   15.",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/pharmpract-14-686.PMC4930855.pdf
"Available  at http://www.fip.org/pictograms_development  (accessed  January 15, 2016 )  17.",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/pharmpract-14-686.PMC4930855.pdf
Available  at  http://www.ergo -eg.com/uploads/digi_lib/362.pdf  (accessed 3/12/2016 )  46.,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/pharmpract-14-686.PMC4930855.pdf
2006.  http://www.moh.gov.my/images/gallery/publications/hi/Pharmacy_Information_System.pdf  (accessed 20 June 2015).,Non-OADS,/arxiv_data1/oa_pdf/85/ab/pharmpract-14-699.PMC4930856.pdf
2010.  http://www.usp.org/usp -nf/notices/retired -compendial -notices/recommendations -prescription -container -labeling    (accessed 20 June 2015).,Non-OADS,/arxiv_data1/oa_pdf/85/ab/pharmpract-14-699.PMC4930856.pdf
2014.  https://www.ismp.org/tools/guidelines/labelFormats/comments/default.as p   (accessed 31 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/85/ab/pharmpract-14-699.PMC4930856.pdf
"5th:   Available at: http://dx.doi.org/10.1176/appi.books.9780890425596.dsm02  (accessed January 21, 2016).",Non-OADS,/arxiv_data1/oa_pdf/9c/8d/pharmpract-14-722.PMC4930860.pdf
"Available from: http://6cpa.com.au/resources/fifth -agreement -rd/mental - health -project/  (accessed January 21, 2016).",Non-OADS,/arxiv_data1/oa_pdf/9c/8d/pharmpract-14-722.PMC4930860.pdf
"Available at:  http://centraltas.co.nz/assets/Publications/Pharmacy -Documents/Implementing -the- CPSA/Community+Pharmacy+Servic es+Agreement+generic+version.pdf  (accessed January 21, 2016).",Non-OADS,/arxiv_data1/oa_pdf/9c/8d/pharmpract-14-722.PMC4930860.pdf
"Medicines Regulation of 1984, NZ [ Available at:   http://www.legislation.govt.nz/regulation/public/1984/0143/latest/DLM95668.html   (accessed June 22, 2016)   22.",Non-OADS,/arxiv_data1/oa_pdf/9c/8d/pharmpract-14-722.PMC4930860.pdf
"Available  at:  http://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+topics/m edicines+and+drugs/clozapine/treating+patients+on+clozapine  (accessed June 22, 2016)   23.",Non-OADS,/arxiv_data1/oa_pdf/9c/8d/pharmpract-14-722.PMC4930860.pdf
"Available from:  https://www.hwa.gov.au/work -programs/workforce -innovation -and-reform/health -professionals -prescribing -pathway - project   (accessed June  29, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/2d/pharmpract-14-723.PMC4930861.pdf
"Available at:  https://canceraustralia.gov.au/publicat ions-and-resources/cancer -australia -publications/shared -care-principles -shared - care  (cccessed March 31,  2016).",Non-OADS,/arxiv_data1/oa_pdf/e1/2d/pharmpract-14-723.PMC4930861.pdf
2014   Available from: http://www.pharmacy.gov.my/v2/en/documents/malaysian -statistics -medicines.html  (accessed 10 April  2015).,Non-OADS,/arxiv_data1/oa_pdf/10/7a/pharmpract-14-740.PMC4930862.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):325-332 325Korean J Physiol Pharmacol 2016;20(4):325-332 http://dx.doi.org/10.4196/kjpp.2016.20.4.325 Author contributions:  M.H.,Non-OADS,/arxiv_data1/oa_pdf/7e/29/kjpp-20-325.PMC4930900.pdf
"326 http://dx.doi.org/10.4196/kjpp.2016.20.4.325 Korean J Physiol Pharmacol 2016;20(4):325-332Hu M and Liu B protein composed of , , and  subunits [11].",Non-OADS,/arxiv_data1/oa_pdf/7e/29/kjpp-20-325.PMC4930900.pdf
328 http://dx.doi.org/10.4196/kjpp.2016.20.4.325 Korean J Physiol Pharmacol 2016;20(4):325-332Hu M and Liu B well as increased ROS production.,Non-OADS,/arxiv_data1/oa_pdf/7e/29/kjpp-20-325.PMC4930900.pdf
330 http://dx.doi.org/10.4196/kjpp.2016.20.4.325 Korean J Physiol Pharmacol 2016;20(4):325-332Hu M and Liu B domains and connect with catenin at their intracellular domains  [27].,Non-OADS,/arxiv_data1/oa_pdf/7e/29/kjpp-20-325.PMC4930900.pdf
332 http://dx.doi.org/10.4196/kjpp.2016.20.4.325 Korean J Physiol Pharmacol 2016;20(4):325-332Hu M and Liu B through AMPK.,Non-OADS,/arxiv_data1/oa_pdf/7e/29/kjpp-20-325.PMC4930900.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):333-340 333Korean J Physiol Pharmacol 2016;20(4):333-340 http://dx.doi.org/10.4196/kjpp.2016.20.4.333 Author contributions:  L.X.L., K.T., C.S.T.",Non-OADS,/arxiv_data1/oa_pdf/6c/79/kjpp-20-333.PMC4930901.pdf
334 http://dx.doi.org/10.4196/kjpp.2016.20.4.333 Korean J Physiol Pharmacol 2016;20(4):333-340Varatharajan R et al progression of nephropathy [11-13] .,Non-OADS,/arxiv_data1/oa_pdf/6c/79/kjpp-20-333.PMC4930901.pdf
336 http://dx.doi.org/10.4196/kjpp.2016.20.4.333 Korean J Physiol Pharmacol 2016;20(4):333-340Varatharajan R et al Effect of edaravone on serum creatinine  concentration The serum creatinine level in diabetic control rats increased  significantly by 2 fold (p<0.001) as compared to normal control group.,Non-OADS,/arxiv_data1/oa_pdf/6c/79/kjpp-20-333.PMC4930901.pdf
"338 http://dx.doi.org/10.4196/kjpp.2016.20.4.333 Korean J Physiol Pharmacol 2016;20(4):333-340Varatharajan R et al DISCUSSION Diabetes mellitus is a chronic metabolic disorder that is  often associated with microvascular complications, including nephropathy, which results in significant morbidity and mortality worldwide  [20-22] .",Non-OADS,/arxiv_data1/oa_pdf/6c/79/kjpp-20-333.PMC4930901.pdf
340 http://dx.doi.org/10.4196/kjpp.2016.20.4.333 Korean J Physiol Pharmacol 2016;20(4):333-340Varatharajan R et al Maxwell AP; Warren 3/UK GoKinD Study Group.,Non-OADS,/arxiv_data1/oa_pdf/6c/79/kjpp-20-333.PMC4930901.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):341-346 341Korean J Physiol Pharmacol 2016;20(4):341-346 http://dx.doi.org/10.4196/kjpp.2016.20.4.341 Author contributions:  A.M. and M.A.A.,Non-OADS,/arxiv_data1/oa_pdf/9a/86/kjpp-20-341.PMC4930902.pdf
342 http://dx.doi.org/10.4196/kjpp.2016.20.4.341 Korean J Physiol Pharmacol 2016;20(4):341-346Moslehi A et al can induce regulatory T cells and TH2 cytokine profiles.,Non-OADS,/arxiv_data1/oa_pdf/9a/86/kjpp-20-341.PMC4930902.pdf
344 http://dx.doi.org/10.4196/kjpp.2016.20.4.341 Korean J Physiol Pharmacol 2016;20(4):341-346Moslehi A et al document shows that the percentage of HLA-G positive ADSCs  may be lower than BM-MSCs.,Non-OADS,/arxiv_data1/oa_pdf/9a/86/kjpp-20-341.PMC4930902.pdf
346 http://dx.doi.org/10.4196/kjpp.2016.20.4.341 Korean J Physiol Pharmacol 2016;20(4):341-346Moslehi A et al 22.,Non-OADS,/arxiv_data1/oa_pdf/9a/86/kjpp-20-341.PMC4930902.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):347-355 347Korean J Physiol Pharmacol 2016;20(4):347-355 http://dx.doi.org/10.4196/kjpp.2016.20.4.347 Author contributions:  XL.R., WW.Z., and WP .L.",Non-OADS,/arxiv_data1/oa_pdf/b1/c7/kjpp-20-347.PMC4930903.pdf
348 http://dx.doi.org/10.4196/kjpp.2016.20.4.347 Korean J Physiol Pharmacol 2016;20(4):347-355Ran X et al at the extracellular C-terminus expressed in endothelial cells.,Non-OADS,/arxiv_data1/oa_pdf/b1/c7/kjpp-20-347.PMC4930903.pdf
350 http://dx.doi.org/10.4196/kjpp.2016.20.4.347 Korean J Physiol Pharmacol 2016;20(4):347-355Ran X et al Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/c7/kjpp-20-347.PMC4930903.pdf
352 http://dx.doi.org/10.4196/kjpp.2016.20.4.347 Korean J Physiol Pharmacol 2016;20(4):347-355Ran X et al CPT inhibited TNF- -induced cellular uptake of DiI- ox-LDL in HUVECs  LOX-1 has been identified as the main receptor for ox-LDL in  endothelial cells and mediated ox-LDL endocytosis [8].,Non-OADS,/arxiv_data1/oa_pdf/b1/c7/kjpp-20-347.PMC4930903.pdf
354 http://dx.doi.org/10.4196/kjpp.2016.20.4.347 Korean J Physiol Pharmacol 2016;20(4):347-355Ran X et al myocardium against ischemia-induced derangements.,Non-OADS,/arxiv_data1/oa_pdf/b1/c7/kjpp-20-347.PMC4930903.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):357-366 357Korean J Physiol Pharmacol 2016;20(4):357-366 http://dx.doi.org/10.4196/kjpp.2016.20.4.357 Author contributions:  B.L.,Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
"358 http://dx.doi.org/10.4196/kjpp.2016.20.4.357 Korean J Physiol Pharmacol 2016;20(4):357-366 Lee B et al that IBU may also be effective for improving PTSD-associated  psychiatric symptoms, such as anxiety.",Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
360 http://dx.doi.org/10.4196/kjpp.2016.20.4.357 Korean J Physiol Pharmacol 2016;20(4):357-366 Lee B et al -2.6 and -3.6) [23].,Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
"All primers were designed using published mRNA sequences of those cytokines and a primer designing software, Primer 3, offered by the Whitehead Institute for Biomedical Research (Cambridge, MA, USA; http://primer3.wi.mit.edu) on the website.",OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
362 http://dx.doi.org/10.4196/kjpp.2016.20.4.357 Korean J Physiol Pharmacol 2016;20(4):357-366 Lee B et al (p=0.416).,Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
364 http://dx.doi.org/10.4196/kjpp.2016.20.4.357 Korean J Physiol Pharmacol 2016;20(4):357-366 Lee B et al expression of BDNF mRNA in the SPS group was significantly  restored in the SPS+IBU40 group (p<0.05).,Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
366 http://dx.doi.org/10.4196/kjpp.2016.20.4.357 Korean J Physiol Pharmacol 2016;20(4):357-366 Lee B et al behavior impaired by single prolonged stress PTSD model.,Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kjpp-20-357.PMC4930904.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):367-378 367Korean J Physiol Pharmacol 2016;20(4):367-378 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Author contributions:  J.Y.H.,Non-OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
368 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Korean J Physiol Pharmacol 2016;20(4):367-378Hong JY et al biological interactions of the molecules is essential.,Non-OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
"370 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Korean J Physiol Pharmacol 2016;20(4):367-378Hong JY et al Analysis of released cytochrome c T o estimate the amount of cytochrome c released from the  mitochondria to the cytosol, the harvested cells were incubated in an ice-cold cell lysis buffer (250 mM sucrose, 70 mM KCl, and 200 M/mL digitonin in PBS) for 5 min, as described previously  [10].",OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
372 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Korean J Physiol Pharmacol 2016;20(4):367-378Hong JY et al selected an optimal model parameter set by fitting the model  simulation results to the experimental data for 50 M cisplatin  (Table 5 ).,Non-OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
374 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Korean J Physiol Pharmacol 2016;20(4):367-378Hong JY et al using SimBiology in MATLAB.,OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
"376 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Korean J Physiol Pharmacol 2016;20(4):367-378Hong JY et al DISCUSSION Mitochondria-ROS generating pathway plays a key role in the  cellular apoptosis induced by a variety of drugs such as cisplatin, gentamicin, doxorubicin, cyclosporin, oxalate,  etc.",Non-OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
378 http://dx.doi.org/10.4196/kjpp.2016.20.4.367 Korean J Physiol Pharmacol 2016;20(4):367-378Hong JY et al sensitivity to cisplatin-induced cell death.,Non-OADS,/arxiv_data1/oa_pdf/39/19/kjpp-20-367.PMC4930905.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):379-385 379Korean J Physiol Pharmacol 2016;20(4):379-385 http://dx.doi.org/10.4196/kjpp.2016.20.4.379 Author contributions:  H.P .,Non-OADS,/arxiv_data1/oa_pdf/b2/32/kjpp-20-379.PMC4930906.pdf
380 http://dx.doi.org/10.4196/kjpp.2016.20.4.379 Korean J Physiol Pharmacol 2016;20(4):379-385Park H et al activities may be a useful strategy in the development of new  therapies for the treatment of many types of pain.,Non-OADS,/arxiv_data1/oa_pdf/b2/32/kjpp-20-379.PMC4930906.pdf
"382 http://dx.doi.org/10.4196/kjpp.2016.20.4.379 Korean J Physiol Pharmacol 2016;20(4):379-385Park H et al The concentrations of compounds used in this study were  lower than adult dose, as reported by U.S. Food and Drug Administration (FD A), but slightly higher than their blood concentrations.",Non-OADS,/arxiv_data1/oa_pdf/b2/32/kjpp-20-379.PMC4930906.pdf
384 http://dx.doi.org/10.4196/kjpp.2016.20.4.379 Korean J Physiol Pharmacol 2016;20(4):379-385Park H et al 1 0.,Non-OADS,/arxiv_data1/oa_pdf/b2/32/kjpp-20-379.PMC4930906.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):387-397 387Korean J Physiol Pharmacol 2016;20(4):387-397 http://dx.doi.org/10.4196/kjpp.2016.20.4.387 Author contributions:  S.I.K.,Non-OADS,/arxiv_data1/oa_pdf/3a/7c/kjpp-20-387.PMC4930907.pdf
"388 http://dx.doi.org/10.4196/kjpp.2016.20.4.387 Korean J Physiol Pharmacol 2016;20(4):387-397Kim SI et al tau, are involved in progression of AD.",OADS,/arxiv_data1/oa_pdf/3a/7c/kjpp-20-387.PMC4930907.pdf
390 http://dx.doi.org/10.4196/kjpp.2016.20.4.387 Korean J Physiol Pharmacol 2016;20(4):387-397Kim SI et al Immunocytochemistry HEK 293 cells were seeded on coverslips in 6-well plates.,OADS,/arxiv_data1/oa_pdf/3a/7c/kjpp-20-387.PMC4930907.pdf
"392 http://dx.doi.org/10.4196/kjpp.2016.20.4.387 Korean J Physiol Pharmacol 2016;20(4):387-397Kim SI et al immunoprecipitated with tau or sorcin antibody, and detected  with respective antibodies in Western blotting.",Non-OADS,/arxiv_data1/oa_pdf/3a/7c/kjpp-20-387.PMC4930907.pdf
394 http://dx.doi.org/10.4196/kjpp.2016.20.4.387 Korean J Physiol Pharmacol 2016;20(4):387-397Kim SI et al associates with fibrillogenic tau species such as GSK3 -induced  hyperphosphorylated and caspase-3-cleaved tau.,Non-OADS,/arxiv_data1/oa_pdf/3a/7c/kjpp-20-387.PMC4930907.pdf
"396 http://dx.doi.org/10.4196/kjpp.2016.20.4.387 Korean J Physiol Pharmacol 2016;20(4):387-397Kim SI et al in ER stress-induced apoptosis, we modulated sorcin expression  levels with transient transfections of sorcin construct or sorcin siRNA.",Non-OADS,/arxiv_data1/oa_pdf/3a/7c/kjpp-20-387.PMC4930907.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):399-406 399Korean J Physiol Pharmacol 2016;20(4):399-406 http://dx.doi.org/10.4196/kjpp.2016.20.4.399 Author contributions:  E.L., S.Y.C.",Non-OADS,/arxiv_data1/oa_pdf/c0/2d/kjpp-20-399.PMC4930908.pdf
400 http://dx.doi.org/10.4196/kjpp.2016.20.4.399 Korean J Physiol Pharmacol 2016;20(4):399-406Lee E et al reports demonstrate that neonatal exposure to PFHxS causes  behavioral and cognitive disturbances in adult mice [6].,Non-OADS,/arxiv_data1/oa_pdf/c0/2d/kjpp-20-399.PMC4930908.pdf
"402 http://dx.doi.org/10.4196/kjpp.2016.20.4.399 Korean J Physiol Pharmacol 2016;20(4):399-406Lee E et al AC-DEVD-CHO, respectively ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/c0/2d/kjpp-20-399.PMC4930908.pdf
"404 http://dx.doi.org/10.4196/kjpp.2016.20.4.399 Korean J Physiol Pharmacol 2016;20(4):399-406Lee E et al receptor leads to excess Ca2+ and membrane depolarization that  causes L-VGCC activation and in turn, further increase [Ca2+]i by  Ca2+-induced Ca2+ release from intracellular calcium storage  [40,41] .",Non-OADS,/arxiv_data1/oa_pdf/c0/2d/kjpp-20-399.PMC4930908.pdf
406 http://dx.doi.org/10.4196/kjpp.2016.20.4.399 Korean J Physiol Pharmacol 2016;20(4):399-406Lee E et al 33.,Non-OADS,/arxiv_data1/oa_pdf/c0/2d/kjpp-20-399.PMC4930908.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):407-414 407Korean J Physiol Pharmacol 2016;20(4):407-414 http://dx.doi.org/10.4196/kjpp.2016.20.4.407 Author contributions:  J.H.L., D.G.",Non-OADS,/arxiv_data1/oa_pdf/ae/c0/kjpp-20-407.PMC4930909.pdf
"408 http://dx.doi.org/10.4196/kjpp.2016.20.4.407 Korean J Physiol Pharmacol 2016;20(4):407-414Lee JH et al trials have also demonstrated the effect of acupuncture on  chemotherapy-induced peripheral neuropathy (CIPN) [12,13] .",Non-OADS,/arxiv_data1/oa_pdf/ae/c0/kjpp-20-407.PMC4930909.pdf
"410 http://dx.doi.org/10.4196/kjpp.2016.20.4.407 Korean J Physiol Pharmacol 2016;20(4):407-414Lee JH et al Effects of non-selective muscarinic and nicotinic  acetylcholine receptor antagonists on EA-induced anti-allodynia To assess which acetylcholine receptors mediate the suppressive  effect of EA at ST36 on cold allodynia, atropine ( non-selective muscarinic receptor antagonist) or mecamylamine (non-selective nicotinic receptor antagonist) was administered intraperitoneally to oxaliplatin-injected rats.",Non-OADS,/arxiv_data1/oa_pdf/ae/c0/kjpp-20-407.PMC4930909.pdf
"412 http://dx.doi.org/10.4196/kjpp.2016.20.4.407 Korean J Physiol Pharmacol 2016;20(4):407-414Lee JH et al in spinal anti-allodynic processes [20,22,25] .",Non-OADS,/arxiv_data1/oa_pdf/ae/c0/kjpp-20-407.PMC4930909.pdf
SUPPLEMENTARY MATERIALS Supplementary data including three figures can be found with  this article online at http://pdf.medrang.co.kr/paper/pdf/Kjpp/Kjpp020-04-10-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/c0/kjpp-20-407.PMC4930909.pdf
414 http://dx.doi.org/10.4196/kjpp.2016.20.4.407 Korean J Physiol Pharmacol 2016;20(4):407-414Lee JH et al aqueductal gray evokes the release of serotonin from spinal  cord.,Non-OADS,/arxiv_data1/oa_pdf/ae/c0/kjpp-20-407.PMC4930909.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):415-424 415Korean J Physiol Pharmacol 2016;20(4):415-424 http://dx.doi.org/10.4196/kjpp.2016.20.4.415 Author contributions:  Y.A.B.,Non-OADS,/arxiv_data1/oa_pdf/53/d6/kjpp-20-415.PMC4930910.pdf
416 http://dx.doi.org/10.4196/kjpp.2016.20.4.415 Korean J Physiol Pharmacol 2016;20(4):415-424Bae YA and Cheon HG to be diverse and need clarification.,Non-OADS,/arxiv_data1/oa_pdf/53/d6/kjpp-20-415.PMC4930910.pdf
418 http://dx.doi.org/10.4196/kjpp.2016.20.4.415 Korean J Physiol Pharmacol 2016;20(4):415-424Bae YA and Cheon HG nuclear translocation of ATF-3 after subcellular fractionation.,Non-OADS,/arxiv_data1/oa_pdf/53/d6/kjpp-20-415.PMC4930910.pdf
420 http://dx.doi.org/10.4196/kjpp.2016.20.4.415 Korean J Physiol Pharmacol 2016;20(4):415-424Bae YA and Cheon HG berberine.,Non-OADS,/arxiv_data1/oa_pdf/53/d6/kjpp-20-415.PMC4930910.pdf
"422 http://dx.doi.org/10.4196/kjpp.2016.20.4.415 Korean J Physiol Pharmacol 2016;20(4):415-424Bae YA and Cheon HG hand, ATF-3 siRNA did not affect berberine-induced AMPK  phosphorylation but blocked the suppression of proinflammatory cytokine production by berberine.",Non-OADS,/arxiv_data1/oa_pdf/53/d6/kjpp-20-415.PMC4930910.pdf
424 http://dx.doi.org/10.4196/kjpp.2016.20.4.415 Korean J Physiol Pharmacol 2016;20(4):415-424Bae YA and Cheon HG plays a crucial role in the development of obesity-related insulin  resistance.,Non-OADS,/arxiv_data1/oa_pdf/53/d6/kjpp-20-415.PMC4930910.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):425-432 425Korean J Physiol Pharmacol 2016;20(4):425-432 http://dx.doi.org/10.4196/kjpp.2016.20.4.425 Author contributions:  Y.H.P ., C.S.L., K.-A.P ., performed electrophysiological  recordings and analysis.",Non-OADS,/arxiv_data1/oa_pdf/b1/a6/kjpp-20-425.PMC4930911.pdf
426 http://dx.doi.org/10.4196/kjpp.2016.20.4.425 Korean J Physiol Pharmacol 2016;20(4):425-432Pai YH et al NMDA receptors are responsible for classical EPSCs.,Non-OADS,/arxiv_data1/oa_pdf/b1/a6/kjpp-20-425.PMC4930911.pdf
428 http://dx.doi.org/10.4196/kjpp.2016.20.4.425 Korean J Physiol Pharmacol 2016;20(4):425-432Pai YH et al NBQX ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/a6/kjpp-20-425.PMC4930911.pdf
"430 http://dx.doi.org/10.4196/kjpp.2016.20.4.425 Korean J Physiol Pharmacol 2016;20(4):425-432Pai YH et al are defined as receptors recruited in response to spontaneous  glutamate release, generating EPSCs, or during low-frequency afferent stimulation (less than 0.05 Hz), while eNMDARs correspond to those not activated during such conditions.",Non-OADS,/arxiv_data1/oa_pdf/b1/a6/kjpp-20-425.PMC4930911.pdf
432 http://dx.doi.org/10.4196/kjpp.2016.20.4.425 Korean J Physiol Pharmacol 2016;20(4):425-432Pai YH et al extrasynaptic NMDA receptors.,Non-OADS,/arxiv_data1/oa_pdf/b1/a6/kjpp-20-425.PMC4930911.pdf
www.kjpp.net Korean J Physiol Pharmacol 2016;20(4):433-440 433Korean J Physiol Pharmacol 2016;20(4):433-440 http://dx.doi.org/10.4196/kjpp.2016.20.4.433 Author contributions:  D.Y.,Non-OADS,/arxiv_data1/oa_pdf/a9/64/kjpp-20-433.PMC4930912.pdf
434 http://dx.doi.org/10.4196/kjpp.2016.20.4.433 Korean J Physiol Pharmacol 2016;20(4):433-440Park PW et al interaction and activation of NBCe1-B by IRBIT [15].,Non-OADS,/arxiv_data1/oa_pdf/a9/64/kjpp-20-433.PMC4930912.pdf
436 http://dx.doi.org/10.4196/kjpp.2016.20.4.433 Korean J Physiol Pharmacol 2016;20(4):433-440Park PW et al mutation of 4 serine residues as well as Ser 1 49 and Thr 1 72 not  existing in mIRBIT into alanine and PEST domain deletion mutant.,Non-OADS,/arxiv_data1/oa_pdf/a9/64/kjpp-20-433.PMC4930912.pdf
438 http://dx.doi.org/10.4196/kjpp.2016.20.4.433 Korean J Physiol Pharmacol 2016;20(4):433-440Park PW et al the brain.,Non-OADS,/arxiv_data1/oa_pdf/a9/64/kjpp-20-433.PMC4930912.pdf
440 http://dx.doi.org/10.4196/kjpp.2016.20.4.433 Korean J Physiol Pharmacol 2016;20(4):433-440Park PW et al WNK/SPAK kinases in regulation of the Na+-HCO3– cotransporters  family.,Non-OADS,/arxiv_data1/oa_pdf/a9/64/kjpp-20-433.PMC4930912.pdf
"]Available from URL: http://globocan.iarc.fr 2 Flegal KM, Kit BK, Orpana H, Graubard BI.",Non-OADS,/arxiv_data1/oa_pdf/d8/5c/TCA-7-387.PMC4930956.pdf
"The optimalTTAC cut-off point (measured in days) was calculated usingmaximally selected log-rank statistics (validated by maxstatpackage from R, http://mirrors.opencas.cn/cran/src/contrib/maxstat_0.7-23.tar.gz).",OADS,/arxiv_data1/oa_pdf/4b/b5/TCA-7-399.PMC4930958.pdf
"Availablefrom URL: http://www.cochrane-handbook.org 15 Sugio K, Uramoto H, Onitsuka T et al .",OADS,/arxiv_data1/oa_pdf/46/0b/TCA-7-406.PMC4930959.pdf
"National Cancer Institute,Bethesda, MD 2006 [Cited 14 Jan 2014] Available fromURL: http://ctep.cancer.gov/protocolDevelopment/ electronic_applications/docs/ctcaev3.pdf 17 Iyer L, King CD, Whitington PF et al.",OADS,/arxiv_data1/oa_pdf/53/3c/TCA-7-467.PMC4930967.pdf
"Design and screening of small activating ribonucleic acid (saRNA) Following the guidelines provided by existing literature and using Ambion software (http://www.ambion.com/tech- lib/misc/siRNA_ ﬁnder.html), we designed ﬁve pairs of small double-stranded RNAs (dsRNA) that could activate the PTEN gene.13,14We used dsRNA non-homologous to the whole human genome as the control small activatingribonucleic acid (saRNA; Table 1).",OADS,/arxiv_data1/oa_pdf/42/d1/TCA-7-481.PMC4930969.pdf
"105 Lab Anim Res 2016: 32(2), 105-115 http://dx.doi.org/10.5625/lar.2016.32.2.105ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Beneficial effect of diosgenin as a stimulator of NGF on the brain  with neuronal damage induced by A β-42 accumulation and  neurotoxican t injection Eun-Kyoung Koh1,†, Woo-Bin Yun1,†, Ji-Eun Kim1, Sung-Hwa Song1, Ji-Eun Sung1, Hyun-Ah Lee1, Eun-Ji Seo1, Seung-Wan Jee2, Chang-Joon Bae2,*, Dae-Youn Hwang1,* 1Department of Biomaterials Science, College of Natural Resources and Life Science/Life and  Industry Convergence Research Institute, Pusan National University, Miryang, Korea 2Biologics Division, Ministry of Food and Drug Administration (MFDS), Cheongju, Korea To investigate the beneficial effects of diosgenin (DG) on the multiple types of brain damage induced by Aβ-42 peptides and neurotoxicants, alterations in the specific aspects of brain functions were measured in trimethyltin (TMT)-injected transgenic 2576 (TG) mice that had been pretreated with DG for 21 days.Multiple types of damage were successfully induced by A β-42 accumulation and TMT injection into the brains of TG mice.",OADS,/arxiv_data1/oa_pdf/c0/07/lar-32-105.PMC4931034.pdf
"116 Lab Anim Res 2016: 32(2), 116-121 http://dx.doi.org/10.5625/lar.2016.32.2.116ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Establishment of a mouse model of 70% lethal dose by total-body irradiation Seung-Hyun Ryu1,#, Jong-Hyung Park1,#, Eui-Suk Jeong1,2, Soo-Young Choi1, Seung-Hoon Ham1, Jin-Il Park1,  Hee-Yeon Jeon1, Jun-Young Kim1, Ran-Ji Yoo3, Yong-Jin Lee3, Sang-KeunWoo3, Yang-Kyu Choi1,* 1Department of Laboratory Animal Medicine, College of Veterinary Medicine, Konkuk University, Seoul, Korea 2Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea 3Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, Seoul, Korea Whereas increasing concerns about radiation exposure to nuclear disasters or side effects of anticancer radiotherapy, relatively little research for radiation damages or remedy has been done.",Non-OADS,/arxiv_data1/oa_pdf/43/d8/lar-32-116.PMC4931035.pdf
"122 Lab Anim Res 2016: 32(2), 122-127 http://dx.doi.org/10.5625/lar.2016.32.2.122ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Detection of Helicobacter felis  in a cat with gastric disease in  laboratory animal facility Sunhwa Hong1, Yungho Chung2, Won-Guk Kang3, Okjin Kim1,3,* 1Center for Animal Resource Development, Wonkwang University, 460 Iksandae-ro, Iksan, Korea 2Department of Companion Animal and Animal Resources Science, Joongbu University, 201 Daehakro, Geumsan-gun, Korea 3Graduate School of Applied Animal Science, Wonkwang University, 460 Iksandaero, Iksan, Korea A 3-month-old male cat in the animal facility was presented for investigation of anorexia and occasional vomiting.",Non-OADS,/arxiv_data1/oa_pdf/19/c3/lar-32-122.PMC4931036.pdf
"128 Lab Anim Res 2016: 32(2), 128-132 http://dx.doi.org/10.5625/lar.2016.32.2.128ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Differential expression of estrogen receptor α and progesterone  receptor in the normal and cryptorchid testis of a dog Hyo Young Jung1,5, Dae Young Yoo1,5, Young Kwang Jo2,5, Geon A Kim2,5, Jin Young Chung3, Jung Hoon Choi4, Goo Jang2,5,6,7,*, In Koo Hwang1,5,* 1Department of Anatomy and Cell Biology, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea 2Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea 3Department of Veterinary Internal Medicine and Geriatrics, College of Veterinary Medicine, Kangwon National University,  Chuncheon 24341, Korea 4Department of Anatomy, College of Veterinary Medicine, Kangwon National University, Chuncheon 24341, Korea 5BK21 PLUS Program for Creative Veterinary Science Research, and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Korea 6Institute of Green Bio Science & Technology, Seoul National University, Pyeong Chang, Kangwon do, Korea 7Emergence Center for Food-Medicine Personalized Therapy System, Advanced Institutes of Convergence Technology, Seoul National University, Gyeonggi-do, Korea Descending of the testes is an important process for spermatogenesis and cryptorchidism is one of the most relevant genital defects in dogs.",Non-OADS,/arxiv_data1/oa_pdf/e7/10/lar-32-128.PMC4931037.pdf
"133 Lab Anim Res 2016: 32(2), 133 http://dx.doi.org/10.5625/lar.2016.32.2.133ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Rapid and efficient identification of the mouse leptin receptor  mutation (C57BLKS/J- Leprdb) by tetra-primer amplification refractory  mutation system-polymerase chain reaction (ARMS-PCR) analysis Harry Jung1, Hajin Nam2, Jun-Gyo Suh1,2,* 1Laboratory Animal Center/Department of Medical Genetics, College of Medicine, Hallym University, Chuncheon, Korea 2Institute of Natural Medicine, Hallym University, Chuncheon, Korea We designed 4 primers for amplification of allele- specific PCR products from leptin receptor mutant and normal alleles using primer design web service for tetra-primer ARMS-PCR (Figure 1) i.e., Lepr-forward outer primer (Lepr-FO); 5'-AGGATACAATACAAGAACAA AAAGCCTG-3', Lepr-forward inner primer (Lepr-FI);5'-TATTAGAAGATGTTTACATTTTGATGGAGGG-3', Lepr-reverse inner primer (Lepr-RI); 5'-GTCATTCAAA CCATAGTTTAGGTTTGTTTA-3', Lepr-reverse outer primer(Lepr-RO); 5'-ATGCAGAGTCCATGAATATCAACTTT AA-3'.Erratum *Corresponding author: Jun-Gyo Suh, Laboratory Animal Center/Department of Medical Genetics, College of Medicine, Hallym University, Chuncheon, Gangwon-do 24252, Korea Tel: +82-33-248-2692; Fax: +82-33-248-2690; E-mail: jgsuh@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original w ork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/3c/lar-32-133.PMC4931038.pdf
"134 Lab Anim Res 2016: 32(2), 134 http://dx.doi.org/10.5625/lar.2016.32.2.134ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Specific nephrotoxicity and cardiotoxicity of BT-CAL®, Sigma Anti-bonding Molecule Calcium Carbonate, in mice Ja-Young Jang#, Jingmei Cai#, Jihyun Kim, Jangbeen Kyung, Dajeong Kim, Ehn-Kyoung Choi, Youngeun Kim, Kwang-Sei Kim, Dongsun Park, Hyun-Gu Kang, Yun-Bae Kim* College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea I, as a corresponding author, regret to withdraw our paper entitled “Specific nephrotoxicity and cardiotoxicity of BT-Cal®, Sigma Anti-bonding Molecule Calcium Carbonate, in mice”, which was published in the Laboratory Animal Research 2013; 29(1): 7-11.",Non-OADS,/arxiv_data1/oa_pdf/f4/71/lar-32-134.PMC4931039.pdf
"79 Lab Anim Res 2016: 32(2), 79-86 http://dx.doi.org/10.5625/lar.2016.32.2.79ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Reference values of clinical path ology parameters in cynomolgus  monkeys ( Macaca fascicularis ) used in preclinical studies Hyun-Kyu Park1, Jae-Woo Cho1, Byoung-Seok Lee1, Heejin Park1, Ji-Seok Han1, Mi-Jin Yang2, Wan-Jung Im1, Do-Yong Park1, Woo-Jin Kim1, Su-Cheol Han3, Yong-Bum Kim1,* 1Pathology Research Center, Korea Institute of Toxicology (KIT), 141 Gajeongro, Yuseong-Gu, Daejeon, Korea 2Pathology Research Center, Korea Institute of Toxicology (KIT), 30 Baekhak 1-gil, Jeongeup, Jeonbuk, Korea 3General Toxicology Research Center, Korea Institute of Toxicology (KIT), 30 Baekhak 1-gil, Jeongeup, Jeonbuk, Korea Nonhuman primates are increasingly used in biomedical research since they are highly homologous to humans compared to other rodent animals.",Non-OADS,/arxiv_data1/oa_pdf/29/31/lar-32-79.PMC4931040.pdf
"87 Lab Anim Res 2016: 32(2), 87-90 http://dx.doi.org/10.5625/lar.2016.32.2.87ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Antimicrobial activity of essential oil of Eucalyptus globulus against fish pathogenic bacteria Joon-Woo Park, Mitchell Wendt, Gang-Joon Heo* College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea The antibacterial activities of the essential oil of Eucalyptus globulus (EOEG) was determined against 7 fish pathogenic bacteria ( Edwardsiella tarda , Streptococcus iniae , S. parauberis , Lactococcus garviae , Vibrio harveyi , V. ichthyoenteri  and Photobacterium damselae ) obtained from farmed olive flounder.",OADS,/arxiv_data1/oa_pdf/89/88/lar-32-87.PMC4931041.pdf
"91 Lab Anim Res 2016: 32(2), 91-98 http://dx.doi.org/10.5625/lar.2016.32.2.91ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Anti-inflammatory effect of  egg white-cha lcanthite and purple bamboo salts mixture on arthritis induced by monosodium iodoacetate in Sprague-Dawley rats Tae-Hee Lee1,2, Hyun-kyung Song1, Ja-Young Jang2, Dong-Yoon Kim1, Hyun-Kyung Park1, Eun-A Choi3, Beom-Seok Han1,2,* 1Department of Bio Applied Toxicology, Graduate school of Hoseo University, Asan, Korea 2Hoseo Toxicological Research Center, Hoseo University, Asan, Korea 3Insan Bamboo Salt Inc. and Insan Korean Medical Cancer Clinic, Hamyang, Korea The aim of this study is to investigate the potential of anti-osteoarthritis effects on egg white-chalcanthite (EC), purple bamboo salts (PBS), and a mixture of EC and PBS (EC+PBS).",Non-OADS,/arxiv_data1/oa_pdf/bb/54/lar-32-91.PMC4931042.pdf
"99 Lab Anim Res 2016: 32(2), 99-104 http://dx.doi.org/10.5625/lar.2016.32.2.99ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Anti-Helicobacter pylori  activity of crude N-acetylneuraminic acid  isolated from glycomacropeptide of whey Dong-Jae Kim1, Min-Jung Kang2, Jin-A Choi3, Dae-Seung Na4, Jin-Beom Kim4, Chun-Soo Na4, Jong-Hwan Park2,* 1Laboratory Animal Resource Center, Daegu Gyeongbuk Institute of Science & Technology (DGIST), Daegu, Korea 2Laboratory Animal Medicine and Brain Korea 21 PLUS Project, College of Veterinary Medicine, Chonnam National University,  Gwangju, Korea 3Department of Biochemistry, College of Medicine, Konyang University, Daejeon, Korea 4Lifetree Biotechnology Institute, Lifetree Bitotech Co. Ltd., Gyeonggi, Korea Helicobacter pylori  colonizes the gastric mucosa of about half of the world’s population, causing chronic gastritis and gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/03/aa/lar-32-99.PMC4931043.pdf
Public access to the database is available at http://www.genome.med.kyoto-u.ac.jp/SnpDB/.,OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
The main functional steps of these pipelines were asfollows: the sequences obtained from the individuals were aligned to thereference genome (NCBI Build 37/hg19) using the Burrows –Wheeler Aligner 9 or Novoalign (http://www.novocraft.com/).,OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
"Downstream processes included the removal of potential PCR duplicates, recalibration of base quality values,local realignment and variation call were analyzed using Samtools, 10Picard (http://broadinstitute.github.io/picard/) and GATK.11The variations that were likely to be false -positive calls were ﬁltered by optimization criteria drawn up at each center (Supplementary Table 2).",OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
"22 Fixation index calculation We calculated unbiased estimates of ﬁxation index (F ST)a sd e s c r i b e d previously.23For the calculation, allele frequencies in African Americans and European Americans were downloaded from the Exome Sequencing Project website (http://evs.gs.washington.edu/EVS/, ESP6500SI).",OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
The HGVD is freely accessible via the internet at http://www.genome.med.kyoto-u.ac.jp/SnpDB.,OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
"The database is developed with PostgreSQL (version 9.1.3) relational database, and the graphical user interface developed on JBrowse 1.4 (http://jbrowse.org/) is accessible on an Apache 2.2.3 server (https:// httpd.apache.org/).",OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
"For further genomics studies, their individual genotypes are available through the National Bioscience Database Center (http://humandbs.biosciencedbc.jp/en/, hum0012).Furthermore, we have also integrated the results of expression-QTL analysis, based on transcriptome data from individuals whose geno- typing and exome sequencing data are available.",OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Human genetic variation database KH i g a s a et al 553 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/jhg201612a.PMC4931044.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg) deletion 60% duplication 5%duplication 5%point mutation 27%consecutive  bases  (insertion) 1%unknown 2% Figure 4 The mutational spectrum from our in-house data and reported data.Genetic diagnosis of Duchenne/Becker muscular dystrophy M Okubo et al 489 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/21/82/jhg20167a.PMC4931045.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055756.115.© 2016 Deng et al.,OADS,/arxiv_data1/oa_pdf/15/20/1109.PMC4931104.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 22:1109 –1119; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1109",Non-OADS,/arxiv_data1/oa_pdf/15/20/1109.PMC4931104.pdf
"Availability The source code, which is available for download from http://bme.ucdavis.edu/aviranlab/rnaprob_software, is freely available for non-commercial use.",OADS,/arxiv_data1/oa_pdf/15/20/1109.PMC4931104.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.056705.116.© 2016 Ramesh and Woolford This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/6a/3b/1153.PMC4931108.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT RNA 22:1153 –1162; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1153",Non-OADS,/arxiv_data1/oa_pdf/6a/3b/1153.PMC4931108.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057505.116.© 2016 Keppetipola et al.,OADS,/arxiv_data1/oa_pdf/6e/94/1172.PMC4931110.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 1172 RNA 22:1172 –1180; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/6e/94/1172.PMC4931110.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054817.115.© 2016 Pawlica et al.,OADS,/arxiv_data1/oa_pdf/5d/e6/1181.PMC4931111.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5d/e6/1181.PMC4931111.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT RNA 22:1181 –1189; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1181",Non-OADS,/arxiv_data1/oa_pdf/5d/e6/1181.PMC4931111.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.056242.116.© 2016 Lopes et al.,OADS,/arxiv_data1/oa_pdf/13/72/1190.PMC4931112.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/13/72/1190.PMC4931112.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/13/72/1190.PMC4931112.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057224.116.© 2016 Eshleman et al.,OADS,/arxiv_data1/oa_pdf/3a/af/1200.PMC4931113.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3a/af/1200.PMC4931113.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3a/af/1200.PMC4931113.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057208.116.© 2016 Garcia et al.,OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
2011) (http://www.modencode.org/).,Non-OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
The heatmap was generated with the “pheatmap ” package from bioconductor (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
2002) and are accessible through GEO Series accession num- ber GSE49587 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49587).,OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
The additional data discussed in this publicationare accessible through GEO Series accession number GSE81121(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81121).,OADS,/arxiv_data1/oa_pdf/6e/94/1215.PMC4931114.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057299.116.© 2016 Eckwahl et al.,OADS,/arxiv_data1/oa_pdf/c0/04/1228.PMC4931115.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c0/04/1228.PMC4931115.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/c0/04/1228.PMC4931115.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.056077.116.© 2016 Chung et al.,OADS,/arxiv_data1/oa_pdf/7a/f1/1239.PMC4931116.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/1239.PMC4931116.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/7a/f1/1239.PMC4931116.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057265.116.© 2016 Hirschi et al.,OADS,/arxiv_data1/oa_pdf/01/a8/1250.PMC4931117.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/01/a8/1250.PMC4931117.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/01/a8/1250.PMC4931117.pdf
"The integrated vol-ume for each signal was determined by measuring the identical areathat encompasses the probe-only control with minimal background.Results of oligonucleotide binding assays were expressed as thefraction of oligonucleotide bound and plotted as a function ofprotein concentration using Prism 6.0 (GraphPad Software, Inc.,http://www.graphpad.com).",OADS,/arxiv_data1/oa_pdf/01/a8/1250.PMC4931117.pdf
"Kinetic data were fitted to a Michaelis –Menten equation us- ing GraphPad Prism 6.0 (GraphPad Software, Inc., http://www.graphpad.com).",OADS,/arxiv_data1/oa_pdf/01/a8/1250.PMC4931117.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.056218.116.© 2016 Schureck et al.,OADS,/arxiv_data1/oa_pdf/25/53/1261.PMC4931118.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/25/53/1261.PMC4931118.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/25/53/1261.PMC4931118.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.056184.116.© 2016 Rupani and Connell This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e8/d1/1271.PMC4931119.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/e8/d1/1271.PMC4931119.pdf
"DNA fragments were elec-trophoresed on a 1.5% agarose gel at 120 V for 0.5 –2 h. For each lane in the gel image, Image J (http://imagej.nih.gov/ij/) was usedto extract the X and Y coordinates for the density histogram.",OADS,/arxiv_data1/oa_pdf/bd/16/EMBJ-35-1465.PMC4931181.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdEDITORIAL Tan http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JDI-7-445.PMC4931190.pdf
4 July 2016 447EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Editorial,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JDI-7-445.PMC4931190.pdf
"4 July 2016 449REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Redox, C-peptide and SIRT1-LKB1-AMPK",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Ido http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"4 July 2016 451REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Redox, C-peptide and SIRT1-LKB1-AMPK",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Ido http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"4 July 2016 453REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Redox, C-peptide and SIRT1-LKB1-AMPK",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Ido http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"4 July 2016 455REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Redox, C-peptide and SIRT1-LKB1-AMPK",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Ido http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"4 July 2016 457REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Redox, C-peptide and SIRT1-LKB1-AMPK",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Ido http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/JDI-7-448.PMC4931191.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JDI-7-459.PMC4931192.pdf
4 July 2016 461MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Role of ZnT8 in T1DM and T2DM,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JDI-7-459.PMC4931192.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JDI-7-459.PMC4931192.pdf
4 July 2016 463MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Role of ZnT8 in T1DM and T2DM,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JDI-7-459.PMC4931192.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JDI-7-459.PMC4931192.pdf
4 July 2016 465MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Role of ZnT8 in T1DM and T2DM,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JDI-7-459.PMC4931192.pdf
4 July 2016 467COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Is ghrelin a GLP-1 secretagogue?,Non-OADS,/arxiv_data1/oa_pdf/cf/64/JDI-7-466.PMC4931193.pdf
4 July 2016 469COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Troponin T and diabetes,Non-OADS,/arxiv_data1/oa_pdf/d8/57/JDI-7-468.PMC4931194.pdf
4 July 2016 471COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Adiponectin and nephropathy,Non-OADS,/arxiv_data1/oa_pdf/2b/34/JDI-7-470.PMC4931195.pdf
4 July 2016 473COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Parental smoking and type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/68/a3/JDI-7-472.PMC4931196.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdCOMMENTARY Chang and Chuang http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/68/a3/JDI-7-472.PMC4931196.pdf
4 July 2016 475COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Parental smoking and type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/68/a3/JDI-7-472.PMC4931196.pdf
4 July 2016 477ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet grafts for diabetes,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
4 July 2016 479ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet grafts for diabetes,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
4 July 2016 481ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet grafts for diabetes,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
4 July 2016 483ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet grafts for diabetes,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f1/12/JDI-7-476.PMC4931197.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
4 July 2016 487ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Immunomodulation of DPSC transplantation,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
4 July 2016 489ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Immunomodulation of DPSC transplantation,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
4 July 2016 491ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Immunomodulation of DPSC transplantation,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
4 July 2016 493ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Immunomodulation of DPSC transplantation,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
4 July 2016 495ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Immunomodulation of DPSC transplantation,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/JDI-7-485.PMC4931198.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
4 July 2016 499ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GIP suppresses periodontitis,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
4 July 2016 501ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GIP suppresses periodontitis,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
4 July 2016 503ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GIP suppresses periodontitis,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
4 July 2016 505ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GIP suppresses periodontitis,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JDI-7-497.PMC4931199.pdf
4 July 2016 507ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Propolis effects in diabetic rat,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
4 July 2016 509ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Propolis effects in diabetic rat,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
4 July 2016 511ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Propolis effects in diabetic rat,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
4 July 2016 513ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Propolis effects in diabetic rat,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/JDI-7-506.PMC4931200.pdf
4 July 2016 515ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A*33-DR3 /DR9enhance the risk of T1D,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
4 July 2016 517ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A*33-DR3 /DR9enhance the risk of T1D,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
4 July 2016 519ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A*33-DR3 /DR9enhance the risk of T1D,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
4 July 2016 521ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A*33-DR3 /DR9enhance the risk of T1D,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JDI-7-514.PMC4931201.pdf
4 July 2016 523ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Osteocalcin and glucose metabolism,Non-OADS,/arxiv_data1/oa_pdf/27/38/JDI-7-522.PMC4931202.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/27/38/JDI-7-522.PMC4931202.pdf
4 July 2016 525ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Osteocalcin and glucose metabolism,Non-OADS,/arxiv_data1/oa_pdf/27/38/JDI-7-522.PMC4931202.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/27/38/JDI-7-522.PMC4931202.pdf
4 July 2016 527ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Osteocalcin and glucose metabolism,Non-OADS,/arxiv_data1/oa_pdf/27/38/JDI-7-522.PMC4931202.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/27/38/JDI-7-522.PMC4931202.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
4 July 2016 531ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle of type 2 diabetes patients,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
4 July 2016 533ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle of type 2 diabetes patients,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
4 July 2016 535ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle of type 2 diabetes patients,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
4 July 2016 537ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle of type 2 diabetes patients,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/25/91/JDI-7-529.PMC4931203.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bf/4f/JDI-7-539.PMC4931204.pdf
4 July 2016 541CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Quality improvement of diabetes care,Non-OADS,/arxiv_data1/oa_pdf/bf/4f/JDI-7-539.PMC4931204.pdf
